Acute Myeloid Leukemia	ABL2 (6):	--2-- |  179_5-Fluorouracil_GDSC1(3) |  1187_CCT245232_GDSC1(4) | Acute Myeloid Leukemia	ALK (10):	--4-- |  172_Embelin_GDSC1(3) |  375_Voxtalisib_GDSC1(5) |  1030_KU-55933_GDSC1(4) |  1813_Fludarabine_GDSC2(2) | Acute Myeloid Leukemia	ARID3B (4):	--3-- |  45_Z-LLNle-CHO_GDSC1(1) |  229_Enzastaurin_GDSC1(2) |  1088_Irinotecan_GDSC2(2) | Acute Myeloid Leukemia	BRD4 (6):	--2-- |  301_PHA-793887_GDSC1(4) |  1617_AZD5582_GDSC2(2) | Acute Myeloid Leukemia	CARD11 (6):	--3-- |  45_Z-LLNle-CHO_GDSC1(2) |  1008_Methotrexate_GDSC1(2) |  1786_AZD4547_GDSC2(4) | Acute Myeloid Leukemia	CSF3R (8):	--3-- |  265_Tubastatin A_GDSC1(2) |  1248_Daporinad_GDSC1(5) |  1560_Alpelisib_GDSC2(4) | Acute Myeloid Leukemia	DNMT1 (13):	--4-- |  41_S-Trityl-L-cysteine_GDSC1(6) |  172_Embelin_GDSC1(3) |  1008_Methotrexate_GDSC1(7) |  1618_GSK2606414_GDSC2(8) | Acute Myeloid Leukemia	EIF4A2 (8):	--3-- |  330_XMD13-2_GDSC1(4) |  476_SB505124_GDSC1(5) |  2046_MK-8776_GDSC2(4) | Acute Myeloid Leukemia	ERG (6):	--3-- |  406_LIMK1 inhibitor BMS4_GDSC1(2) |  427_Ara-G_GDSC1(3) |  1829_667880_GDSC2(2) | Acute Myeloid Leukemia	ESR1 (6):	--2-- |  1013_Nilotinib_GDSC1(3) |  1449_AZD1208_GDSC1(4) | Acute Myeloid Leukemia	ETV1 (8):	--2-- |  277_Linifanib_GDSC1(5) |  1049_PD173074_GDSC1(4) | Acute Myeloid Leukemia	FGFR4 (5):	--2-- |  219_AT-7519_GDSC1(3) |  1733_ULK1_4989_GDSC2(2) | Acute Myeloid Leukemia	FYN (3):	--2-- |  312_Tivozanib_GDSC1(2) |  1023_GW441756_GDSC1(2) | Acute Myeloid Leukemia	GATA2 (3):	--3-- |  1011_Navitoclax_GDSC2(1) |  1494_SN-38_GDSC2(1) |  1922_Cediranib_GDSC2(1) | Acute Myeloid Leukemia	GNA12 (5):	--2-- |  1030_KU-55933_GDSC1(4) |  2037_GSK343_GDSC2(2) | Acute Myeloid Leukemia	HGF (5):	--2-- |  265_Tubastatin A_GDSC1(2) |  1365_BAY-HDAC11_2_GDSC1(3) | Acute Myeloid Leukemia	IGF1R (6):	--3-- |  127_GSK269962A_GDSC1(4) |  199_Pazopanib_GDSC1(3) |  1136_Capivasertib_GDSC1(2) | Acute Myeloid Leukemia	IL7R (3):	--2-- |  159_HG6-64-1_GDSC1(1) |  1931_MIRA-1_GDSC2(2) | Acute Myeloid Leukemia	INSR (8):	--4-- |  177_GSK650394_GDSC1(2) |  265_Tubastatin A_GDSC1(3) |  1030_KU-55933_GDSC1(4) |  1529_Pevonedistat_GDSC1(3) | Acute Myeloid Leukemia	KIT (7):	--4-- |  88_Entinostat_GDSC1(3) |  134_Etoposide_GDSC1(4) |  1393_Gemcitabine_GDSC1(2) |  1088_Irinotecan_GDSC2(3) | Acute Myeloid Leukemia	MAP4K4 (7):	--4-- |  1187_CCT245232_GDSC1(4) |  1266_ICL1100013_GDSC1(2) |  1813_Fludarabine_GDSC2(2) |  1940_WIKI4_GDSC2(3) | Acute Myeloid Leukemia	MDM2 (5):	--3-- |  380_BIBF-1120_GDSC1(2) |  1037_BX795_GDSC1(2) |  1007_Docetaxel_GDSC2(2) | Acute Myeloid Leukemia	MGAM (18):	--4-- |  127_GSK269962A_GDSC1(7) |  172_Embelin_GDSC1(7) |  254_Quizartinib_GDSC1(9) |  1618_GSK2606414_GDSC2(9) | Acute Myeloid Leukemia	MLLT3 (6):	--2-- |  546_FTY-720_GDSC1(4) |  2011_ICL-SIRT078_GDSC2(3) | Acute Myeloid Leukemia	MST1R (3):	--2-- |  59_WZ-1-84_GDSC1(2) |  236_IC-87114_GDSC1(2) | Acute Myeloid Leukemia	MYBL1 (7):	--2-- |  1375_Temozolomide_GDSC2(5) |  2011_ICL-SIRT078_GDSC2(3) | Acute Myeloid Leukemia	NR4A3 (5):	--3-- |  301_PHA-793887_GDSC1(3) |  1184_AZ20_GDSC1(3) |  1835_Elephantin_GDSC2(1) | Acute Myeloid Leukemia	NT5C2 (6):	--2-- |  1463_AZD1332_GDSC2(4) |  2011_ICL-SIRT078_GDSC2(3) | Acute Myeloid Leukemia	NTRK3 (11):	--2-- |  221_TAK-715_GDSC1(9) |  254_Quizartinib_GDSC1(7) | Acute Myeloid Leukemia	NUP98 (10):	--3-- |  151_QS11_GDSC1(3) |  437_Trichostatin A_GDSC1(5) |  1428_IAP_5620_GDSC1(5) | Acute Myeloid Leukemia	PAX8 (4):	--3-- |  229_Enzastaurin_GDSC1(2) |  1250_AZ960_GDSC2(2) |  1733_ULK1_4989_GDSC2(2) | Acute Myeloid Leukemia	PIK3CB (5):	--2-- |  199_Pazopanib_GDSC1(3) |  206_Ruxolitinib_GDSC1(3) | Acute Myeloid Leukemia	PIK3CD (3):	--2-- |  437_Trichostatin A_GDSC1(1) |  1084_Rapamycin_GDSC2(2) | Acute Myeloid Leukemia	PLCG1 (7):	--3-- |  292_Masitinib_GDSC1(3) |  1459_PARP_0108_GDSC1(3) |  1560_Alpelisib_GDSC2(4) | Acute Myeloid Leukemia	PLCG2 (10):	--2-- |  104_Bortezomib_GDSC1(6) |  1049_PD173074_GDSC2(7) | Acute Myeloid Leukemia	RICTOR (6):	--3-- |  292_Masitinib_GDSC1(3) |  1073_5-Fluorouracil_GDSC2(2) |  1249_BMS-345541_GDSC2(2) | Acute Myeloid Leukemia	TSHR (9):	--2-- |  1498_Selumetinib_GDSC1(3) |  1494_SN-38_GDSC2(6) | Acute Myeloid Leukemia	VAV1 (11):	--2-- |  41_S-Trityl-L-cysteine_GDSC1(5) |  1254_GSK-J4_GDSC1(8) | B-Cell Non-Hodgkin's Lymphoma	ABL1 (7):	--3-- |  432_Flavopiridol_GDSC1(4) |  1031_Elesclomol_GDSC1(3) |  1187_CCT245232_GDSC1(3) | B-Cell Non-Hodgkin's Lymphoma	AKT1 (6):	--2-- |  1038_NU7441_GDSC1(4) |  1377_Afatinib_GDSC1(3) | B-Cell Non-Hodgkin's Lymphoma	AKT3 (6):	--3-- |  38_Saracatinib_GDSC1(3) |  412_Venotoclax_GDSC1(4) |  1622_Wnt-C59_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	AXL (5):	--2-- |  197_Bryostatin 1_GDSC1(2) |  1168_Erlotinib_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	BCL2 (13):	--3-- |  412_Venotoclax_GDSC1(8) |  1394_AZD6738_GDSC1(6) |  1909_Venetoclax_GDSC2(8) | B-Cell Non-Hodgkin's Lymphoma	BRAF (6):	--2-- |  1261_rTRAIL_GDSC1(4) |  1931_MIRA-1_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	BRD3 (7):	--2-- |  1030_KU-55933_GDSC1(4) |  1494_SN-38_GDSC2(5) | B-Cell Non-Hodgkin's Lymphoma	CARD11 (8):	--2-- |  416_CAY10566_GDSC1(5) |  1494_SN-38_GDSC2(6) | B-Cell Non-Hodgkin's Lymphoma	CDK6 (3):	--3-- |  190_Bleomycin_GDSC1(1) |  301_PHA-793887_GDSC1(1) |  1250_AZ960_GDSC2(1) | B-Cell Non-Hodgkin's Lymphoma	COP1 (9):	--3-- |  152_CP466722_GDSC1(4) |  1042_Doramapimod_GDSC2(4) |  1910_ABT737_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	DDR2 (4):	--2-- |  206_Ruxolitinib_GDSC1(2) |  1042_Doramapimod_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	DDX4 (7):	--2-- |  1003_Camptothecin_GDSC2(5) |  1080_Paclitaxel_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	DOT1L (13):	--3-- |  1236_UNC0638_GDSC1(9) |  1259_Talazoparib_GDSC2(6) |  1624_I-BET-762_GDSC2(7) | B-Cell Non-Hodgkin's Lymphoma	E2F3 (3):	--2-- |  1017_Olaparib_GDSC1(2) |  1362_BAY ACCi_GDSC1(2) | B-Cell Non-Hodgkin's Lymphoma	EZH1 (7):	--2-- |  416_CAY10566_GDSC1(4) |  1003_Camptothecin_GDSC2(5) | B-Cell Non-Hodgkin's Lymphoma	FGFR2 (8):	--2-- |  1003_Camptothecin_GDSC2(6) |  1912_Afuresertib_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	FLT4 (12):	--2-- |  1419_FEN1_3940_GDSC1(7) |  1564_SCH772984_GDSC2(7) | B-Cell Non-Hodgkin's Lymphoma	GNB1 (6):	--2-- |  38_Saracatinib_GDSC1(3) |  1030_KU-55933_GDSC1(4) | B-Cell Non-Hodgkin's Lymphoma	GTF2I (6):	--2-- |  416_CAY10566_GDSC1(4) |  1003_Camptothecin_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	H2AC17 (3):	--2-- |  253_XMD14-99_GDSC1(2) |  1251_N22899-6-C1_GDSC1(2) | B-Cell Non-Hodgkin's Lymphoma	HGF (10):	--4-- |  35_NVP-TAE684_GDSC1(4) |  416_CAY10566_GDSC1(6) |  1046_Wee1 Inhibitor_GDSC1(5) |  1378_Bleomycin (50 uM)_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	HMGA2 (6):	--3-- |  288_WHI-P97_GDSC1(2) |  1003_Camptothecin_GDSC2(4) |  1014_Refametinib_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	IGF1R (5):	--2-- |  1053_MK-2206_GDSC2(2) |  1829_667880_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	IKBKE (3):	--2-- |  1020_Lenalidomide_GDSC2(2) |  1042_Doramapimod_GDSC2(2) | B-Cell Non-Hodgkin's Lymphoma	INSR (12):	--3-- |  416_CAY10566_GDSC1(6) |  1372_Trametinib_GDSC2(4) |  1912_Afuresertib_GDSC2(7) | B-Cell Non-Hodgkin's Lymphoma	KDR (9):	--3-- |  29_AZ628_GDSC1(5) |  238_Idelalisib_GDSC1(6) |  1451_PLK_6522_GDSC1(3) | B-Cell Non-Hodgkin's Lymphoma	LRP6 (10):	--3-- |  175_PAC-1_GDSC1(6) |  1089_Oxaliplatin_GDSC2(6) |  1631_PRT062607_GDSC2(5) | B-Cell Non-Hodgkin's Lymphoma	MDM2 (6):	--3-- |  288_WHI-P97_GDSC1(2) |  1014_Refametinib_GDSC2(4) |  2110_GSK591_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	MKI67 (11):	--3-- |  1236_UNC0638_GDSC1(7) |  1016_Temsirolimus_GDSC2(4) |  1917_AZD6738_GDSC2(8) | B-Cell Non-Hodgkin's Lymphoma	MPL (4):	--2-- |  1251_N22899-6-C1_GDSC1(2) |  1268_XAV939_GDSC2(2) | B-Cell Non-Hodgkin's Lymphoma	MYBL1 (6):	--2-- |  1017_Olaparib_GDSC1(2) |  1564_SCH772984_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	NR4A3 (5):	--2-- |  1003_Camptothecin_GDSC2(3) |  1131_PRIMA-1MET_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	NSD2 (8):	--2-- |  1003_Camptothecin_GDSC2(6) |  1561_Taselisib_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	NTRK3 (9):	--3-- |  1419_FEN1_3940_GDSC1(4) |  1050_ZM447439_GDSC2(5) |  1058_Pictilisib_GDSC2(5) | B-Cell Non-Hodgkin's Lymphoma	NUP214 (5):	--3-- |  1003_Camptothecin_GDSC2(3) |  1441_AZD2014_GDSC2(1) |  1624_I-BET-762_GDSC2(2) | B-Cell Non-Hodgkin's Lymphoma	PAK5 (7):	--2-- |  1003_Camptothecin_GDSC2(5) |  1058_Pictilisib_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	PDGFRA (7):	--2-- |  282_Pelitinib_GDSC1(4) |  1089_Oxaliplatin_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	PDGFRB (9):	--2-- |  306_Fedratinib_GDSC1(6) |  1419_FEN1_3940_GDSC1(4) | B-Cell Non-Hodgkin's Lymphoma	PIK3CB (6):	--3-- |  282_Pelitinib_GDSC1(4) |  288_WHI-P97_GDSC1(2) |  1003_Camptothecin_GDSC2(4) | B-Cell Non-Hodgkin's Lymphoma	PIK3CG (8):	--2-- |  1419_FEN1_3940_GDSC1(4) |  1564_SCH772984_GDSC2(5) | B-Cell Non-Hodgkin's Lymphoma	PLCG1 (7):	--3-- |  35_NVP-TAE684_GDSC1(3) |  332_XMD15-27_GDSC1(2) |  1367_BAY-HDAC11_4_GDSC1(3) | B-Cell Non-Hodgkin's Lymphoma	ROS1 (11):	--3-- |  416_CAY10566_GDSC1(6) |  1042_Doramapimod_GDSC2(5) |  1931_MIRA-1_GDSC2(6) | B-Cell Non-Hodgkin's Lymphoma	SF3B1 (9):	--4-- |  163_JQ1_GDSC1(4) |  416_CAY10566_GDSC1(5) |  1248_Daporinad_GDSC1(5) |  1054_Palbociclib_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	SMO (4):	--2-- |  206_Ruxolitinib_GDSC1(2) |  1629_ML323_GDSC2(3) | B-Cell Non-Hodgkin's Lymphoma	STAT6 (7):	--2-- |  30_Sorafenib_GDSC1(5) |  1549_Sapitinib_GDSC2(4) | B-Lymphoblastic Leukemia	ACVR1 (6):	--2-- |  410_MetAP2 Inhibitor, A832234_GDSC1(3) |  1407_Dyrk1b_0191_GDSC1(4) | B-Lymphoblastic Leukemia	BCL2 (4):	--2-- |  1853_OF-1_GDSC2(2) |  1926_GNE-317_GDSC2(2) | B-Lymphoblastic Leukemia	CDK8 (3):	--2-- |  1049_PD173074_GDSC1(2) |  1261_rTRAIL_GDSC1(2) | B-Lymphoblastic Leukemia	COP1 (7):	--3-- |  86_A-443654_GDSC1(3) |  88_Entinostat_GDSC1(3) |  1218_JQ1_GDSC1(3) | B-Lymphoblastic Leukemia	CRKL (4):	--2-- |  1170_CCT-018159_GDSC1(3) |  2039_AGK2_GDSC2(2) | B-Lymphoblastic Leukemia	CYP19A1 (4):	--2-- |  1218_JQ1_GDSC1(3) |  2037_GSK343_GDSC2(2) | B-Lymphoblastic Leukemia	DDR2 (8):	--2-- |  104_Bortezomib_GDSC1(3) |  1091_BMS-536924_GDSC1(6) | B-Lymphoblastic Leukemia	DNMT1 (10):	--4-- |  293_Amuvatinib_GDSC1(4) |  476_SB505124_GDSC1(4) |  1016_Temsirolimus_GDSC2(6) |  1558_Lapatinib_GDSC2(7) | B-Lymphoblastic Leukemia	ERBB3 (6):	--3-- |  53_CGP-60474_GDSC1(2) |  1046_Wee1 Inhibitor_GDSC1(4) |  1218_JQ1_GDSC1(3) | B-Lymphoblastic Leukemia	GAB2 (5):	--2-- |  53_CGP-60474_GDSC1(2) |  1359_965-D2_GDSC1(4) | B-Lymphoblastic Leukemia	GLI1 (6):	--2-- |  53_CGP-60474_GDSC1(3) |  1046_Wee1 Inhibitor_GDSC1(4) | B-Lymphoblastic Leukemia	HDAC7 (4):	--2-- |  1853_OF-1_GDSC2(2) |  1926_GNE-317_GDSC2(2) | B-Lymphoblastic Leukemia	HGF (4):	--2-- |  185_Linsitinib_GDSC1(2) |  2037_GSK343_GDSC2(2) | B-Lymphoblastic Leukemia	JAK3 (5):	--2-- |  53_CGP-60474_GDSC1(2) |  1359_965-D2_GDSC1(4) | B-Lymphoblastic Leukemia	MAP2K2 (5):	--2-- |  1129_PF-4708671_GDSC1(2) |  1394_AZD6738_GDSC1(3) | B-Lymphoblastic Leukemia	MAP4K4 (4):	--3-- |  11_Paclitaxel_GDSC1(1) |  53_CGP-60474_GDSC1(1) |  279_BIX02189_GDSC1(2) | B-Lymphoblastic Leukemia	NT5C2 (9):	--2-- |  1558_Lapatinib_GDSC2(7) |  1630_Entospletinib_GDSC2(6) | B-Lymphoblastic Leukemia	PDGFRA (7):	--3-- |  32_Tozasertib_GDSC1(2) |  106_XMD8-85_GDSC1(3) |  293_Amuvatinib_GDSC1(3) | B-Lymphoblastic Leukemia	PIK3CD (4):	--2-- |  11_Paclitaxel_GDSC1(1) |  1449_AZD1208_GDSC1(3) | B-Lymphoblastic Leukemia	PTPN11 (4):	--3-- |  106_XMD8-85_GDSC1(1) |  140_Vinorelbine_GDSC1(2) |  476_SB505124_GDSC1(1) | B-Lymphoblastic Leukemia	RICTOR (3):	--2-- |  17_Cyclopamine_GDSC1(2) |  254_Quizartinib_GDSC1(2) | B-Lymphoblastic Leukemia	RUNX1T1 (4):	--3-- |  11_Paclitaxel_GDSC1(1) |  53_CGP-60474_GDSC1(1) |  279_BIX02189_GDSC1(2) | B-Lymphoblastic Leukemia	SGK1 (5):	--2-- |  53_CGP-60474_GDSC1(2) |  1359_965-D2_GDSC1(4) | B-Lymphoblastic Leukemia	TFE3 (3):	--2-- |  17_Cyclopamine_GDSC1(2) |  154_CHIR-99021_GDSC1(2) | B-Lymphoblastic Leukemia	VAV1 (8):	--2-- |  104_Bortezomib_GDSC1(3) |  1091_BMS-536924_GDSC1(6) | Bladder Carcinoma	ACVR1 (7):	--2-- |  177_GSK650394_GDSC1(5) |  1051_Alisertib_GDSC2(6) | Bladder Carcinoma	ADHFE1 (3):	--2-- |  1429_IAP_7638_GDSC1(2) |  1449_AZD1208_GDSC1(2) | Bladder Carcinoma	AKT2 (4):	--2-- |  134_Etoposide_GDSC1(2) |  344_THZ-2-49_GDSC1(3) | Bladder Carcinoma	ARID3B (3):	--2-- |  272_AR-42_GDSC1(1) |  293_Amuvatinib_GDSC1(2) | Bladder Carcinoma	AXL (3):	--2-- |  317_WYE-125132_GDSC1(1) |  1038_NU7441_GDSC1(2) | Bladder Carcinoma	BCL6 (4):	--2-- |  317_WYE-125132_GDSC1(2) |  1038_NU7441_GDSC1(3) | Bladder Carcinoma	BRAF (5):	--2-- |  1261_rTRAIL_GDSC1(3) |  1048_Mirin_GDSC2(3) | Bladder Carcinoma	BTK (4):	--3-- |  1248_Daporinad_GDSC1(1) |  1392_Bleomycin (10 uM)_GDSC1(2) |  1926_GNE-317_GDSC2(2) | Bladder Carcinoma	CARD11 (5):	--2-- |  1578_Leflunomide_GDSC2(3) |  1714_ERK_6604_GDSC2(3) | Bladder Carcinoma	DNMT1 (4):	--2-- |  203_BMS-345541_GDSC1(2) |  1038_NU7441_GDSC1(3) | Bladder Carcinoma	DOT1L (5):	--3-- |  172_Embelin_GDSC1(2) |  1006_Cytarabine_GDSC1(1) |  1847_BEN_GDSC2(3) | Bladder Carcinoma	ERBB3 (4):	--2-- |  158_PF-562271_GDSC1(3) |  261_TL-1-85_GDSC1(3) | Bladder Carcinoma	FGFR1 (5):	--2-- |  310_YM201636_GDSC1(3) |  1444_AZD8186_GDSC1(3) | Bladder Carcinoma	FLT4 (5):	--2-- |  1019_Bosutinib_GDSC1(3) |  1261_rTRAIL_GDSC1(3) | Bladder Carcinoma	GNAQ (3):	--2-- |  1019_Bosutinib_GDSC1(2) |  1073_5-Fluorouracil_GDSC2(2) | Bladder Carcinoma	GTF2I (3):	--2-- |  317_WYE-125132_GDSC1(1) |  1038_NU7441_GDSC1(2) | Bladder Carcinoma	HDAC7 (4):	--2-- |  185_Linsitinib_GDSC1(2) |  344_THZ-2-49_GDSC1(3) | Bladder Carcinoma	HGF (4):	--2-- |  1449_AZD1208_GDSC1(2) |  1593_Entinostat_GDSC2(3) | Bladder Carcinoma	HIF1A (3):	--2-- |  1449_AZD1208_GDSC1(2) |  1073_5-Fluorouracil_GDSC2(2) | Bladder Carcinoma	HMGA1 (4):	--2-- |  196_Phenformin_GDSC1(3) |  331_QL-X-138_GDSC1(1) | Bladder Carcinoma	IGF1R (8):	--2-- |  207_AS601245_GDSC1(6) |  1024_Lestaurtinib_GDSC2(6) | Bladder Carcinoma	IL6ST (3):	--2-- |  317_WYE-125132_GDSC1(1) |  1038_NU7441_GDSC1(2) | Bladder Carcinoma	INSR (3):	--2-- |  317_WYE-125132_GDSC1(1) |  1038_NU7441_GDSC1(2) | Bladder Carcinoma	KDM5A (5):	--2-- |  1053_MK-2206_GDSC2(3) |  1259_Talazoparib_GDSC2(3) | Bladder Carcinoma	KSR2 (5):	--2-- |  1377_Afatinib_GDSC1(3) |  1553_Uprosertib_GDSC2(4) | Bladder Carcinoma	LRP6 (6):	--2-- |  1008_Methotrexate_GDSC1(3) |  1008_Methotrexate_GDSC2(4) | Bladder Carcinoma	MECOM (7):	--2-- |  177_GSK650394_GDSC1(5) |  305_TPCA-1_GDSC1(5) | Bladder Carcinoma	MKI67 (4):	--2-- |  276_CAY10603_GDSC1(2) |  293_Amuvatinib_GDSC1(2) | Bladder Carcinoma	MSI1 (4):	--2-- |  134_Etoposide_GDSC1(2) |  262_VX-11e_GDSC1(3) | Bladder Carcinoma	MSI2 (5):	--2-- |  1367_BAY-HDAC11_4_GDSC1(2) |  1593_Entinostat_GDSC2(4) | Bladder Carcinoma	NCOA3 (7):	--3-- |  1019_Bosutinib_GDSC1(3) |  1578_Leflunomide_GDSC2(4) |  1873_Buparlisib_GDSC2(4) | Bladder Carcinoma	NRAS (4):	--2-- |  317_WYE-125132_GDSC1(2) |  1038_NU7441_GDSC1(3) | Bladder Carcinoma	NT5C2 (5):	--2-- |  1038_NU7441_GDSC1(3) |  1564_SCH772984_GDSC2(4) | Bladder Carcinoma	NTRK1 (5):	--2-- |  1038_NU7441_GDSC1(3) |  1713_ERK_2440_GDSC2(4) | Bladder Carcinoma	PAX8 (3):	--2-- |  203_BMS-345541_GDSC1(2) |  275_I-BET-762_GDSC1(2) | Bladder Carcinoma	PIK3CB (4):	--2-- |  317_WYE-125132_GDSC1(2) |  1054_Palbociclib_GDSC2(2) | Bladder Carcinoma	PRKCI (4):	--2-- |  1006_Cytarabine_GDSC1(1) |  1553_Uprosertib_GDSC2(3) | Bladder Carcinoma	RHOA (4):	--2-- |  133_Doxorubicin_GDSC1(2) |  1128_FS106_GDSC1(2) | Bladder Carcinoma	ROS1 (7):	--2-- |  1038_NU7441_GDSC1(3) |  2109_AZ6102_GDSC2(5) | Bladder Carcinoma	SMYD3 (5):	--2-- |  372_Pilaralisib_GDSC1(3) |  1449_AZD1208_GDSC1(2) | Bladder Carcinoma	SQSTM1 (4):	--2-- |  317_WYE-125132_GDSC1(2) |  1054_Palbociclib_GDSC2(2) | Bladder Carcinoma	STAT5B (4):	--2-- |  1052_RO-3306_GDSC1(3) |  1261_rTRAIL_GDSC1(3) | Bladder Carcinoma	UBR5 (7):	--2-- |  156_AZD6482_GDSC1(5) |  305_TPCA-1_GDSC1(5) | Bladder Carcinoma	USP8 (6):	--3-- |  172_Embelin_GDSC1(3) |  1370_BAY-MPS-combo 2 (paclitaxel 1 uM)_GDSC1(2) |  1827_Dihydrorotenone_GDSC2(3) | Bladder Carcinoma	VAV1 (5):	--3-- |  1038_NU7441_GDSC1(3) |  1367_BAY-HDAC11_4_GDSC1(2) |  1714_ERK_6604_GDSC2(3) | Bladder Carcinoma	WWP1 (4):	--2-- |  301_PHA-793887_GDSC1(3) |  372_Pilaralisib_GDSC1(3) | Bladder Carcinoma	WWTR1 (4):	--2-- |  203_BMS-345541_GDSC1(2) |  228_AKT inhibitor VIII_GDSC1(3) | Breast Carcinoma	ABL2 (21):	--3-- |  229_Enzastaurin_GDSC1(9) |  1184_AZ20_GDSC1(15) |  1377_Afatinib_GDSC1(12) | Breast Carcinoma	ACVR1 (12):	--2-- |  204_Tipifarnib_GDSC1(7) |  362_CI-1033_GDSC1(10) | Breast Carcinoma	AKT3 (17):	--3-- |  172_Embelin_GDSC1(9) |  179_5-Fluorouracil_GDSC1(9) |  257_NPK76-II-72-1_GDSC1(8) | Breast Carcinoma	ATXN7 (12):	--3-- |  178_BAY-61-3606_GDSC1(7) |  179_5-Fluorouracil_GDSC1(7) |  1732_TAF1_5496_GDSC2(6) | Breast Carcinoma	BCL6 (9):	--2-- |  1021_Axitinib_GDSC2(5) |  1919_Osimertinib_GDSC2(5) | Breast Carcinoma	BRAF (17):	--3-- |  152_CP466722_GDSC1(10) |  576_RU-SKI 43_GDSC1(8) |  1011_Navitoclax_GDSC2(9) | Breast Carcinoma	BRD4 (17):	--2-- |  283_Omipalisib_GDSC1(14) |  2171_BMS-754807_GDSC2(9) | Breast Carcinoma	CARD11 (17):	--4-- |  438_Panobinostat_GDSC1(12) |  1088_Irinotecan_GDSC2(5) |  1732_TAF1_5496_GDSC2(7) |  1778_GSK2110183B_GDSC2(7) | Breast Carcinoma	CCND3 (14):	--3-- |  293_Amuvatinib_GDSC1(7) |  1031_Elesclomol_GDSC1(6) |  1560_Alpelisib_GDSC2(8) | Breast Carcinoma	COP1 (13):	--3-- |  1192_GSK269962A_GDSC1(5) |  1799_Ibrutinib_GDSC2(7) |  2172_JQ1_GDSC2(8) | Breast Carcinoma	DDX4 (12):	--2-- |  1032_Afatinib_GDSC1(7) |  2170_AT13148_GDSC2(6) | Breast Carcinoma	DNMT1 (13):	--5-- |  238_Idelalisib_GDSC1(4) |  292_Masitinib_GDSC1(6) |  305_TPCA-1_GDSC1(7) |  1006_Cytarabine_GDSC2(4) |  1007_Docetaxel_GDSC2(8) | Breast Carcinoma	DOT1L (19):	--3-- |  301_PHA-793887_GDSC1(11) |  326_GSK690693_GDSC1(13) |  1059_AZD8055_GDSC1(10) | Breast Carcinoma	EPOR (9):	--3-- |  1005_Cisplatin_GDSC1(4) |  1037_BX795_GDSC1(4) |  1919_Osimertinib_GDSC2(5) | Breast Carcinoma	ERBB2 (12):	--2-- |  1377_Afatinib_GDSC1(9) |  1930_Telomerase Inhibitor IX_GDSC2(8) | Breast Carcinoma	ERG (11):	--3-- |  257_NPK76-II-72-1_GDSC1(7) |  1059_AZD8055_GDSC1(5) |  2170_AT13148_GDSC2(7) | Breast Carcinoma	ESR1 (10):	--3-- |  439_LCL161_GDSC1(4) |  1012_Vorinostat_GDSC1(6) |  1070_CRT0105950_GDSC1(5) | Breast Carcinoma	GAB1 (11):	--4-- |  1031_Elesclomol_GDSC1(6) |  1494_SN-38_GDSC2(5) |  1799_Ibrutinib_GDSC2(7) |  1932_NVP-ADW742_GDSC2(5) | Breast Carcinoma	GLI1 (7):	--2-- |  171_AKT inhibitor VIII_GDSC1(4) |  362_CI-1033_GDSC1(5) | Breast Carcinoma	GNA13 (7):	--2-- |  1011_Navitoclax_GDSC1(4) |  2046_MK-8776_GDSC2(3) | Breast Carcinoma	GNAS (21):	--3-- |  326_GSK690693_GDSC1(12) |  1012_Vorinostat_GDSC1(13) |  1494_SN-38_GDSC1(12) | Breast Carcinoma	IGF2 (11):	--2-- |  275_I-BET-762_GDSC1(6) |  1003_Camptothecin_GDSC2(6) | Breast Carcinoma	IL6ST (10):	--4-- |  1037_BX795_GDSC1(5) |  1070_CRT0105950_GDSC1(6) |  1835_Elephantin_GDSC2(5) |  2169_AZD6482_GDSC2(5) | Breast Carcinoma	IRS1 (5):	--2-- |  304_SB52334_GDSC1(3) |  1739_JAK_8517_GDSC2(3) | Breast Carcinoma	JAK3 (14):	--3-- |  165_DMOG_GDSC1(5) |  238_Idelalisib_GDSC1(5) |  1549_Sapitinib_GDSC2(8) | Breast Carcinoma	KDM5A (17):	--3-- |  293_Amuvatinib_GDSC1(8) |  1004_Vinblastine_GDSC1(11) |  1032_Afatinib_GDSC1(9) | Breast Carcinoma	KLF5 (6):	--3-- |  197_Bryostatin 1_GDSC1(2) |  281_Alectinib_GDSC1(2) |  1088_Irinotecan_GDSC2(3) | Breast Carcinoma	LRP6 (13):	--3-- |  275_I-BET-762_GDSC1(6) |  1006_Cytarabine_GDSC2(4) |  1549_Sapitinib_GDSC2(8) | Breast Carcinoma	MAP2K1 (6):	--3-- |  1005_Cisplatin_GDSC1(3) |  1015_CI-1040_GDSC1(3) |  1133_Serdemetan_GDSC2(2) | Breast Carcinoma	MAP3K13 (12):	--3-- |  177_GSK650394_GDSC1(7) |  203_BMS-345541_GDSC1(6) |  1932_NVP-ADW742_GDSC2(6) | Breast Carcinoma	MAPK1 (8):	--2-- |  255_CP724714_GDSC1(4) |  1997_WEHI-539_GDSC2(5) | Breast Carcinoma	MPL (3):	--2-- |  238_Idelalisib_GDSC1(2) |  2010_HKMTI-1-005_GDSC2(2) | Breast Carcinoma	MSI2 (19):	--4-- |  293_Amuvatinib_GDSC1(8) |  1031_Elesclomol_GDSC1(11) |  1032_Afatinib_GDSC1(8) |  1813_Fludarabine_GDSC2(4) | Breast Carcinoma	MYC (3):	--2-- |  330_XMD13-2_GDSC1(2) |  1079_Dasatinib_GDSC2(2) | Breast Carcinoma	NT5C2 (7):	--2-- |  283_Omipalisib_GDSC1(5) |  1054_Palbociclib_GDSC1(4) | Breast Carcinoma	PDGFRA (16):	--3-- |  223_ZSTK474_GDSC1(10) |  1054_Palbociclib_GDSC1(6) |  1192_GSK269962A_GDSC1(6) | Breast Carcinoma	PIK3CG (14):	--3-- |  152_CP466722_GDSC1(8) |  293_Amuvatinib_GDSC1(7) |  1778_GSK2110183B_GDSC2(7) | Breast Carcinoma	PLCG1 (12):	--4-- |  179_5-Fluorouracil_GDSC1(7) |  221_TAK-715_GDSC1(3) |  255_CP724714_GDSC1(5) |  1021_Axitinib_GDSC2(7) | Breast Carcinoma	PPM1D (11):	--4-- |  176_IPA-3_GDSC1(6) |  221_TAK-715_GDSC1(4) |  1006_Cytarabine_GDSC2(4) |  1626_OTX015_GDSC2(6) | Breast Carcinoma	PRKACA (14):	--3-- |  1014_Refametinib_GDSC1(7) |  1003_Camptothecin_GDSC2(7) |  1932_NVP-ADW742_GDSC2(6) | Breast Carcinoma	REL (6):	--3-- |  552_BAM7_GDSC1(3) |  1039_SL0101_GDSC1(2) |  1510_Linsitinib_GDSC2(2) | Breast Carcinoma	REV3L (20):	--5-- |  275_I-BET-762_GDSC1(8) |  1032_Afatinib_GDSC1(8) |  1451_PLK_6522_GDSC1(8) |  1084_Rapamycin_GDSC2(7) |  1720_AZD5991_GDSC2(11) | Breast Carcinoma	RHOA (5):	--2-- |  219_AT-7519_GDSC1(2) |  376_Brivanib, BMS-540215_GDSC1(3) | Breast Carcinoma	RNASEH2A (5):	--2-- |  1495_Olaparib_GDSC1(2) |  2096_VX-11e_GDSC2(4) | Breast Carcinoma	RRAGC (5):	--3-- |  1005_Cisplatin_GDSC1(3) |  1083_Crizotinib_GDSC2(3) |  1088_Irinotecan_GDSC2(3) | Breast Carcinoma	RRAS2 (3):	--2-- |  1050_ZM447439_GDSC1(2) |  2111_VE821_GDSC2(2) | Breast Carcinoma	RUNX1T1 (14):	--4-- |  153_Midostaurin_GDSC1(6) |  304_SB52334_GDSC1(5) |  1186_FS112_GDSC1(6) |  1187_CCT245232_GDSC1(6) | Breast Carcinoma	STAT5B (9):	--2-- |  1050_ZM447439_GDSC2(6) |  1919_Osimertinib_GDSC2(5) | Breast Carcinoma	SYK (11):	--5-- |  203_BMS-345541_GDSC1(5) |  576_RU-SKI 43_GDSC1(5) |  1196_FY069_GDSC1(4) |  1425_BPTES_GDSC1(3) |  1088_Irinotecan_GDSC2(4) | Breast Carcinoma	TERT (15):	--3-- |  563_Kobe2602_GDSC1(5) |  1026_Tanespimycin_GDSC1(8) |  1809_Teniposide_GDSC2(8) | Breast Carcinoma	TRIM27 (8):	--3-- |  177_GSK650394_GDSC1(4) |  219_AT-7519_GDSC1(4) |  477_A-83-01_GDSC1(4) | Breast Carcinoma	USP8 (16):	--3-- |  151_QS11_GDSC1(6) |  300_CX-5461_GDSC1(5) |  1022_AZD7762_GDSC1(10) | Breast Carcinoma	XPO1 (15):	--5-- |  147_NSC-87877_GDSC1(3) |  265_Tubastatin A_GDSC1(3) |  292_Masitinib_GDSC1(7) |  1088_Irinotecan_GDSC2(6) |  2109_AZ6102_GDSC2(8) | Burkitt's Lymphoma	ABL2 (4):	--2-- |  1392_Bleomycin (10 uM)_GDSC1(3) |  1453_RAF_9304_GDSC1(1) | Burkitt's Lymphoma	ATXN7 (4):	--2-- |  1392_Bleomycin (10 uM)_GDSC1(3) |  1453_RAF_9304_GDSC1(1) | Burkitt's Lymphoma	BRD3 (4):	--4-- |  11_Paclitaxel_GDSC1(1) |  45_Z-LLNle-CHO_GDSC1(1) |  294_MPS-1-IN-1_GDSC1(1) |  366_TWS119_GDSC1(1) | Burkitt's Lymphoma	CARD11 (5):	--5-- |  111_Salubrinal_GDSC1(1) |  249_Cabozantinib_GDSC1(1) |  1001_AICA Ribonucleotide_GDSC1(1) |  1187_CCT245232_GDSC1(1) |  1720_AZD5991_GDSC2(1) | Burkitt's Lymphoma	CDK8 (5):	--5-- |  111_Salubrinal_GDSC1(1) |  249_Cabozantinib_GDSC1(1) |  1001_AICA Ribonucleotide_GDSC1(1) |  1187_CCT245232_GDSC1(1) |  1720_AZD5991_GDSC2(1) | Burkitt's Lymphoma	GAB1 (4):	--4-- |  11_Paclitaxel_GDSC1(1) |  45_Z-LLNle-CHO_GDSC1(1) |  294_MPS-1-IN-1_GDSC1(1) |  366_TWS119_GDSC1(1) | Burkitt's Lymphoma	GNAS (4):	--2-- |  1392_Bleomycin (10 uM)_GDSC1(3) |  1453_RAF_9304_GDSC1(1) | Burkitt's Lymphoma	HMGA2 (5):	--2-- |  1019_Bosutinib_GDSC2(4) |  1026_Tanespimycin_GDSC2(4) | Burkitt's Lymphoma	IL6ST (4):	--4-- |  207_AS601245_GDSC1(1) |  366_TWS119_GDSC1(1) |  1135_AZD4547_GDSC1(1) |  1939_UMI-77_GDSC2(1) | Burkitt's Lymphoma	KDR (4):	--2-- |  1392_Bleomycin (10 uM)_GDSC1(3) |  1453_RAF_9304_GDSC1(1) | Burkitt's Lymphoma	MAP4K4 (4):	--2-- |  439_LCL161_GDSC1(3) |  1434_JAK3_7406_GDSC1(3) | Burkitt's Lymphoma	MDM4 (4):	--2-- |  151_QS11_GDSC1(3) |  439_LCL161_GDSC1(3) | Burkitt's Lymphoma	MLLT10 (5):	--2-- |  1259_Talazoparib_GDSC1(4) |  1494_SN-38_GDSC2(4) | Burkitt's Lymphoma	NTRK1 (4):	--2-- |  1392_Bleomycin (10 uM)_GDSC1(3) |  1453_RAF_9304_GDSC1(1) | Burkitt's Lymphoma	PPM1D (4):	--2-- |  1392_Bleomycin (10 uM)_GDSC1(3) |  1453_RAF_9304_GDSC1(1) | Burkitt's Lymphoma	RPTOR (5):	--5-- |  111_Salubrinal_GDSC1(1) |  249_Cabozantinib_GDSC1(1) |  1001_AICA Ribonucleotide_GDSC1(1) |  1187_CCT245232_GDSC1(1) |  1720_AZD5991_GDSC2(1) | Burkitt's Lymphoma	SETBP1 (4):	--2-- |  1392_Bleomycin (10 uM)_GDSC1(3) |  1453_RAF_9304_GDSC1(1) | Burkitt's Lymphoma	SETD1A (4):	--4-- |  207_AS601245_GDSC1(1) |  366_TWS119_GDSC1(1) |  1135_AZD4547_GDSC1(1) |  1939_UMI-77_GDSC2(1) | Burkitt's Lymphoma	SS18 (4):	--2-- |  1392_Bleomycin (10 uM)_GDSC1(3) |  1453_RAF_9304_GDSC1(1) | Burkitt's Lymphoma	STAT3 (4):	--2-- |  1392_Bleomycin (10 uM)_GDSC1(3) |  1453_RAF_9304_GDSC1(1) | Cervical Carcinoma	CD28 (3):	--2-- |  176_IPA-3_GDSC1(2) |  1070_CRT0105950_GDSC1(2) | Cervical Carcinoma	COP1 (3):	--2-- |  1070_CRT0105950_GDSC1(2) |  1014_Refametinib_GDSC2(2) | Cervical Carcinoma	FGFR2 (4):	--2-- |  178_BAY-61-3606_GDSC1(3) |  2156_5-azacytidine_GDSC2(3) | Cervical Carcinoma	GAB2 (3):	--2-- |  1070_CRT0105950_GDSC1(2) |  1014_Refametinib_GDSC2(2) | Cervical Carcinoma	LYN (5):	--2-- |  179_5-Fluorouracil_GDSC1(3) |  1079_Dasatinib_GDSC2(4) | Cervical Carcinoma	MAP2K2 (3):	--2-- |  186_Bexarotene_GDSC1(2) |  1070_CRT0105950_GDSC1(2) | Cervical Carcinoma	MAP4K4 (5):	--2-- |  1079_Dasatinib_GDSC2(4) |  1088_Irinotecan_GDSC2(4) | Cervical Carcinoma	MET (7):	--2-- |  1196_FY069_GDSC1(5) |  1046_Wee1 Inhibitor_GDSC2(5) | Cervical Carcinoma	MGAM (6):	--2-- |  293_Amuvatinib_GDSC1(4) |  1732_TAF1_5496_GDSC2(4) | Cervical Carcinoma	MKI67 (5):	--2-- |  177_GSK650394_GDSC1(4) |  1046_Wee1 Inhibitor_GDSC2(4) | Cervical Carcinoma	MTOR (5):	--2-- |  301_PHA-793887_GDSC1(3) |  1170_CCT-018159_GDSC1(4) | Cervical Carcinoma	NUF2 (3):	--2-- |  171_AKT inhibitor VIII_GDSC1(2) |  176_IPA-3_GDSC1(2) | Cervical Carcinoma	NUP214 (5):	--2-- |  1014_Refametinib_GDSC1(4) |  1498_Selumetinib_GDSC1(4) | Cervical Carcinoma	PAK1 (3):	--2-- |  260_NG-25_GDSC1(2) |  1070_CRT0105950_GDSC1(2) | Cervical Carcinoma	PDCD1LG2 (3):	--2-- |  153_Midostaurin_GDSC1(2) |  186_Bexarotene_GDSC1(2) | Cervical Carcinoma	PIK3CA (4):	--2-- |  291_KIN001-266_GDSC1(3) |  1053_MK-2206_GDSC2(3) | Cervical Carcinoma	SGK1 (5):	--2-- |  152_CP466722_GDSC1(4) |  178_BAY-61-3606_GDSC1(3) | Cervical Carcinoma	WWP1 (3):	--2-- |  1070_CRT0105950_GDSC1(2) |  1014_Refametinib_GDSC2(2) | Chronic Myelogenous Leukemia	BCR (4):	--2-- |  410_MetAP2 Inhibitor, A832234_GDSC1(3) |  1463_AZD1332_GDSC1(3) | Chronic Myelogenous Leukemia	CCNB3 (4):	--2-- |  410_MetAP2 Inhibitor, A832234_GDSC1(3) |  1463_AZD1332_GDSC1(3) | Chronic Myelogenous Leukemia	RUNX1T1 (4):	--2-- |  410_MetAP2 Inhibitor, A832234_GDSC1(3) |  1185_KU-60019_GDSC1(3) | Chronic Myelogenous Leukemia	USP8 (4):	--2-- |  106_XMD8-85_GDSC1(3) |  1016_Temsirolimus_GDSC2(3) | Chronic Myelogenous Leukemia	WWP1 (4):	--2-- |  410_MetAP2 Inhibitor, A832234_GDSC1(3) |  1463_AZD1332_GDSC1(3) | Colorectal Carcinoma	ABL2 (17):	--4-- |  133_Doxorubicin_GDSC1(5) |  300_CX-5461_GDSC1(8) |  1372_Trametinib_GDSC2(12) |  1558_Lapatinib_GDSC2(9) | Colorectal Carcinoma	ACVR1 (20):	--3-- |  228_AKT inhibitor VIII_GDSC1(11) |  1060_PD0325901_GDSC1(13) |  1046_Wee1 Inhibitor_GDSC2(12) | Colorectal Carcinoma	AKT1 (8):	--2-- |  437_Trichostatin A_GDSC1(6) |  1835_Elephantin_GDSC2(5) | Colorectal Carcinoma	AKT3 (19):	--3-- |  182_Obatoclax Mesylate_GDSC1(12) |  300_CX-5461_GDSC1(9) |  1401_AZD5438_GDSC2(12) | Colorectal Carcinoma	ATF1 (10):	--3-- |  326_GSK690693_GDSC1(4) |  1133_Serdemetan_GDSC1(3) |  1372_Trametinib_GDSC2(6) | Colorectal Carcinoma	AURKB (9):	--2-- |  437_Trichostatin A_GDSC1(7) |  1558_Lapatinib_GDSC2(5) | Colorectal Carcinoma	AXL (23):	--3-- |  208_Ispinesib Mesylate_GDSC1(15) |  1048_Mirin_GDSC2(13) |  1091_BMS-536924_GDSC2(15) | Colorectal Carcinoma	BAALC (13):	--4-- |  153_Midostaurin_GDSC1(5) |  252_WZ3105_GDSC1(6) |  1060_PD0325901_GDSC2(7) |  1578_Leflunomide_GDSC2(5) | Colorectal Carcinoma	BCL3 (7):	--3-- |  308_Foretinib_GDSC1(3) |  576_RU-SKI 43_GDSC1(2) |  1068_Obatoclax Mesylate_GDSC2(5) | Colorectal Carcinoma	BCL9 (17):	--3-- |  164_JQ12_GDSC1(8) |  303_PIK-93_GDSC1(10) |  1558_Lapatinib_GDSC2(8) | Colorectal Carcinoma	BCR (20):	--4-- |  153_Midostaurin_GDSC1(6) |  208_Ispinesib Mesylate_GDSC1(14) |  1133_Serdemetan_GDSC1(5) |  1613_VE-822_GDSC2(4) | Colorectal Carcinoma	BRD3 (18):	--2-- |  208_Ispinesib Mesylate_GDSC1(12) |  1401_AZD5438_GDSC2(12) | Colorectal Carcinoma	BTK (15):	--3-- |  1427_AZD5582_GDSC1(9) |  1564_SCH772984_GDSC2(7) |  1803_Acetalax_GDSC2(9) | Colorectal Carcinoma	CALR (10):	--2-- |  260_NG-25_GDSC1(6) |  1617_AZD5582_GDSC2(7) | Colorectal Carcinoma	CARD11 (21):	--4-- |  303_PIK-93_GDSC1(11) |  415_CPI-613_GDSC1(13) |  1133_Serdemetan_GDSC1(5) |  1060_PD0325901_GDSC2(13) | Colorectal Carcinoma	CCNB3 (12):	--3-- |  5_Sunitinib_GDSC1(3) |  300_CX-5461_GDSC1(7) |  1014_Refametinib_GDSC2(7) | Colorectal Carcinoma	CCND3 (8):	--3-- |  221_TAK-715_GDSC1(4) |  260_NG-25_GDSC1(5) |  1372_Trametinib_GDSC1(3) | Colorectal Carcinoma	CD276 (7):	--3-- |  272_AR-42_GDSC1(4) |  326_GSK690693_GDSC1(3) |  1372_Trametinib_GDSC2(3) | Colorectal Carcinoma	CD28 (7):	--2-- |  1008_Methotrexate_GDSC1(5) |  1806_Oxaliplatin_GDSC2(3) | Colorectal Carcinoma	CDC42 (13):	--3-- |  252_WZ3105_GDSC1(6) |  1058_Pictilisib_GDSC1(8) |  1847_BEN_GDSC2(8) | Colorectal Carcinoma	CDK8 (9):	--2-- |  437_Trichostatin A_GDSC1(7) |  1068_Obatoclax Mesylate_GDSC2(7) | Colorectal Carcinoma	CTNNB1 (17):	--3-- |  366_TWS119_GDSC1(10) |  1053_MK-2206_GDSC1(8) |  1392_Bleomycin (10 uM)_GDSC1(10) | Colorectal Carcinoma	CYP19A1 (15):	--4-- |  275_I-BET-762_GDSC1(7) |  356_AT7867_GDSC1(6) |  1015_CI-1040_GDSC1(6) |  2040_Foretinib_GDSC2(9) | Colorectal Carcinoma	DCUN1D1 (15):	--3-- |  228_AKT inhibitor VIII_GDSC1(9) |  1060_PD0325901_GDSC1(10) |  1372_Trametinib_GDSC2(10) | Colorectal Carcinoma	DEK (10):	--2-- |  300_CX-5461_GDSC1(6) |  1006_Cytarabine_GDSC2(5) | Colorectal Carcinoma	DNMT1 (21):	--4-- |  178_BAY-61-3606_GDSC1(11) |  225_Genentech Cpd 10_GDSC1(12) |  1006_Cytarabine_GDSC2(10) |  1372_Trametinib_GDSC2(15) | Colorectal Carcinoma	DOT1L (19):	--3-- |  207_AS601245_GDSC1(9) |  228_AKT inhibitor VIII_GDSC1(10) |  1372_Trametinib_GDSC2(14) | Colorectal Carcinoma	E2F3 (8):	--3-- |  576_RU-SKI 43_GDSC1(2) |  1068_Obatoclax Mesylate_GDSC2(6) |  1617_AZD5582_GDSC2(5) | Colorectal Carcinoma	EGFL7 (12):	--3-- |  221_TAK-715_GDSC1(5) |  1426_AZD7969_GDSC1(7) |  1809_Teniposide_GDSC2(8) | Colorectal Carcinoma	EIF4A2 (18):	--2-- |  208_Ispinesib Mesylate_GDSC1(13) |  1048_Mirin_GDSC2(13) | Colorectal Carcinoma	EIF4E (7):	--3-- |  277_Linifanib_GDSC1(2) |  288_WHI-P97_GDSC1(2) |  1826_50869_GDSC2(3) | Colorectal Carcinoma	ERBB2 (14):	--3-- |  203_BMS-345541_GDSC1(10) |  301_PHA-793887_GDSC1(9) |  1133_Serdemetan_GDSC1(5) | Colorectal Carcinoma	ERG (21):	--3-- |  415_CPI-613_GDSC1(13) |  1419_FEN1_3940_GDSC1(11) |  1490_SN-38_GDSC1(13) | Colorectal Carcinoma	ESR1 (22):	--5-- |  208_Ispinesib Mesylate_GDSC1(12) |  1032_Afatinib_GDSC1(7) |  1080_Paclitaxel_GDSC2(7) |  1558_Lapatinib_GDSC2(11) |  1866_BDP-00009066_GDSC2(11) | Colorectal Carcinoma	ETV1 (20):	--3-- |  208_Ispinesib Mesylate_GDSC1(13) |  415_CPI-613_GDSC1(13) |  1048_Mirin_GDSC2(12) | Colorectal Carcinoma	ETV4 (8):	--2-- |  326_GSK690693_GDSC1(4) |  1068_Obatoclax Mesylate_GDSC2(6) | Colorectal Carcinoma	EWSR1 (18):	--3-- |  301_PHA-793887_GDSC1(10) |  1248_Daporinad_GDSC2(6) |  1372_Trametinib_GDSC2(13) | Colorectal Carcinoma	FGF3 (7):	--2-- |  326_GSK690693_GDSC1(4) |  1068_Obatoclax Mesylate_GDSC2(5) | Colorectal Carcinoma	FGFR3 (14):	--2-- |  228_AKT inhibitor VIII_GDSC1(9) |  1553_Uprosertib_GDSC2(9) | Colorectal Carcinoma	FGFR4 (11):	--3-- |  221_TAK-715_GDSC1(5) |  300_CX-5461_GDSC1(7) |  1133_Serdemetan_GDSC1(4) | Colorectal Carcinoma	FLT1 (28):	--4-- |  275_I-BET-762_GDSC1(10) |  1053_MK-2206_GDSC1(11) |  1046_Wee1 Inhibitor_GDSC2(16) |  1847_BEN_GDSC2(15) | Colorectal Carcinoma	FLT3 (25):	--4-- |  208_Ispinesib Mesylate_GDSC1(15) |  1073_5-Fluorouracil_GDSC2(12) |  1401_AZD5438_GDSC2(15) |  1844_776928_GDSC2(12) | Colorectal Carcinoma	FLT4 (26):	--3-- |  1392_Bleomycin (10 uM)_GDSC1(14) |  1046_Wee1 Inhibitor_GDSC2(16) |  1733_ULK1_4989_GDSC2(19) | Colorectal Carcinoma	FYN (18):	--3-- |  5_Sunitinib_GDSC1(4) |  228_AKT inhibitor VIII_GDSC1(11) |  1932_NVP-ADW742_GDSC2(10) | Colorectal Carcinoma	GAB1 (15):	--3-- |  175_PAC-1_GDSC1(3) |  1386_Doxorubicin_GDSC1(11) |  1060_PD0325901_GDSC2(9) | Colorectal Carcinoma	GLI1 (15):	--4-- |  153_Midostaurin_GDSC1(5) |  300_CX-5461_GDSC1(8) |  1048_Mirin_GDSC1(5) |  1085_Sorafenib_GDSC2(8) | Colorectal Carcinoma	GNA11 (11):	--2-- |  356_AT7867_GDSC1(6) |  1003_Camptothecin_GDSC2(7) | Colorectal Carcinoma	GNA13 (6):	--2-- |  1264_SGC0946_GDSC1(2) |  1047_Nutlin-3a (-)_GDSC2(4) | Colorectal Carcinoma	GNAQ (14):	--3-- |  407_kb NB 142-70_GDSC1(9) |  1080_Paclitaxel_GDSC2(5) |  1558_Lapatinib_GDSC2(8) | Colorectal Carcinoma	GNB1 (8):	--4-- |  310_YM201636_GDSC1(4) |  439_LCL161_GDSC1(4) |  1038_NU7441_GDSC2(4) |  1833_741909_GDSC2(3) | Colorectal Carcinoma	GSK3B (22):	--3-- |  300_CX-5461_GDSC1(10) |  1393_Gemcitabine_GDSC1(12) |  1866_BDP-00009066_GDSC2(13) | Colorectal Carcinoma	HDAC1 (12):	--4-- |  287_KIN001-244_GDSC1(5) |  1019_Bosutinib_GDSC1(3) |  1048_Mirin_GDSC2(7) |  1250_AZ960_GDSC2(7) | Colorectal Carcinoma	HDAC7 (19):	--5-- |  221_TAK-715_GDSC1(6) |  344_THZ-2-49_GDSC1(6) |  1011_Navitoclax_GDSC2(11) |  1060_PD0325901_GDSC2(12) |  1732_TAF1_5496_GDSC2(5) | Colorectal Carcinoma	HGF (18):	--3-- |  203_BMS-345541_GDSC1(11) |  301_PHA-793887_GDSC1(10) |  1048_Mirin_GDSC2(12) | Colorectal Carcinoma	HIF1A (18):	--4-- |  71_Pyrimethamine_GDSC1(3) |  366_TWS119_GDSC1(10) |  1050_ZM447439_GDSC1(6) |  1613_VE-822_GDSC2(4) | Colorectal Carcinoma	HRAS (5):	--3-- |  432_Flavopiridol_GDSC1(3) |  1386_Doxorubicin_GDSC1(3) |  1430_IGFR_3801_GDSC1(2) | Colorectal Carcinoma	IDH1 (11):	--2-- |  1053_MK-2206_GDSC1(7) |  1006_Cytarabine_GDSC2(6) | Colorectal Carcinoma	IGF1 (11):	--3-- |  164_JQ12_GDSC1(6) |  1372_Trametinib_GDSC1(5) |  1073_5-Fluorouracil_GDSC2(7) | Colorectal Carcinoma	IGF1R (21):	--3-- |  228_AKT inhibitor VIII_GDSC1(12) |  1070_CRT0105950_GDSC1(10) |  1372_Trametinib_GDSC2(15) | Colorectal Carcinoma	IGF2 (11):	--3-- |  300_CX-5461_GDSC1(6) |  1372_Trametinib_GDSC1(4) |  1558_Lapatinib_GDSC2(6) | Colorectal Carcinoma	IKBKE (19):	--3-- |  208_Ispinesib Mesylate_GDSC1(14) |  1048_Mirin_GDSC2(12) |  1372_Trametinib_GDSC2(14) | Colorectal Carcinoma	IL6ST (15):	--3-- |  260_NG-25_GDSC1(8) |  303_PIK-93_GDSC1(9) |  1080_Paclitaxel_GDSC2(6) | Colorectal Carcinoma	IL7R (17):	--4-- |  228_AKT inhibitor VIII_GDSC1(9) |  1014_Refametinib_GDSC2(11) |  1494_SN-38_GDSC2(7) |  1594_OSI-027_GDSC2(4) | Colorectal Carcinoma	INSR (20):	--5-- |  207_AS601245_GDSC1(9) |  356_AT7867_GDSC1(8) |  415_CPI-613_GDSC1(13) |  1060_PD0325901_GDSC2(13) |  1820_123829_GDSC2(11) | Colorectal Carcinoma	IRS2 (10):	--3-- |  252_WZ3105_GDSC1(4) |  372_Pilaralisib_GDSC1(3) |  1558_Lapatinib_GDSC2(6) | Colorectal Carcinoma	JAK2 (22):	--3-- |  228_AKT inhibitor VIII_GDSC1(11) |  407_kb NB 142-70_GDSC1(11) |  1372_Trametinib_GDSC2(16) | Colorectal Carcinoma	JAK3 (20):	--3-- |  208_Ispinesib Mesylate_GDSC1(12) |  1046_Wee1 Inhibitor_GDSC2(12) |  1401_AZD5438_GDSC2(12) | Colorectal Carcinoma	KDM5A (22):	--3-- |  153_Midostaurin_GDSC1(6) |  228_AKT inhibitor VIII_GDSC1(12) |  1866_BDP-00009066_GDSC2(12) | Colorectal Carcinoma	LCK (12):	--3-- |  300_CX-5461_GDSC1(7) |  1008_Methotrexate_GDSC1(7) |  1006_Cytarabine_GDSC2(7) | Colorectal Carcinoma	LGR5 (18):	--3-- |  208_Ispinesib Mesylate_GDSC1(12) |  1372_Trametinib_GDSC2(13) |  1820_123829_GDSC2(10) | Colorectal Carcinoma	LMO2 (8):	--2-- |  252_WZ3105_GDSC1(3) |  1068_Obatoclax Mesylate_GDSC2(6) | Colorectal Carcinoma	LRP6 (25):	--3-- |  225_Genentech Cpd 10_GDSC1(14) |  1464_TTK_3146_GDSC1(13) |  1372_Trametinib_GDSC2(19) | Colorectal Carcinoma	LTK (16):	--3-- |  228_AKT inhibitor VIII_GDSC1(10) |  407_kb NB 142-70_GDSC1(10) |  1142_HG-5-113-01_GDSC1(8) | Colorectal Carcinoma	LYN (16):	--3-- |  221_TAK-715_GDSC1(6) |  228_AKT inhibitor VIII_GDSC1(9) |  1553_Uprosertib_GDSC2(10) | Colorectal Carcinoma	MAP2K1 (8):	--2-- |  326_GSK690693_GDSC1(4) |  1068_Obatoclax Mesylate_GDSC2(6) | Colorectal Carcinoma	MCL1 (8):	--2-- |  326_GSK690693_GDSC1(4) |  1068_Obatoclax Mesylate_GDSC2(6) | Colorectal Carcinoma	MDM2 (11):	--2-- |  272_AR-42_GDSC1(8) |  431_Alisertib_GDSC1(6) | Colorectal Carcinoma	MEF2D (11):	--4-- |  156_AZD6482_GDSC1(3) |  356_AT7867_GDSC1(6) |  1085_Sorafenib_GDSC2(6) |  2170_AT13148_GDSC2(5) | Colorectal Carcinoma	MKI67 (26):	--3-- |  1392_Bleomycin (10 uM)_GDSC1(14) |  1490_SN-38_GDSC1(16) |  1733_ULK1_4989_GDSC2(19) | Colorectal Carcinoma	MLLT3 (20):	--3-- |  208_Ispinesib Mesylate_GDSC1(13) |  221_TAK-715_GDSC1(6) |  1916_AZD5363_GDSC2(10) | Colorectal Carcinoma	MPL (13):	--3-- |  177_GSK650394_GDSC1(5) |  300_CX-5461_GDSC1(7) |  1558_Lapatinib_GDSC2(7) | Colorectal Carcinoma	MSI1 (9):	--2-- |  437_Trichostatin A_GDSC1(7) |  1068_Obatoclax Mesylate_GDSC2(7) | Colorectal Carcinoma	MSI2 (16):	--3-- |  221_TAK-715_GDSC1(5) |  1372_Trametinib_GDSC1(7) |  1553_Uprosertib_GDSC2(10) | Colorectal Carcinoma	MST1R (13):	--2-- |  300_CX-5461_GDSC1(7) |  1426_AZD7969_GDSC1(8) | Colorectal Carcinoma	MYBL1 (16):	--3-- |  164_JQ12_GDSC1(8) |  300_CX-5461_GDSC1(8) |  1392_Bleomycin (10 uM)_GDSC1(10) | Colorectal Carcinoma	MYD88 (10):	--2-- |  170_Shikonin_GDSC1(5) |  1709_CDK9_5038_GDSC2(7) | Colorectal Carcinoma	NADK (15):	--3-- |  228_AKT inhibitor VIII_GDSC1(9) |  275_I-BET-762_GDSC1(7) |  1048_Mirin_GDSC2(10) | Colorectal Carcinoma	NCOA3 (23):	--4-- |  71_Pyrimethamine_GDSC1(4) |  208_Ispinesib Mesylate_GDSC1(14) |  1372_Trametinib_GDSC2(17) |  1820_123829_GDSC2(12) | Colorectal Carcinoma	NCSTN (17):	--2-- |  228_AKT inhibitor VIII_GDSC1(10) |  1060_PD0325901_GDSC1(12) | Colorectal Carcinoma	NSD2 (23):	--4-- |  300_CX-5461_GDSC1(10) |  1007_Docetaxel_GDSC1(13) |  1490_SN-38_GDSC1(15) |  1866_BDP-00009066_GDSC2(13) | Colorectal Carcinoma	NTRK1 (18):	--4-- |  153_Midostaurin_GDSC1(5) |  208_Ispinesib Mesylate_GDSC1(12) |  221_TAK-715_GDSC1(6) |  1372_Trametinib_GDSC2(13) | Colorectal Carcinoma	NTRK2 (21):	--5-- |  356_AT7867_GDSC1(8) |  1007_Docetaxel_GDSC1(12) |  1048_Mirin_GDSC2(11) |  1613_VE-822_GDSC2(4) |  1910_ABT737_GDSC2(8) | Colorectal Carcinoma	NUP214 (23):	--5-- |  153_Midostaurin_GDSC1(6) |  301_PHA-793887_GDSC1(12) |  1038_NU7441_GDSC2(8) |  1048_Mirin_GDSC2(12) |  1062_Selumetinib_GDSC2(9) | Colorectal Carcinoma	NUP98 (22):	--3-- |  268_Sepantronium bromide_GDSC1(14) |  1372_Trametinib_GDSC2(16) |  1401_AZD5438_GDSC2(14) | Colorectal Carcinoma	PAK5 (16):	--5-- |  177_GSK650394_GDSC1(7) |  300_CX-5461_GDSC1(9) |  1048_Mirin_GDSC2(9) |  1060_PD0325901_GDSC2(9) |  1080_Paclitaxel_GDSC2(6) | Colorectal Carcinoma	PDCD1LG2 (12):	--3-- |  439_LCL161_GDSC1(5) |  1048_Mirin_GDSC1(5) |  1048_Mirin_GDSC2(7) | Colorectal Carcinoma	PDGFB (8):	--2-- |  287_KIN001-244_GDSC1(4) |  1038_NU7441_GDSC2(5) | Colorectal Carcinoma	PDGFRA (16):	--3-- |  300_CX-5461_GDSC1(9) |  1080_Paclitaxel_GDSC2(6) |  1558_Lapatinib_GDSC2(9) | Colorectal Carcinoma	PDGFRB (18):	--3-- |  208_Ispinesib Mesylate_GDSC1(14) |  1048_Mirin_GDSC2(10) |  1372_Trametinib_GDSC2(13) | Colorectal Carcinoma	PIK3CD (14):	--3-- |  260_NG-25_GDSC1(8) |  1048_Mirin_GDSC2(9) |  1549_Sapitinib_GDSC2(7) | Colorectal Carcinoma	PIK3CG (14):	--3-- |  356_AT7867_GDSC1(8) |  1066_AZD6482_GDSC1(3) |  1048_Mirin_GDSC2(10) | Colorectal Carcinoma	PLCG1 (19):	--3-- |  208_Ispinesib Mesylate_GDSC1(12) |  1073_5-Fluorouracil_GDSC2(10) |  1372_Trametinib_GDSC2(14) | Colorectal Carcinoma	PPARG (10):	--3-- |  186_Bexarotene_GDSC1(3) |  1427_AZD5582_GDSC1(5) |  1250_AZ960_GDSC2(7) | Colorectal Carcinoma	PPM1D (13):	--4-- |  153_Midostaurin_GDSC1(4) |  300_CX-5461_GDSC1(7) |  1073_5-Fluorouracil_GDSC2(9) |  1249_BMS-345541_GDSC2(5) | Colorectal Carcinoma	PRKACA (15):	--3-- |  356_AT7867_GDSC1(6) |  1460_PARP_9482_GDSC1(8) |  1810_Mitoxantrone_GDSC2(10) | Colorectal Carcinoma	PRKCI (16):	--3-- |  300_CX-5461_GDSC1(8) |  1426_AZD7969_GDSC1(10) |  1553_Uprosertib_GDSC2(10) | Colorectal Carcinoma	PSMB2 (8):	--2-- |  300_CX-5461_GDSC1(5) |  1068_Obatoclax Mesylate_GDSC2(6) | Colorectal Carcinoma	RAF1 (16):	--3-- |  407_kb NB 142-70_GDSC1(10) |  428_Pemetrexed_GDSC1(10) |  2040_Foretinib_GDSC2(11) | Colorectal Carcinoma	RHEB (10):	--3-- |  437_Trichostatin A_GDSC1(6) |  1249_BMS-345541_GDSC2(5) |  1827_Dihydrorotenone_GDSC2(5) | Colorectal Carcinoma	RIT1 (5):	--2-- |  272_AR-42_GDSC1(3) |  382_Apitolisib_GDSC1(3) | Colorectal Carcinoma	RNASEH2A (7):	--3-- |  153_Midostaurin_GDSC1(3) |  186_Bexarotene_GDSC1(4) |  1720_AZD5991_GDSC2(3) | Colorectal Carcinoma	RRAGC (12):	--3-- |  153_Midostaurin_GDSC1(4) |  1014_Refametinib_GDSC2(8) |  1080_Paclitaxel_GDSC2(5) | Colorectal Carcinoma	RRAS (8):	--2-- |  1089_Oxaliplatin_GDSC2(5) |  1250_AZ960_GDSC2(5) | Colorectal Carcinoma	RUNX1T1 (20):	--3-- |  366_TWS119_GDSC1(12) |  1053_MK-2206_GDSC1(9) |  1048_Mirin_GDSC2(12) | Colorectal Carcinoma	SCG5 (7):	--3-- |  171_AKT inhibitor VIII_GDSC1(2) |  221_TAK-715_GDSC1(4) |  288_WHI-P97_GDSC1(2) | Colorectal Carcinoma	SET (7):	--3-- |  288_WHI-P97_GDSC1(2) |  1050_ZM447439_GDSC1(4) |  1143_HG-5-88-01_GDSC1(3) | Colorectal Carcinoma	SETD1A (19):	--4-- |  71_Pyrimethamine_GDSC1(3) |  208_Ispinesib Mesylate_GDSC1(12) |  1372_Trametinib_GDSC2(13) |  1558_Lapatinib_GDSC2(9) | Colorectal Carcinoma	SF3B1 (18):	--3-- |  208_Ispinesib Mesylate_GDSC1(11) |  1048_Mirin_GDSC2(10) |  1372_Trametinib_GDSC2(13) | Colorectal Carcinoma	SHOC2 (9):	--3-- |  1015_CI-1040_GDSC1(3) |  1068_Obatoclax Mesylate_GDSC2(7) |  2171_BMS-754807_GDSC2(4) | Colorectal Carcinoma	SMO (20):	--5-- |  153_Midostaurin_GDSC1(6) |  300_CX-5461_GDSC1(9) |  1133_Serdemetan_GDSC1(5) |  1060_PD0325901_GDSC2(13) |  1613_VE-822_GDSC2(4) | Colorectal Carcinoma	SMYD3 (19):	--3-- |  203_BMS-345541_GDSC1(11) |  1266_ICL1100013_GDSC1(12) |  1464_TTK_3146_GDSC1(11) | Colorectal Carcinoma	SOS1 (20):	--3-- |  208_Ispinesib Mesylate_GDSC1(12) |  1046_Wee1 Inhibitor_GDSC2(12) |  1401_AZD5438_GDSC2(12) | Colorectal Carcinoma	SOX2 (3):	--2-- |  1019_Bosutinib_GDSC1(2) |  1434_JAK3_7406_GDSC1(2) | Colorectal Carcinoma	STAT6 (19):	--3-- |  208_Ispinesib Mesylate_GDSC1(12) |  1048_Mirin_GDSC2(11) |  1372_Trametinib_GDSC2(14) | Colorectal Carcinoma	SYK (13):	--3-- |  356_AT7867_GDSC1(6) |  1048_Mirin_GDSC1(5) |  1048_Mirin_GDSC2(8) | Colorectal Carcinoma	TAL1 (3):	--2-- |  272_AR-42_GDSC1(1) |  326_GSK690693_GDSC1(2) | Colorectal Carcinoma	TCL1A (5):	--2-- |  1578_Leflunomide_GDSC2(3) |  1613_VE-822_GDSC2(3) | Colorectal Carcinoma	TLX1 (3):	--2-- |  1631_PRT062607_GDSC2(2) |  1834_743380_GDSC2(2) | Colorectal Carcinoma	TLX3 (5):	--3-- |  287_KIN001-244_GDSC1(3) |  1133_Serdemetan_GDSC1(2) |  1430_IGFR_3801_GDSC1(2) | Colorectal Carcinoma	TRIM27 (11):	--3-- |  1427_AZD5582_GDSC1(5) |  1006_Cytarabine_GDSC2(5) |  1250_AZ960_GDSC2(7) | Colorectal Carcinoma	VAV2 (23):	--3-- |  151_QS11_GDSC1(9) |  208_Ispinesib Mesylate_GDSC1(14) |  1401_AZD5438_GDSC2(14) | Colorectal Carcinoma	VEGFA (8):	--2-- |  153_Midostaurin_GDSC1(4) |  1427_AZD5582_GDSC1(5) | Colorectal Carcinoma	WWTR1 (14):	--4-- |  203_BMS-345541_GDSC1(9) |  372_Pilaralisib_GDSC1(3) |  1732_TAF1_5496_GDSC2(4) |  2040_Foretinib_GDSC2(10) | Colorectal Carcinoma	XBP1 (5):	--2-- |  94_TGX221_GDSC1(2) |  1624_I-BET-762_GDSC2(3) | Colorectal Carcinoma	YAP1 (12):	--3-- |  372_Pilaralisib_GDSC1(3) |  439_LCL161_GDSC1(5) |  1809_Teniposide_GDSC2(7) | Endometrial Carcinoma	ABL2 (5):	--2-- |  1490_SN-38_GDSC1(4) |  1059_AZD8055_GDSC2(1) | Endometrial Carcinoma	AGO1 (4):	--2-- |  245_UNC0638_GDSC1(3) |  1413_EphB4_9721_GDSC1(1) | Endometrial Carcinoma	BCL3 (4):	--2-- |  1015_CI-1040_GDSC1(3) |  1021_Axitinib_GDSC2(3) | Endometrial Carcinoma	CCNE1 (4):	--2-- |  291_KIN001-266_GDSC1(3) |  1021_Axitinib_GDSC2(3) | Endometrial Carcinoma	FGFR3 (6):	--2-- |  1239_YK-4-279_GDSC2(5) |  1511_Epirubicin_GDSC2(5) | Endometrial Carcinoma	FLT4 (4):	--2-- |  158_PF-562271_GDSC1(3) |  199_Pazopanib_GDSC1(3) | Endometrial Carcinoma	FURIN (4):	--2-- |  156_AZD6482_GDSC1(3) |  199_Pazopanib_GDSC1(3) | Endometrial Carcinoma	FYN (6):	--2-- |  184_BMS-754807_GDSC1(4) |  1266_ICL1100013_GDSC1(5) | Endometrial Carcinoma	GNA11 (4):	--2-- |  245_UNC0638_GDSC1(3) |  1413_EphB4_9721_GDSC1(1) | Endometrial Carcinoma	KDR (4):	--2-- |  1007_Docetaxel_GDSC2(3) |  1732_TAF1_5496_GDSC2(3) | Endometrial Carcinoma	MAPK3 (5):	--2-- |  1490_SN-38_GDSC1(4) |  1059_AZD8055_GDSC2(1) | Endometrial Carcinoma	MPL (4):	--2-- |  291_KIN001-266_GDSC1(3) |  1015_CI-1040_GDSC1(3) | Endometrial Carcinoma	MST1R (4):	--2-- |  1007_Docetaxel_GDSC2(3) |  1732_TAF1_5496_GDSC2(3) | Endometrial Carcinoma	PDCD1 (4):	--2-- |  158_PF-562271_GDSC1(3) |  199_Pazopanib_GDSC1(3) | Endometrial Carcinoma	PDCD1LG2 (4):	--2-- |  1007_Docetaxel_GDSC2(3) |  1732_TAF1_5496_GDSC2(3) | Endometrial Carcinoma	SF3B1 (4):	--2-- |  1037_BX795_GDSC1(3) |  1021_Axitinib_GDSC2(3) | Endometrial Carcinoma	STAT6 (4):	--2-- |  245_UNC0638_GDSC1(3) |  1413_EphB4_9721_GDSC1(1) | Endometrial Carcinoma	TFE3 (4):	--2-- |  291_KIN001-266_GDSC1(3) |  1037_BX795_GDSC1(3) | Endometrial Carcinoma	YY1 (4):	--2-- |  291_KIN001-266_GDSC1(3) |  1015_CI-1040_GDSC1(3) | Esophageal Squamous Cell Carcinoma	ABL1 (7):	--2-- |  158_PF-562271_GDSC1(5) |  185_Linsitinib_GDSC1(4) | Esophageal Squamous Cell Carcinoma	ABL2 (10):	--3-- |  219_AT-7519_GDSC1(4) |  268_Sepantronium bromide_GDSC1(6) |  2149_CT7033-2_GDSC2(4) | Esophageal Squamous Cell Carcinoma	ADHFE1 (6):	--3-- |  199_Pazopanib_GDSC1(4) |  1561_Taselisib_GDSC2(3) |  1843_LMP744_GDSC2(2) | Esophageal Squamous Cell Carcinoma	ARHGEF28 (14):	--3-- |  163_JQ1_GDSC1(8) |  1593_Entinostat_GDSC2(7) |  1829_667880_GDSC2(6) | Esophageal Squamous Cell Carcinoma	AXL (8):	--2-- |  380_BIBF-1120_GDSC1(5) |  1451_PLK_6522_GDSC1(5) | Esophageal Squamous Cell Carcinoma	CCNB3 (4):	--2-- |  186_Bexarotene_GDSC1(2) |  1624_I-BET-762_GDSC2(2) | Esophageal Squamous Cell Carcinoma	CDK6 (5):	--3-- |  194_Luminespib_GDSC1(3) |  268_Sepantronium bromide_GDSC1(1) |  1392_Bleomycin (10 uM)_GDSC1(2) | Esophageal Squamous Cell Carcinoma	CXCR4 (3):	--2-- |  574_Wnt-C59_GDSC1(2) |  1054_Palbociclib_GDSC2(2) | Esophageal Squamous Cell Carcinoma	CYSLTR2 (4):	--2-- |  436_CAP-232, TT-232, TLN-232_GDSC1(3) |  1849_Sabutoclax_GDSC2(2) | Esophageal Squamous Cell Carcinoma	DCUN1D1 (6):	--3-- |  287_KIN001-244_GDSC1(3) |  428_Pemetrexed_GDSC1(4) |  2044_Pyridostatin_GDSC2(3) | Esophageal Squamous Cell Carcinoma	DOT1L (13):	--2-- |  1170_CCT-018159_GDSC1(9) |  1048_Mirin_GDSC2(8) | Esophageal Squamous Cell Carcinoma	EGFL7 (8):	--3-- |  156_AZD6482_GDSC1(3) |  1053_MK-2206_GDSC1(5) |  1847_BEN_GDSC2(4) | Esophageal Squamous Cell Carcinoma	ERG (5):	--2-- |  204_Tipifarnib_GDSC1(3) |  432_Flavopiridol_GDSC1(3) | Esophageal Squamous Cell Carcinoma	EZH1 (9):	--2-- |  163_JQ1_GDSC1(4) |  2040_Foretinib_GDSC2(6) | Esophageal Squamous Cell Carcinoma	FGF4 (6):	--2-- |  300_CX-5461_GDSC1(4) |  2111_VE821_GDSC2(3) | Esophageal Squamous Cell Carcinoma	FGFR4 (5):	--2-- |  1007_Docetaxel_GDSC1(3) |  1847_BEN_GDSC2(3) | Esophageal Squamous Cell Carcinoma	FLT3 (10):	--2-- |  461_NSC319726_GDSC1(6) |  1529_Pevonedistat_GDSC2(6) | Esophageal Squamous Cell Carcinoma	FYN (6):	--2-- |  229_Enzastaurin_GDSC1(4) |  1926_GNE-317_GDSC2(3) | Esophageal Squamous Cell Carcinoma	GAB2 (9):	--2-- |  245_UNC0638_GDSC1(6) |  1080_Paclitaxel_GDSC2(5) | Esophageal Squamous Cell Carcinoma	GTF2I (9):	--3-- |  1008_Methotrexate_GDSC1(4) |  1054_Palbociclib_GDSC1(6) |  1593_Entinostat_GDSC2(5) | Esophageal Squamous Cell Carcinoma	HMGA1 (4):	--3-- |  1187_CCT245232_GDSC1(2) |  1843_LMP744_GDSC2(1) |  1926_GNE-317_GDSC2(2) | Esophageal Squamous Cell Carcinoma	IKBKE (12):	--2-- |  164_JQ12_GDSC1(6) |  1032_Afatinib_GDSC2(8) | Esophageal Squamous Cell Carcinoma	KDR (5):	--2-- |  172_Embelin_GDSC1(3) |  1812_Bleomycin_GDSC2(2) | Esophageal Squamous Cell Carcinoma	KIT (7):	--2-- |  225_Genentech Cpd 10_GDSC1(4) |  1005_Cisplatin_GDSC1(5) | Esophageal Squamous Cell Carcinoma	LYN (8):	--2-- |  308_Foretinib_GDSC1(5) |  474_ARRY-520_GDSC1(5) | Esophageal Squamous Cell Carcinoma	MAP2K2 (8):	--3-- |  1031_Elesclomol_GDSC1(5) |  1080_Paclitaxel_GDSC2(5) |  1248_Daporinad_GDSC2(2) | Esophageal Squamous Cell Carcinoma	MAPK1 (4):	--2-- |  135_Gemcitabine_GDSC1(1) |  1062_Selumetinib_GDSC2(3) | Esophageal Squamous Cell Carcinoma	MDM4 (9):	--2-- |  134_Etoposide_GDSC1(5) |  1919_Osimertinib_GDSC2(5) | Esophageal Squamous Cell Carcinoma	MLLT3 (7):	--3-- |  163_JQ1_GDSC1(3) |  1022_AZD7762_GDSC1(3) |  1016_Temsirolimus_GDSC2(4) | Esophageal Squamous Cell Carcinoma	MSI1 (5):	--3-- |  1050_ZM447439_GDSC1(3) |  1359_965-D2_GDSC1(2) |  1069_EHT-1864_GDSC2(2) | Esophageal Squamous Cell Carcinoma	NCSTN (3):	--2-- |  317_WYE-125132_GDSC1(1) |  1908_Ulixertinib_GDSC2(2) | Esophageal Squamous Cell Carcinoma	NSD2 (8):	--3-- |  326_GSK690693_GDSC1(3) |  1613_VE-822_GDSC2(4) |  1939_UMI-77_GDSC2(5) | Esophageal Squamous Cell Carcinoma	NTRK2 (6):	--2-- |  283_Omipalisib_GDSC1(3) |  1739_JAK_8517_GDSC2(3) | Esophageal Squamous Cell Carcinoma	PIK3CA (11):	--3-- |  226_GSK1070916_GDSC1(5) |  1026_Tanespimycin_GDSC1(6) |  1496_Cisplatin_GDSC1(6) | Esophageal Squamous Cell Carcinoma	PIK3CG (6):	--3-- |  576_RU-SKI 43_GDSC1(2) |  1378_Bleomycin (50 uM)_GDSC1(4) |  1561_Taselisib_GDSC2(3) | Esophageal Squamous Cell Carcinoma	PPARG (3):	--2-- |  288_WHI-P97_GDSC1(2) |  1618_GSK2606414_GDSC2(2) | Esophageal Squamous Cell Carcinoma	PPM1D (7):	--2-- |  415_CPI-613_GDSC1(4) |  1026_Tanespimycin_GDSC2(3) | Esophageal Squamous Cell Carcinoma	PRKACA (7):	--3-- |  268_Sepantronium bromide_GDSC1(2) |  283_Omipalisib_GDSC1(4) |  308_Foretinib_GDSC1(4) | Esophageal Squamous Cell Carcinoma	RAC1 (11):	--3-- |  1496_Cisplatin_GDSC1(7) |  1378_Bleomycin (50 uM)_GDSC2(6) |  1912_Afuresertib_GDSC2(8) | Esophageal Squamous Cell Carcinoma	RET (6):	--3-- |  260_NG-25_GDSC1(4) |  574_Wnt-C59_GDSC1(3) |  1249_BMS-345541_GDSC2(3) | Esophageal Squamous Cell Carcinoma	SMO (6):	--2-- |  140_Vinorelbine_GDSC1(3) |  1919_Osimertinib_GDSC2(4) | Esophageal Squamous Cell Carcinoma	SRC (8):	--2-- |  283_Omipalisib_GDSC1(5) |  1248_Daporinad_GDSC1(3) | Esophageal Squamous Cell Carcinoma	STAT5A (4):	--2-- |  186_Bexarotene_GDSC1(2) |  439_LCL161_GDSC1(2) | Esophageal Squamous Cell Carcinoma	TAL1 (3):	--2-- |  552_BAM7_GDSC1(2) |  1451_PLK_6522_GDSC1(1) | Esophageal Squamous Cell Carcinoma	TERT (8):	--4-- |  252_WZ3105_GDSC1(5) |  308_Foretinib_GDSC1(5) |  1050_ZM447439_GDSC1(4) |  1128_FS106_GDSC1(5) | Ewing's Sarcoma	ADHFE1 (4):	--2-- |  3_Rapamycin_GDSC1(3) |  1089_Oxaliplatin_GDSC2(3) | Ewing's Sarcoma	ARID3B (5):	--3-- |  376_Brivanib, BMS-540215_GDSC1(3) |  1738_IGF1R_3801_GDSC2(2) |  1803_Acetalax_GDSC2(3) | Ewing's Sarcoma	ATXN7 (4):	--2-- |  257_NPK76-II-72-1_GDSC1(2) |  1261_rTRAIL_GDSC1(3) | Ewing's Sarcoma	BCL9 (3):	--2-- |  1359_965-D2_GDSC1(2) |  1999_N25720-51-A1_GDSC2(2) | Ewing's Sarcoma	BRAF (4):	--2-- |  1618_GSK2606414_GDSC2(2) |  1918_AZD8186_GDSC2(3) | Ewing's Sarcoma	CDK6 (4):	--2-- |  127_GSK269962A_GDSC1(2) |  1052_RO-3306_GDSC2(3) | Ewing's Sarcoma	CSF3R (4):	--2-- |  362_CI-1033_GDSC1(2) |  1196_FY069_GDSC1(3) | Ewing's Sarcoma	DDR2 (4):	--3-- |  173_FH535_GDSC1(1) |  287_KIN001-244_GDSC1(2) |  1490_SN-38_GDSC1(2) | Ewing's Sarcoma	EGFR (4):	--2-- |  298_OSI-930_GDSC1(2) |  1175_Rucaparib_GDSC2(2) | Ewing's Sarcoma	FLT4 (3):	--2-- |  59_WZ-1-84_GDSC1(2) |  225_Genentech Cpd 10_GDSC1(1) | Ewing's Sarcoma	FUS (3):	--2-- |  111_Salubrinal_GDSC1(2) |  127_GSK269962A_GDSC1(2) | Ewing's Sarcoma	GTF2I (4):	--2-- |  171_AKT inhibitor VIII_GDSC1(2) |  2047_Ulixertinib_GDSC2(3) | Ewing's Sarcoma	INSR (4):	--2-- |  9_MG-132_GDSC1(3) |  1910_ABT737_GDSC2(2) | Ewing's Sarcoma	JAK2 (5):	--3-- |  179_5-Fluorouracil_GDSC1(2) |  257_NPK76-II-72-1_GDSC1(2) |  1051_Alisertib_GDSC2(2) | Ewing's Sarcoma	KIT (4):	--2-- |  376_Brivanib, BMS-540215_GDSC1(3) |  1191_Bortezomib_GDSC2(2) | Ewing's Sarcoma	LTK (3):	--2-- |  56_WH-4-023_GDSC1(2) |  1024_Lestaurtinib_GDSC2(1) | Ewing's Sarcoma	MLLT10 (3):	--2-- |  59_WZ-1-84_GDSC1(2) |  225_Genentech Cpd 10_GDSC1(1) | Ewing's Sarcoma	NUP98 (7):	--2-- |  1626_OTX015_GDSC2(5) |  1922_Cediranib_GDSC2(4) | Ewing's Sarcoma	PDGFRB (4):	--2-- |  127_GSK269962A_GDSC1(2) |  1170_CCT-018159_GDSC1(3) | Ewing's Sarcoma	PIK3CA (3):	--2-- |  59_WZ-1-84_GDSC1(2) |  225_Genentech Cpd 10_GDSC1(1) | Ewing's Sarcoma	RICTOR (5):	--3-- |  291_KIN001-266_GDSC1(2) |  1006_Cytarabine_GDSC1(2) |  1007_Docetaxel_GDSC1(2) | Ewing's Sarcoma	ROS1 (3):	--2-- |  1249_BMS-345541_GDSC2(2) |  1558_Lapatinib_GDSC2(2) | Ewing's Sarcoma	SETBP1 (4):	--2-- |  1089_Oxaliplatin_GDSC2(3) |  1997_WEHI-539_GDSC2(3) | Ewing's Sarcoma	SGK1 (3):	--2-- |  298_OSI-930_GDSC1(2) |  1021_Axitinib_GDSC1(2) | Ewing's Sarcoma	SHOC2 (4):	--2-- |  1046_Wee1 Inhibitor_GDSC1(2) |  1844_776928_GDSC2(2) | Ewing's Sarcoma	SOS1 (4):	--2-- |  1046_Wee1 Inhibitor_GDSC1(2) |  1844_776928_GDSC2(2) | Ewing's Sarcoma	SQSTM1 (3):	--2-- |  1131_PRIMA-1MET_GDSC2(2) |  1786_AZD4547_GDSC2(2) | Ewing's Sarcoma	UBR5 (8):	--3-- |  51_Dasatinib_GDSC1(4) |  203_BMS-345541_GDSC1(3) |  1463_AZD1332_GDSC1(4) | Ewing's Sarcoma	WWTR1 (4):	--2-- |  1451_PLK_6522_GDSC1(2) |  2148_POMHEX_GDSC2(2) | Gastric Carcinoma	ACVR1 (12):	--3-- |  219_AT-7519_GDSC1(7) |  1032_Afatinib_GDSC1(5) |  1168_Erlotinib_GDSC2(4) | Gastric Carcinoma	ADHFE1 (4):	--2-- |  262_VX-11e_GDSC1(2) |  1168_Erlotinib_GDSC2(3) | Gastric Carcinoma	ATF1 (3):	--2-- |  238_Idelalisib_GDSC1(2) |  255_CP724714_GDSC1(2) | Gastric Carcinoma	AXL (7):	--2-- |  376_Brivanib, BMS-540215_GDSC1(3) |  1249_BMS-345541_GDSC2(5) | Gastric Carcinoma	BCL2 (4):	--2-- |  293_Amuvatinib_GDSC1(3) |  1069_EHT-1864_GDSC2(2) | Gastric Carcinoma	CCND3 (8):	--3-- |  176_IPA-3_GDSC1(4) |  380_BIBF-1120_GDSC1(3) |  1736_Selumetinib_GDSC2(4) | Gastric Carcinoma	CCNE1 (10):	--2-- |  1219_PFI-1_GDSC1(6) |  2096_VX-11e_GDSC2(7) | Gastric Carcinoma	CD28 (3):	--2-- |  1168_Erlotinib_GDSC2(2) |  1919_Osimertinib_GDSC2(2) | Gastric Carcinoma	CSF3R (14):	--4-- |  171_AKT inhibitor VIII_GDSC1(5) |  1236_UNC0638_GDSC1(6) |  1372_Trametinib_GDSC2(6) |  1578_Leflunomide_GDSC2(7) | Gastric Carcinoma	DCUN1D1 (5):	--3-- |  176_IPA-3_GDSC1(3) |  1022_AZD7762_GDSC1(3) |  1495_Olaparib_GDSC1(2) | Gastric Carcinoma	DDX4 (5):	--2-- |  170_Shikonin_GDSC1(2) |  1036_PLX-4720_GDSC2(3) | Gastric Carcinoma	EPOR (3):	--2-- |  151_QS11_GDSC1(2) |  1613_VE-822_GDSC2(2) | Gastric Carcinoma	ERBB4 (11):	--4-- |  156_AZD6482_GDSC1(4) |  1236_UNC0638_GDSC1(4) |  1249_BMS-345541_GDSC2(5) |  1372_Trametinib_GDSC2(4) | Gastric Carcinoma	ETV5 (3):	--2-- |  576_RU-SKI 43_GDSC1(2) |  1624_I-BET-762_GDSC2(2) | Gastric Carcinoma	FGF3 (5):	--2-- |  170_Shikonin_GDSC1(2) |  1510_Linsitinib_GDSC2(3) | Gastric Carcinoma	FGFR2 (14):	--5-- |  172_Embelin_GDSC1(5) |  1021_Axitinib_GDSC1(5) |  1016_Temsirolimus_GDSC2(5) |  1053_MK-2206_GDSC2(8) |  2046_MK-8776_GDSC2(5) | Gastric Carcinoma	FGFR3 (5):	--2-- |  1720_AZD5991_GDSC2(4) |  1778_GSK2110183B_GDSC2(2) | Gastric Carcinoma	FGFR4 (3):	--2-- |  1185_KU-60019_GDSC1(2) |  1054_Palbociclib_GDSC2(2) | Gastric Carcinoma	FLT1 (12):	--3-- |  303_PIK-93_GDSC1(7) |  474_ARRY-520_GDSC1(7) |  1048_Mirin_GDSC1(5) | Gastric Carcinoma	FLT4 (13):	--4-- |  201_Epothilone B_GDSC1(7) |  204_Tipifarnib_GDSC1(7) |  1066_AZD6482_GDSC1(6) |  1261_rTRAIL_GDSC1(5) | Gastric Carcinoma	FUS (4):	--2-- |  275_I-BET-762_GDSC1(3) |  1451_PLK_6522_GDSC1(1) | Gastric Carcinoma	FYN (6):	--3-- |  435_C-75_GDSC1(2) |  1185_KU-60019_GDSC1(3) |  1054_Palbociclib_GDSC2(3) | Gastric Carcinoma	GNA12 (9):	--2-- |  221_TAK-715_GDSC1(6) |  303_PIK-93_GDSC1(6) | Gastric Carcinoma	GNAQ (7):	--3-- |  308_Foretinib_GDSC1(3) |  1062_Selumetinib_GDSC2(4) |  1511_Epirubicin_GDSC2(3) | Gastric Carcinoma	GNAS (16):	--3-- |  226_GSK1070916_GDSC1(9) |  436_CAP-232, TT-232, TLN-232_GDSC1(9) |  1494_SN-38_GDSC2(10) | Gastric Carcinoma	GNB1 (7):	--2-- |  199_Pazopanib_GDSC1(5) |  208_Ispinesib Mesylate_GDSC1(5) | Gastric Carcinoma	HDAC1 (3):	--2-- |  175_PAC-1_GDSC1(2) |  1069_EHT-1864_GDSC2(2) | Gastric Carcinoma	HMGA1 (8):	--3-- |  474_ARRY-520_GDSC1(4) |  1527_Pictilisib_GDSC1(3) |  1578_Leflunomide_GDSC2(5) | Gastric Carcinoma	IDH1 (3):	--2-- |  1449_AZD1208_GDSC1(2) |  1855_KRAS (G12C) Inhibitor-12_GDSC2(2) | Gastric Carcinoma	IL3 (4):	--2-- |  261_TL-1-85_GDSC1(2) |  1461_TANK_1366_GDSC1(2) | Gastric Carcinoma	IL6ST (8):	--2-- |  264_ACY-1215_GDSC1(5) |  1918_AZD8186_GDSC2(5) | Gastric Carcinoma	IRS1 (8):	--2-- |  177_GSK650394_GDSC1(4) |  1021_Axitinib_GDSC2(5) | Gastric Carcinoma	JAK2 (12):	--4-- |  1232_I-BET-151_GDSC1(5) |  1239_YK-4-279_GDSC1(4) |  1427_AZD5582_GDSC1(7) |  1804_Acetalax_GDSC2(5) | Gastric Carcinoma	MAP3K13 (12):	--2-- |  1135_AZD4547_GDSC1(7) |  1578_Leflunomide_GDSC2(7) | Gastric Carcinoma	MDM2 (5):	--3-- |  1248_Daporinad_GDSC1(1) |  1373_Dabrafenib_GDSC1(2) |  1997_WEHI-539_GDSC2(2) | Gastric Carcinoma	MEF2D (4):	--2-- |  1047_Nutlin-3a (-)_GDSC2(3) |  1736_Selumetinib_GDSC2(3) | Gastric Carcinoma	MPL (3):	--2-- |  376_Brivanib, BMS-540215_GDSC1(2) |  1129_PF-4708671_GDSC1(2) | Gastric Carcinoma	MSI1 (3):	--2-- |  1248_Daporinad_GDSC1(1) |  1373_Dabrafenib_GDSC1(2) | Gastric Carcinoma	NADK (4):	--3-- |  1058_Pictilisib_GDSC1(1) |  1266_ICL1100013_GDSC1(2) |  1372_Trametinib_GDSC1(1) | Gastric Carcinoma	NSD2 (15):	--4-- |  163_JQ1_GDSC1(6) |  1031_Elesclomol_GDSC1(5) |  1453_RAF_9304_GDSC1(8) |  1190_Gemcitabine_GDSC2(10) | Gastric Carcinoma	NTRK1 (13):	--3-- |  153_Midostaurin_GDSC1(6) |  310_YM201636_GDSC1(7) |  1426_AZD7969_GDSC1(6) | Gastric Carcinoma	NTRK2 (8):	--2-- |  310_YM201636_GDSC1(5) |  1183_CRT0160829_GDSC1(5) | Gastric Carcinoma	NTRK3 (14):	--3-- |  476_SB505124_GDSC1(10) |  1190_Gemcitabine_GDSC2(9) |  1511_Epirubicin_GDSC2(8) | Gastric Carcinoma	NUP214 (10):	--3-- |  179_5-Fluorouracil_GDSC1(6) |  1553_Uprosertib_GDSC2(6) |  1593_Entinostat_GDSC2(3) | Gastric Carcinoma	NUP98 (12):	--3-- |  171_AKT inhibitor VIII_GDSC1(5) |  310_YM201636_GDSC1(7) |  1553_Uprosertib_GDSC2(7) | Gastric Carcinoma	PIK3CB (9):	--2-- |  301_PHA-793887_GDSC1(6) |  1261_rTRAIL_GDSC1(4) | Gastric Carcinoma	PIK3CD (9):	--2-- |  1091_BMS-536924_GDSC1(6) |  1006_Cytarabine_GDSC2(5) | Gastric Carcinoma	PRKACA (9):	--3-- |  165_DMOG_GDSC1(3) |  285_SU11274_GDSC1(5) |  1187_CCT245232_GDSC1(4) | Gastric Carcinoma	RAC1 (8):	--3-- |  155_Ponatinib_GDSC1(4) |  171_AKT inhibitor VIII_GDSC1(4) |  1444_AZD8186_GDSC1(4) | Gastric Carcinoma	RAF1 (6):	--3-- |  153_Midostaurin_GDSC1(4) |  1185_KU-60019_GDSC1(3) |  1022_AZD7762_GDSC2(4) | Gastric Carcinoma	RHOA (8):	--3-- |  135_Gemcitabine_GDSC1(4) |  1036_PLX-4720_GDSC2(3) |  1510_Linsitinib_GDSC2(3) | Gastric Carcinoma	RRAGC (3):	--2-- |  255_CP724714_GDSC1(2) |  344_THZ-2-49_GDSC1(2) | Gastric Carcinoma	SET (4):	--2-- |  261_TL-1-85_GDSC1(2) |  1720_AZD5991_GDSC2(3) | Gastric Carcinoma	SGK1 (8):	--2-- |  260_NG-25_GDSC1(5) |  1062_Selumetinib_GDSC1(3) | Gastric Carcinoma	STAT3 (6):	--3-- |  300_CX-5461_GDSC1(3) |  344_THZ-2-49_GDSC1(3) |  1011_Navitoclax_GDSC1(4) | Gastric Carcinoma	STAT5B (5):	--2-- |  1243_Piperlongumine_GDSC1(2) |  1179_MK-1775_GDSC2(3) | Gastric Carcinoma	TRIM27 (3):	--2-- |  1168_Erlotinib_GDSC2(2) |  1840_630600_GDSC2(2) | Gastric Carcinoma	UBR5 (12):	--2-- |  303_PIK-93_GDSC1(8) |  1419_FEN1_3940_GDSC1(7) | Gastric Carcinoma	VAV2 (14):	--4-- |  171_AKT inhibitor VIII_GDSC1(5) |  476_SB505124_GDSC1(9) |  1046_Wee1 Inhibitor_GDSC2(4) |  1917_AZD6738_GDSC2(6) | Gastric Carcinoma	VEGFA (6):	--3-- |  272_AR-42_GDSC1(1) |  1068_Obatoclax Mesylate_GDSC2(3) |  1191_Bortezomib_GDSC2(3) | Gastric Carcinoma	XBP1 (7):	--3-- |  1242_(5Z)-7-Oxozeaenol_GDSC1(3) |  1578_Leflunomide_GDSC2(5) |  1855_KRAS (G12C) Inhibitor-12_GDSC2(3) | Gastric Carcinoma	XPO1 (5):	--2-- |  173_FH535_GDSC1(3) |  1259_Talazoparib_GDSC2(3) | Gastric Carcinoma	YES1 (3):	--2-- |  344_THZ-2-49_GDSC1(2) |  1430_IGFR_3801_GDSC1(1) | Glioblastoma	ABL1 (7):	--2-- |  328_SNX-2112_GDSC1(4) |  1494_SN-38_GDSC1(5) | Glioblastoma	AFF4 (4):	--2-- |  186_Bexarotene_GDSC1(2) |  1009_Tretinoin_GDSC1(3) | Glioblastoma	AR (3):	--2-- |  428_Pemetrexed_GDSC1(2) |  1197_ZL049_GDSC1(2) | Glioblastoma	BAALC (3):	--2-- |  1008_Methotrexate_GDSC1(2) |  1036_PLX-4720_GDSC1(2) | Glioblastoma	BCL3 (3):	--2-- |  294_MPS-1-IN-1_GDSC1(2) |  2096_VX-11e_GDSC2(2) | Glioblastoma	BTK (11):	--3-- |  295_NVP-BHG712_GDSC1(3) |  415_CPI-613_GDSC1(7) |  1232_I-BET-151_GDSC1(6) | Glioblastoma	CCND2 (5):	--3-- |  51_Dasatinib_GDSC1(2) |  1011_Navitoclax_GDSC2(3) |  1089_Oxaliplatin_GDSC2(2) | Glioblastoma	CD274 (6):	--2-- |  252_WZ3105_GDSC1(2) |  1052_RO-3306_GDSC2(4) | Glioblastoma	CDC42 (3):	--2-- |  1197_ZL049_GDSC1(2) |  2096_VX-11e_GDSC2(2) | Glioblastoma	COP1 (7):	--2-- |  1451_PLK_6522_GDSC1(5) |  1372_Trametinib_GDSC2(4) | Glioblastoma	CYP19A1 (3):	--2-- |  262_VX-11e_GDSC1(2) |  1177_Niraparib_GDSC2(2) | Glioblastoma	DNMT1 (14):	--3-- |  264_ACY-1215_GDSC1(9) |  342_Tenovin-6_GDSC1(10) |  1266_ICL1100013_GDSC1(7) | Glioblastoma	EGFL7 (11):	--3-- |  156_AZD6482_GDSC1(4) |  299_OSI-027_GDSC1(7) |  1024_Lestaurtinib_GDSC1(7) | Glioblastoma	EIF4A2 (6):	--2-- |  1005_Cisplatin_GDSC1(4) |  1409_AZD4877_GDSC1(4) | Glioblastoma	ERBB2 (8):	--3-- |  1392_Bleomycin (10 uM)_GDSC1(3) |  1190_Gemcitabine_GDSC2(5) |  2040_Foretinib_GDSC2(5) | Glioblastoma	ERBB3 (6):	--3-- |  180_Thapsigargin_GDSC1(4) |  299_OSI-027_GDSC1(3) |  1527_Pictilisib_GDSC1(2) | Glioblastoma	FGFR3 (7):	--2-- |  269_NSC-207895_GDSC1(3) |  1409_AZD4877_GDSC1(5) | Glioblastoma	FLI1 (5):	--2-- |  1008_Methotrexate_GDSC1(2) |  1060_PD0325901_GDSC2(3) | Glioblastoma	HMGA1 (8):	--2-- |  208_Ispinesib Mesylate_GDSC1(6) |  1617_AZD5582_GDSC2(5) | Glioblastoma	IDH2 (3):	--2-- |  1030_KU-55933_GDSC1(2) |  1261_rTRAIL_GDSC1(2) | Glioblastoma	IGF1 (3):	--2-- |  1197_ZL049_GDSC1(2) |  1261_rTRAIL_GDSC1(2) | Glioblastoma	KDM5A (9):	--2-- |  449_CD532_GDSC1(5) |  1232_I-BET-151_GDSC1(5) | Glioblastoma	KSR2 (15):	--3-- |  291_KIN001-266_GDSC1(9) |  1001_AICA Ribonucleotide_GDSC1(6) |  1407_Dyrk1b_0191_GDSC1(8) | Glioblastoma	LGR5 (3):	--2-- |  1732_TAF1_5496_GDSC2(2) |  2145_PBD-288_GDSC2(1) | Glioblastoma	MAP2K1 (5):	--3-- |  59_WZ-1-84_GDSC1(2) |  1009_Tretinoin_GDSC1(2) |  1564_SCH772984_GDSC2(3) | Glioblastoma	MAP4K4 (10):	--3-- |  252_WZ3105_GDSC1(6) |  304_SB52334_GDSC1(5) |  1261_rTRAIL_GDSC1(4) | Glioblastoma	MKI67 (11):	--3-- |  133_Doxorubicin_GDSC1(7) |  172_Embelin_GDSC1(8) |  302_PI-103_GDSC1(7) | Glioblastoma	MST1R (5):	--2-- |  252_WZ3105_GDSC1(2) |  372_Pilaralisib_GDSC1(4) | Glioblastoma	PDGFRA (4):	--2-- |  185_Linsitinib_GDSC1(2) |  197_Bryostatin 1_GDSC1(2) | Glioblastoma	PIK3CG (5):	--2-- |  295_NVP-BHG712_GDSC1(2) |  1052_RO-3306_GDSC2(3) | Glioblastoma	PRKCI (9):	--4-- |  331_QL-X-138_GDSC1(5) |  432_Flavopiridol_GDSC1(6) |  1142_HG-5-113-01_GDSC1(1) |  1393_Gemcitabine_GDSC1(4) | Glioblastoma	RAC1 (5):	--2-- |  230_GSK429286A_GDSC1(3) |  304_SB52334_GDSC1(3) | Glioblastoma	SETD1A (6):	--2-- |  159_HG6-64-1_GDSC1(4) |  1180_Dinaciclib_GDSC2(4) | Glioblastoma	SQSTM1 (5):	--3-- |  51_Dasatinib_GDSC1(1) |  1232_I-BET-151_GDSC1(2) |  1011_Navitoclax_GDSC2(3) | Glioblastoma	STAT3 (6):	--3-- |  328_SNX-2112_GDSC1(3) |  432_Flavopiridol_GDSC1(3) |  461_NSC319726_GDSC1(3) | Glioblastoma	STAT6 (5):	--2-- |  136_Mitomycin-C_GDSC1(3) |  1047_Nutlin-3a (-)_GDSC1(4) | Glioblastoma	TSHR (8):	--3-- |  1494_SN-38_GDSC1(6) |  1250_AZ960_GDSC2(4) |  1804_Acetalax_GDSC2(3) | Glioblastoma	TYK2 (5):	--3-- |  151_QS11_GDSC1(3) |  197_Bryostatin 1_GDSC1(2) |  1557_LCL161_GDSC2(2) | Glioma	BRAF (4):	--2-- |  260_NG-25_GDSC1(3) |  1016_Temsirolimus_GDSC2(1) | Glioma	DNMT1 (4):	--2-- |  1498_Selumetinib_GDSC1(3) |  1046_Wee1 Inhibitor_GDSC2(1) | Head and Neck Carcinoma	AXL (8):	--2-- |  171_AKT inhibitor VIII_GDSC1(5) |  372_Pilaralisib_GDSC1(4) | Head and Neck Carcinoma	CSF3R (4):	--2-- |  135_Gemcitabine_GDSC1(1) |  1425_BPTES_GDSC1(3) | Head and Neck Carcinoma	FGFR1 (4):	--2-- |  1249_BMS-345541_GDSC2(3) |  1915_AZD3759_GDSC2(3) | Head and Neck Carcinoma	GNAS (4):	--2-- |  249_Cabozantinib_GDSC1(2) |  260_NG-25_GDSC1(3) | Head and Neck Carcinoma	KDM5A (4):	--2-- |  133_Doxorubicin_GDSC1(1) |  1425_BPTES_GDSC1(3) | Head and Neck Carcinoma	MAP3K13 (3):	--2-- |  1008_Methotrexate_GDSC2(2) |  2044_Pyridostatin_GDSC2(2) | Head and Neck Carcinoma	NRG1 (4):	--2-- |  171_AKT inhibitor VIII_GDSC1(3) |  1421_FGFR_0939_GDSC1(2) | Head and Neck Carcinoma	NTRK2 (4):	--2-- |  249_Cabozantinib_GDSC1(2) |  1382_AZD3514_GDSC1(3) | Head and Neck Carcinoma	PLCG1 (4):	--3-- |  249_Cabozantinib_GDSC1(2) |  1428_IAP_5620_GDSC1(2) |  1495_Olaparib_GDSC1(2) | Head and Neck Carcinoma	PPM1D (4):	--2-- |  1382_AZD3514_GDSC1(3) |  1425_BPTES_GDSC1(3) | Head and Neck Carcinoma	PRKACA (4):	--2-- |  275_I-BET-762_GDSC1(3) |  375_Voxtalisib_GDSC1(3) | Head and Neck Carcinoma	REV3L (4):	--2-- |  194_Luminespib_GDSC1(2) |  1425_BPTES_GDSC1(3) | Head and Neck Carcinoma	RICTOR (6):	--2-- |  1026_Tanespimycin_GDSC1(3) |  1425_BPTES_GDSC1(4) | Hepatocellular Carcinoma	ARID3B (3):	--2-- |  375_Voxtalisib_GDSC1(2) |  2172_JQ1_GDSC2(2) | Hepatocellular Carcinoma	BRD3 (4):	--2-- |  1183_CRT0160829_GDSC1(3) |  1219_PFI-1_GDSC1(3) | Hepatocellular Carcinoma	CALR (4):	--2-- |  1026_Tanespimycin_GDSC2(3) |  1060_PD0325901_GDSC2(3) | Hepatocellular Carcinoma	CCND2 (3):	--2-- |  175_PAC-1_GDSC1(2) |  1091_BMS-536924_GDSC1(2) | Hepatocellular Carcinoma	CYP19A1 (5):	--2-- |  380_BIBF-1120_GDSC1(1) |  1810_Mitoxantrone_GDSC2(4) | Hepatocellular Carcinoma	DOT1L (6):	--2-- |  1011_Navitoclax_GDSC2(5) |  1713_ERK_2440_GDSC2(5) | Hepatocellular Carcinoma	EGFL7 (7):	--2-- |  155_Ponatinib_GDSC1(5) |  305_TPCA-1_GDSC1(5) | Hepatocellular Carcinoma	EGFR (5):	--2-- |  446_MIM1_GDSC1(4) |  1135_AZD4547_GDSC1(4) | Hepatocellular Carcinoma	ERBB3 (6):	--2-- |  1192_GSK269962A_GDSC1(2) |  1416_AZD8931_GDSC1(5) | Hepatocellular Carcinoma	ERBB4 (7):	--2-- |  1561_Taselisib_GDSC2(5) |  1713_ERK_2440_GDSC2(5) | Hepatocellular Carcinoma	FGFR2 (6):	--2-- |  1086_BI-2536_GDSC2(4) |  1091_BMS-536924_GDSC2(5) | Hepatocellular Carcinoma	GNA12 (4):	--2-- |  301_PHA-793887_GDSC1(3) |  1714_ERK_6604_GDSC2(3) | Hepatocellular Carcinoma	GNAS (4):	--2-- |  1011_Navitoclax_GDSC1(3) |  1188_CCT245467_GDSC1(3) | Hepatocellular Carcinoma	GTF2I (4):	--2-- |  1835_Elephantin_GDSC2(3) |  1910_ABT737_GDSC2(3) | Hepatocellular Carcinoma	IDH2 (3):	--2-- |  1062_Selumetinib_GDSC1(2) |  1091_BMS-536924_GDSC1(2) | Hepatocellular Carcinoma	IGF2 (3):	--2-- |  1062_Selumetinib_GDSC1(2) |  1091_BMS-536924_GDSC1(2) | Hepatocellular Carcinoma	LMO2 (3):	--2-- |  375_Voxtalisib_GDSC1(2) |  1091_BMS-536924_GDSC1(2) | Hepatocellular Carcinoma	MSI2 (7):	--2-- |  203_BMS-345541_GDSC1(5) |  1617_AZD5582_GDSC2(4) | Hepatocellular Carcinoma	NCSTN (4):	--2-- |  285_SU11274_GDSC1(3) |  1021_Axitinib_GDSC1(2) | Hepatocellular Carcinoma	PDCD1LG2 (5):	--2-- |  208_Ispinesib Mesylate_GDSC1(3) |  224_AS605240_GDSC1(4) | Hepatocellular Carcinoma	RAC1 (5):	--2-- |  269_NSC-207895_GDSC1(4) |  1808_Topotecan_GDSC2(4) | Hepatocellular Carcinoma	SF3B1 (4):	--2-- |  208_Ispinesib Mesylate_GDSC1(3) |  476_SB505124_GDSC1(3) | Hepatocellular Carcinoma	TERT (3):	--2-- |  1062_Selumetinib_GDSC1(2) |  1091_BMS-536924_GDSC1(2) | Hepatocellular Carcinoma	USP8 (7):	--2-- |  287_KIN001-244_GDSC1(5) |  1086_BI-2536_GDSC2(4) | Kidney Carcinoma	AFF4 (5):	--2-- |  1084_Rapamycin_GDSC2(3) |  1085_Sorafenib_GDSC2(3) | Kidney Carcinoma	ARID3B (4):	--2-- |  317_WYE-125132_GDSC1(2) |  1049_PD173074_GDSC2(3) | Kidney Carcinoma	ATXN7 (5):	--3-- |  1432_AZD1480_GDSC1(3) |  1047_Nutlin-3a (-)_GDSC2(3) |  1168_Erlotinib_GDSC2(3) | Kidney Carcinoma	BAALC (5):	--2-- |  261_TL-1-85_GDSC1(3) |  1085_Sorafenib_GDSC2(3) | Kidney Carcinoma	BCL6 (6):	--2-- |  1378_Bleomycin (50 uM)_GDSC1(4) |  1422_FGFR_3831_GDSC1(3) | Kidney Carcinoma	BRD3 (5):	--2-- |  256_JW-7-24-1_GDSC1(2) |  1085_Sorafenib_GDSC2(3) | Kidney Carcinoma	BRD4 (6):	--2-- |  1022_AZD7762_GDSC1(4) |  1378_Bleomycin (50 uM)_GDSC1(4) | Kidney Carcinoma	CCND1 (3):	--3-- |  159_HG6-64-1_GDSC1(1) |  1012_Vorinostat_GDSC1(1) |  2040_Foretinib_GDSC2(1) | Kidney Carcinoma	CDK6 (3):	--2-- |  1010_Gefitinib_GDSC1(2) |  1096_Tozasertib_GDSC2(2) | Kidney Carcinoma	COP1 (8):	--2-- |  1197_ZL049_GDSC1(3) |  1080_Paclitaxel_GDSC2(5) | Kidney Carcinoma	DDR2 (4):	--2-- |  134_Etoposide_GDSC1(1) |  1432_AZD1480_GDSC1(3) | Kidney Carcinoma	DDX4 (6):	--2-- |  1378_Bleomycin (50 uM)_GDSC1(4) |  1038_NU7441_GDSC2(4) | Kidney Carcinoma	DNMT1 (11):	--3-- |  1183_CRT0160829_GDSC1(3) |  1392_Bleomycin (10 uM)_GDSC1(5) |  1179_MK-1775_GDSC2(6) | Kidney Carcinoma	ERBB2 (6):	--2-- |  1490_SN-38_GDSC1(4) |  1037_BX795_GDSC2(3) | Kidney Carcinoma	EWSR1 (3):	--2-- |  1197_ZL049_GDSC1(2) |  1360_993-D2_GDSC1(2) | Kidney Carcinoma	FGFR4 (5):	--2-- |  1378_Bleomycin (50 uM)_GDSC1(3) |  1422_FGFR_3831_GDSC1(3) | Kidney Carcinoma	FLT3 (4):	--2-- |  1084_Rapamycin_GDSC2(3) |  1578_Leflunomide_GDSC2(2) | Kidney Carcinoma	GNA12 (6):	--2-- |  1378_Bleomycin (50 uM)_GDSC1(4) |  1422_FGFR_3831_GDSC1(3) | Kidney Carcinoma	GSK3B (3):	--2-- |  1031_Elesclomol_GDSC1(1) |  1060_PD0325901_GDSC2(2) | Kidney Carcinoma	HDAC7 (10):	--3-- |  133_Doxorubicin_GDSC1(4) |  449_CD532_GDSC1(5) |  1416_AZD8931_GDSC1(7) | Kidney Carcinoma	INSR (6):	--2-- |  1378_Bleomycin (50 uM)_GDSC1(4) |  1422_FGFR_3831_GDSC1(3) | Kidney Carcinoma	JAK2 (9):	--2-- |  1062_Selumetinib_GDSC1(6) |  1079_Dasatinib_GDSC2(5) | Kidney Carcinoma	MECOM (7):	--2-- |  1378_Bleomycin (50 uM)_GDSC1(5) |  1416_AZD8931_GDSC1(4) | Kidney Carcinoma	MPL (4):	--2-- |  1490_SN-38_GDSC1(2) |  1037_BX795_GDSC2(3) | Kidney Carcinoma	NCOA3 (5):	--3-- |  228_AKT inhibitor VIII_GDSC1(3) |  261_TL-1-85_GDSC1(3) |  287_KIN001-244_GDSC1(3) | Kidney Carcinoma	NR4A3 (4):	--2-- |  1578_Leflunomide_GDSC2(2) |  2096_VX-11e_GDSC2(3) | Kidney Carcinoma	NT5C2 (8):	--2-- |  256_JW-7-24-1_GDSC1(4) |  268_Sepantronium bromide_GDSC1(5) | Kidney Carcinoma	NTRK1 (8):	--2-- |  1008_Methotrexate_GDSC2(4) |  1932_NVP-ADW742_GDSC2(5) | Kidney Carcinoma	NUP214 (10):	--3-- |  1026_Tanespimycin_GDSC1(4) |  1038_NU7441_GDSC2(6) |  1048_Mirin_GDSC2(5) | Kidney Carcinoma	NUP98 (7):	--2-- |  382_Apitolisib_GDSC1(5) |  1012_Vorinostat_GDSC1(4) | Kidney Carcinoma	PAK5 (5):	--3-- |  135_Gemcitabine_GDSC1(1) |  1463_AZD1332_GDSC1(2) |  1179_MK-1775_GDSC2(2) | Kidney Carcinoma	PDGFRA (9):	--2-- |  165_DMOG_GDSC1(5) |  264_ACY-1215_GDSC1(4) | Kidney Carcinoma	PIK3CB (6):	--2-- |  154_CHIR-99021_GDSC1(3) |  1022_AZD7762_GDSC1(4) | Kidney Carcinoma	PIK3CD (6):	--3-- |  1378_Bleomycin (50 uM)_GDSC1(3) |  1422_FGFR_3831_GDSC1(3) |  1048_Mirin_GDSC2(4) | Kidney Carcinoma	PLCG1 (7):	--2-- |  1378_Bleomycin (50 uM)_GDSC1(5) |  2171_BMS-754807_GDSC2(5) | Kidney Carcinoma	RET (7):	--2-- |  1378_Bleomycin (50 uM)_GDSC1(5) |  1422_FGFR_3831_GDSC1(4) | Kidney Carcinoma	REV3L (8):	--2-- |  208_Ispinesib Mesylate_GDSC1(4) |  1048_Mirin_GDSC2(5) | Kidney Carcinoma	ROS1 (7):	--2-- |  1378_Bleomycin (50 uM)_GDSC1(5) |  1490_SN-38_GDSC1(5) | Kidney Carcinoma	SETD1A (8):	--2-- |  1048_Mirin_GDSC1(5) |  2171_BMS-754807_GDSC2(5) | Kidney Carcinoma	SGK1 (6):	--3-- |  1052_RO-3306_GDSC1(2) |  1038_NU7441_GDSC2(4) |  1593_Entinostat_GDSC2(4) | Kidney Carcinoma	SMO (5):	--2-- |  285_SU11274_GDSC1(3) |  1908_Ulixertinib_GDSC2(2) | Kidney Carcinoma	SYK (3):	--2-- |  317_WYE-125132_GDSC1(1) |  1432_AZD1480_GDSC1(2) | Kidney Carcinoma	TSHR (6):	--3-- |  203_BMS-345541_GDSC1(4) |  258_STF-62247_GDSC1(3) |  261_TL-1-85_GDSC1(3) | Kidney Carcinoma	VAV1 (11):	--2-- |  223_ZSTK474_GDSC1(7) |  1179_MK-1775_GDSC2(7) | Melanoma	ABL1 (8):	--3-- |  165_DMOG_GDSC1(4) |  300_CX-5461_GDSC1(4) |  1738_IGF1R_3801_GDSC2(4) | Melanoma	ABL2 (12):	--2-- |  362_CI-1033_GDSC1(8) |  1004_Vinblastine_GDSC1(9) | Melanoma	ADHFE1 (7):	--2-- |  1183_CRT0160829_GDSC1(4) |  1259_Talazoparib_GDSC2(4) | Melanoma	AKT1 (6):	--3-- |  1066_AZD6482_GDSC1(3) |  1014_Refametinib_GDSC2(3) |  1069_EHT-1864_GDSC2(2) | Melanoma	AKT3 (8):	--3-- |  54_CGP-082996_GDSC1(3) |  228_AKT inhibitor VIII_GDSC1(5) |  1008_Methotrexate_GDSC2(5) | Melanoma	ATXN7 (8):	--2-- |  293_Amuvatinib_GDSC1(4) |  1008_Methotrexate_GDSC2(5) | Melanoma	BAALC (6):	--2-- |  173_FH535_GDSC1(4) |  308_Foretinib_GDSC1(3) | Melanoma	BCL2 (3):	--3-- |  190_Bleomycin_GDSC1(1) |  1024_Lestaurtinib_GDSC1(1) |  1184_AZ20_GDSC1(1) | Melanoma	BRD4 (8):	--2-- |  228_AKT inhibitor VIII_GDSC1(5) |  1008_Methotrexate_GDSC2(5) | Melanoma	BTK (8):	--2-- |  158_PF-562271_GDSC1(4) |  1016_Temsirolimus_GDSC2(4) | Melanoma	CCND2 (3):	--2-- |  1186_FS112_GDSC1(1) |  1425_BPTES_GDSC1(2) | Melanoma	CRKL (3):	--2-- |  265_Tubastatin A_GDSC1(2) |  576_RU-SKI 43_GDSC1(2) | Melanoma	DEK (3):	--2-- |  416_CAY10566_GDSC1(2) |  2111_VE821_GDSC2(2) | Melanoma	EIF4E (3):	--2-- |  147_NSC-87877_GDSC1(2) |  194_Luminespib_GDSC1(1) | Melanoma	ERBB3 (13):	--3-- |  152_CP466722_GDSC1(5) |  245_UNC0638_GDSC1(7) |  363_PF-00299804_GDSC1(5) | Melanoma	ETV5 (5):	--3-- |  1050_ZM447439_GDSC1(3) |  1203_QL-XII-61_GDSC1(2) |  1558_Lapatinib_GDSC2(3) | Melanoma	FGF3 (4):	--2-- |  147_NSC-87877_GDSC1(2) |  180_Thapsigargin_GDSC1(2) | Melanoma	FGFR2 (17):	--2-- |  157_JNK-9L_GDSC1(13) |  1559_Luminespib_GDSC2(10) | Melanoma	FGFR3 (7):	--2-- |  179_5-Fluorouracil_GDSC1(4) |  1614_WZ4003_GDSC2(4) | Melanoma	FLT4 (19):	--2-- |  157_JNK-9L_GDSC1(15) |  1559_Luminespib_GDSC2(11) | Melanoma	GLI1 (6):	--4-- |  133_Doxorubicin_GDSC1(2) |  342_Tenovin-6_GDSC1(3) |  362_CI-1033_GDSC1(2) |  1186_FS112_GDSC1(3) | Melanoma	HDAC7 (12):	--3-- |  228_AKT inhibitor VIII_GDSC1(6) |  1190_Gemcitabine_GDSC2(7) |  1529_Pevonedistat_GDSC2(5) | Melanoma	HGF (15):	--3-- |  163_JQ1_GDSC1(7) |  1427_AZD5582_GDSC1(7) |  1085_Sorafenib_GDSC2(9) | Melanoma	IDH2 (5):	--3-- |  285_SU11274_GDSC1(3) |  1458_PARP_9495_GDSC1(3) |  1051_Alisertib_GDSC2(3) | Melanoma	IGF1 (9):	--4-- |  410_MetAP2 Inhibitor, A832234_GDSC1(2) |  439_LCL161_GDSC1(4) |  1185_KU-60019_GDSC1(4) |  1011_Navitoclax_GDSC2(4) | Melanoma	JAK3 (15):	--2-- |  180_Thapsigargin_GDSC1(12) |  1243_Piperlongumine_GDSC1(10) | Melanoma	LRP6 (14):	--4-- |  1059_AZD8055_GDSC1(7) |  1239_YK-4-279_GDSC1(9) |  1430_IGFR_3801_GDSC1(9) |  1553_Uprosertib_GDSC2(6) | Melanoma	LYN (10):	--4-- |  293_Amuvatinib_GDSC1(6) |  410_MetAP2 Inhibitor, A832234_GDSC1(2) |  1129_PF-4708671_GDSC1(3) |  1011_Navitoclax_GDSC2(4) | Melanoma	MAP2K1 (7):	--2-- |  1614_WZ4003_GDSC2(4) |  2171_BMS-754807_GDSC2(4) | Melanoma	MAPK1 (3):	--2-- |  147_NSC-87877_GDSC1(2) |  180_Thapsigargin_GDSC1(1) | Melanoma	MDM2 (5):	--3-- |  140_Vinorelbine_GDSC1(2) |  238_Idelalisib_GDSC1(2) |  1560_Alpelisib_GDSC2(2) | Melanoma	MECOM (25):	--4-- |  185_Linsitinib_GDSC1(8) |  362_CI-1033_GDSC1(19) |  1036_PLX-4720_GDSC1(12) |  1136_Capivasertib_GDSC1(12) | Melanoma	MLLT10 (10):	--3-- |  185_Linsitinib_GDSC1(5) |  428_Pemetrexed_GDSC1(4) |  1007_Docetaxel_GDSC2(6) | Melanoma	MSI2 (19):	--4-- |  127_GSK269962A_GDSC1(3) |  1059_AZD8055_GDSC1(8) |  1593_Entinostat_GDSC2(10) |  2096_VX-11e_GDSC2(11) | Melanoma	MST1R (6):	--3-- |  265_Tubastatin A_GDSC1(2) |  1031_Elesclomol_GDSC1(3) |  1042_Doramapimod_GDSC2(3) | Melanoma	MTOR (23):	--4-- |  163_JQ1_GDSC1(11) |  223_ZSTK474_GDSC1(15) |  1058_Pictilisib_GDSC1(11) |  1367_BAY-HDAC11_4_GDSC1(8) | Melanoma	MYBL1 (6):	--3-- |  221_TAK-715_GDSC1(2) |  1014_Refametinib_GDSC2(3) |  1069_EHT-1864_GDSC2(2) | Melanoma	NCOA3 (10):	--4-- |  228_AKT inhibitor VIII_GDSC1(6) |  410_MetAP2 Inhibitor, A832234_GDSC1(2) |  1203_QL-XII-61_GDSC1(2) |  1908_Ulixertinib_GDSC2(5) | Melanoma	NTRK3 (22):	--2-- |  362_CI-1033_GDSC1(16) |  1930_Telomerase Inhibitor IX_GDSC2(18) | Melanoma	NUP214 (20):	--3-- |  276_CAY10603_GDSC1(14) |  362_CI-1033_GDSC1(14) |  1365_BAY-HDAC11_2_GDSC1(7) | Melanoma	PAK1 (7):	--3-- |  224_AS605240_GDSC1(3) |  428_Pemetrexed_GDSC1(4) |  1624_I-BET-762_GDSC2(4) | Melanoma	PDGFB (6):	--2-- |  300_CX-5461_GDSC1(4) |  306_Fedratinib_GDSC1(4) | Melanoma	PIK3CA (3):	--2-- |  172_Embelin_GDSC1(1) |  1069_EHT-1864_GDSC1(2) | Melanoma	PIK3CB (11):	--3-- |  133_Doxorubicin_GDSC1(6) |  190_Bleomycin_GDSC1(6) |  264_ACY-1215_GDSC1(6) | Melanoma	PPARG (5):	--2-- |  285_SU11274_GDSC1(3) |  428_Pemetrexed_GDSC1(3) | Melanoma	PRKACA (8):	--3-- |  147_NSC-87877_GDSC1(3) |  1564_SCH772984_GDSC2(4) |  1997_WEHI-539_GDSC2(2) | Melanoma	PTPN11 (6):	--2-- |  170_Shikonin_GDSC1(4) |  330_XMD13-2_GDSC1(2) | Melanoma	REV3L (11):	--3-- |  265_Tubastatin A_GDSC1(3) |  330_XMD13-2_GDSC1(3) |  1015_CI-1040_GDSC1(7) | Melanoma	RUNX1T1 (10):	--3-- |  300_CX-5461_GDSC1(5) |  1015_CI-1040_GDSC1(6) |  1164_XMD8-92_GDSC1(4) | Melanoma	SET (7):	--2-- |  170_Shikonin_GDSC1(5) |  293_Amuvatinib_GDSC1(4) | Melanoma	SETD1A (9):	--2-- |  362_CI-1033_GDSC1(6) |  1004_Vinblastine_GDSC1(6) | Melanoma	SMO (7):	--2-- |  153_Midostaurin_GDSC1(4) |  1183_CRT0160829_GDSC1(4) | Melanoma	SMYD3 (17):	--3-- |  304_SB52334_GDSC1(9) |  1062_Selumetinib_GDSC2(10) |  1873_Buparlisib_GDSC2(12) | Melanoma	WWTR1 (10):	--3-- |  196_Phenformin_GDSC1(6) |  228_AKT inhibitor VIII_GDSC1(6) |  1036_PLX-4720_GDSC1(4) | Mesothelioma	AKT2 (4):	--2-- |  439_LCL161_GDSC1(2) |  1011_Navitoclax_GDSC1(2) | Mesothelioma	ARHGEF28 (5):	--2-- |  1037_BX795_GDSC1(3) |  1049_PD173074_GDSC2(4) | Mesothelioma	DNMT1 (4):	--2-- |  228_AKT inhibitor VIII_GDSC1(2) |  1847_BEN_GDSC2(3) | Mesothelioma	EIF4A2 (3):	--2-- |  176_IPA-3_GDSC1(2) |  177_GSK650394_GDSC1(2) | Mesothelioma	ETV1 (4):	--2-- |  249_Cabozantinib_GDSC1(2) |  1037_BX795_GDSC1(3) | Mesothelioma	FGFR1 (4):	--2-- |  170_Shikonin_GDSC1(2) |  1088_Irinotecan_GDSC2(3) | Mesothelioma	FLT1 (5):	--3-- |  273_CUDC-101_GDSC1(1) |  1142_HG-5-113-01_GDSC1(1) |  1926_GNE-317_GDSC2(3) | Mesothelioma	GAB2 (4):	--2-- |  439_LCL161_GDSC1(2) |  1007_Docetaxel_GDSC2(2) | Mesothelioma	GNA11 (3):	--2-- |  1460_PARP_9482_GDSC1(1) |  1053_MK-2206_GDSC2(2) | Mesothelioma	GNAS (10):	--3-- |  152_CP466722_GDSC1(7) |  303_PIK-93_GDSC1(4) |  2172_JQ1_GDSC2(6) | Mesothelioma	KIT (5):	--2-- |  461_NSC319726_GDSC1(2) |  1427_AZD5582_GDSC1(4) | Mesothelioma	LGR5 (4):	--2-- |  346_THZ-2-102-1_GDSC1(1) |  1015_CI-1040_GDSC1(3) | Mesothelioma	MDM2 (3):	--2-- |  293_Amuvatinib_GDSC1(2) |  1377_Afatinib_GDSC1(2) | Mesothelioma	MEF2B (4):	--2-- |  346_THZ-2-102-1_GDSC1(1) |  1015_CI-1040_GDSC1(3) | Mesothelioma	MEF2D (4):	--2-- |  229_Enzastaurin_GDSC1(3) |  1186_FS112_GDSC1(1) | Mesothelioma	MET (4):	--2-- |  261_TL-1-85_GDSC1(3) |  302_PI-103_GDSC1(3) | Mesothelioma	MSI2 (7):	--3-- |  133_Doxorubicin_GDSC1(3) |  172_Embelin_GDSC1(2) |  1459_PARP_0108_GDSC1(3) | Mesothelioma	NRG1 (6):	--2-- |  1014_Refametinib_GDSC1(4) |  1453_RAF_9304_GDSC1(4) | Mesothelioma	NSD2 (4):	--2-- |  1015_CI-1040_GDSC1(3) |  1049_PD173074_GDSC1(3) | Mesothelioma	NTRK1 (4):	--2-- |  1007_Docetaxel_GDSC2(2) |  1786_AZD4547_GDSC2(3) | Mesothelioma	NUP98 (5):	--2-- |  1037_BX795_GDSC1(3) |  1049_PD173074_GDSC2(3) | Mesothelioma	PGR (4):	--2-- |  135_Gemcitabine_GDSC1(1) |  1932_NVP-ADW742_GDSC2(3) | Mesothelioma	PLCG1 (4):	--2-- |  164_JQ12_GDSC1(3) |  203_BMS-345541_GDSC1(2) | Mesothelioma	PRKACA (3):	--2-- |  1197_ZL049_GDSC1(2) |  1425_BPTES_GDSC1(2) | Mesothelioma	RICTOR (8):	--3-- |  363_PF-00299804_GDSC1(5) |  1003_Camptothecin_GDSC2(5) |  1917_AZD6738_GDSC2(3) | Mesothelioma	SHOC2 (3):	--2-- |  293_Amuvatinib_GDSC1(2) |  1377_Afatinib_GDSC1(2) | Mesothelioma	SOS1 (3):	--2-- |  439_LCL161_GDSC1(2) |  1446_PI3Ka_4409_GDSC1(2) | Mesothelioma	SQSTM1 (3):	--2-- |  203_BMS-345541_GDSC1(2) |  1011_Navitoclax_GDSC2(2) | Mesothelioma	TERT (4):	--2-- |  346_THZ-2-102-1_GDSC1(1) |  1015_CI-1040_GDSC1(3) | Mesothelioma	VAV1 (3):	--2-- |  439_LCL161_GDSC1(2) |  1446_PI3Ka_4409_GDSC1(2) | Mesothelioma	WWTR1 (3):	--2-- |  190_Bleomycin_GDSC1(1) |  293_Amuvatinib_GDSC1(2) | Mesothelioma	YES1 (4):	--2-- |  269_NSC-207895_GDSC1(2) |  1425_BPTES_GDSC1(2) | Neuroblastoma	AKT3 (5):	--3-- |  63_BMS-509744_GDSC1(2) |  199_Pazopanib_GDSC1(2) |  230_GSK429286A_GDSC1(3) | Neuroblastoma	ARHGEF28 (15):	--4-- |  261_TL-1-85_GDSC1(10) |  1241_CHIR-99021_GDSC1(4) |  2096_VX-11e_GDSC2(8) |  2111_VE821_GDSC2(5) | Neuroblastoma	ATXN7 (6):	--2-- |  163_JQ1_GDSC1(3) |  1062_Selumetinib_GDSC2(4) | Neuroblastoma	AXL (8):	--3-- |  30_Sorafenib_GDSC1(4) |  1062_Selumetinib_GDSC1(3) |  1259_Talazoparib_GDSC2(3) | Neuroblastoma	BCL9 (7):	--2-- |  415_CPI-613_GDSC1(4) |  2171_BMS-754807_GDSC2(5) | Neuroblastoma	BRD4 (5):	--3-- |  273_CUDC-101_GDSC1(3) |  281_Alectinib_GDSC1(2) |  431_Alisertib_GDSC1(2) | Neuroblastoma	CD28 (4):	--2-- |  1032_Afatinib_GDSC1(2) |  1036_PLX-4720_GDSC1(2) | Neuroblastoma	CD79B (3):	--2-- |  253_XMD14-99_GDSC1(2) |  1066_AZD6482_GDSC1(2) | Neuroblastoma	CDK4 (3):	--2-- |  262_VX-11e_GDSC1(2) |  1032_Afatinib_GDSC1(2) | Neuroblastoma	ERBB2 (6):	--2-- |  1197_ZL049_GDSC1(3) |  1564_SCH772984_GDSC2(4) | Neuroblastoma	FGFR2 (10):	--3-- |  173_FH535_GDSC1(6) |  302_PI-103_GDSC1(4) |  2111_VE821_GDSC2(4) | Neuroblastoma	FGFR3 (6):	--2-- |  412_Venotoclax_GDSC1(3) |  1093_GSK1904529A_GDSC2(3) | Neuroblastoma	FURIN (3):	--2-- |  51_Dasatinib_GDSC1(2) |  63_BMS-509744_GDSC1(2) | Neuroblastoma	GAB1 (6):	--2-- |  412_Venotoclax_GDSC1(3) |  576_RU-SKI 43_GDSC1(4) | Neuroblastoma	GNAS (7):	--3-- |  224_AS605240_GDSC1(4) |  1241_CHIR-99021_GDSC1(3) |  1084_Rapamycin_GDSC2(2) | Neuroblastoma	HMGA2 (6):	--2-- |  5_Sunitinib_GDSC1(3) |  1062_Selumetinib_GDSC1(3) | Neuroblastoma	IDH2 (6):	--4-- |  152_CP466722_GDSC1(2) |  226_GSK1070916_GDSC1(3) |  282_Pelitinib_GDSC1(2) |  431_Alisertib_GDSC1(3) | Neuroblastoma	IGF1 (5):	--2-- |  177_GSK650394_GDSC1(3) |  1008_Methotrexate_GDSC1(3) | Neuroblastoma	INSR (9):	--4-- |  5_Sunitinib_GDSC1(4) |  252_WZ3105_GDSC1(3) |  1057_Dactolisib_GDSC1(5) |  1093_GSK1904529A_GDSC2(3) | Neuroblastoma	IRS1 (5):	--2-- |  37_Crizotinib_GDSC1(2) |  56_WH-4-023_GDSC1(3) | Neuroblastoma	JAK3 (8):	--2-- |  330_XMD13-2_GDSC1(4) |  1026_Tanespimycin_GDSC2(5) | Neuroblastoma	KIT (7):	--3-- |  1008_Methotrexate_GDSC1(4) |  1026_Tanespimycin_GDSC2(4) |  1806_Oxaliplatin_GDSC2(2) | Neuroblastoma	KLF5 (3):	--2-- |  1062_Selumetinib_GDSC1(2) |  1261_rTRAIL_GDSC1(2) | Neuroblastoma	LRP6 (9):	--2-- |  29_AZ628_GDSC1(6) |  1997_WEHI-539_GDSC2(6) | Neuroblastoma	MAP3K13 (7):	--2-- |  152_CP466722_GDSC1(2) |  1367_BAY-HDAC11_4_GDSC1(5) | Neuroblastoma	MST1R (3):	--2-- |  1032_Afatinib_GDSC1(2) |  1084_Rapamycin_GDSC2(2) | Neuroblastoma	MTOR (7):	--2-- |  1062_Selumetinib_GDSC2(4) |  1933_P22077_GDSC2(3) | Neuroblastoma	NCSTN (5):	--3-- |  576_RU-SKI 43_GDSC1(3) |  1250_AZ960_GDSC2(2) |  1932_NVP-ADW742_GDSC2(2) | Neuroblastoma	NR4A3 (8):	--3-- |  273_CUDC-101_GDSC1(4) |  1242_(5Z)-7-Oxozeaenol_GDSC1(4) |  1080_Paclitaxel_GDSC2(6) | Neuroblastoma	NRG1 (6):	--2-- |  290_KIN001-260_GDSC1(2) |  1367_BAY-HDAC11_4_GDSC1(4) | Neuroblastoma	NTRK1 (6):	--2-- |  412_Venotoclax_GDSC1(3) |  1409_AZD4877_GDSC1(4) | Neuroblastoma	NTRK3 (11):	--3-- |  152_CP466722_GDSC1(4) |  256_JW-7-24-1_GDSC1(7) |  1232_I-BET-151_GDSC1(4) | Neuroblastoma	NUP214 (13):	--3-- |  208_Ispinesib Mesylate_GDSC1(4) |  1053_MK-2206_GDSC2(7) |  2046_MK-8776_GDSC2(9) | Neuroblastoma	NUP98 (9):	--3-- |  64_CMK_GDSC1(6) |  152_CP466722_GDSC1(3) |  163_JQ1_GDSC1(4) | Neuroblastoma	PIK3CA (4):	--2-- |  1008_Methotrexate_GDSC1(3) |  1185_KU-60019_GDSC1(3) | Neuroblastoma	PRKACA (7):	--2-- |  88_Entinostat_GDSC1(3) |  330_XMD13-2_GDSC1(5) | Neuroblastoma	REV3L (6):	--2-- |  342_Tenovin-6_GDSC1(4) |  1409_AZD4877_GDSC1(4) | Neuroblastoma	RICTOR (9):	--2-- |  309_Y-39983_GDSC1(7) |  1997_WEHI-539_GDSC2(6) | Neuroblastoma	SETD1A (3):	--2-- |  1062_Selumetinib_GDSC1(2) |  1377_Afatinib_GDSC1(2) | Neuroblastoma	SMYD3 (11):	--3-- |  32_Tozasertib_GDSC1(6) |  203_BMS-345541_GDSC1(6) |  1617_AZD5582_GDSC2(5) | Neuroblastoma	SOS1 (12):	--2-- |  64_CMK_GDSC1(6) |  1873_Buparlisib_GDSC2(9) | Neuroblastoma	SQSTM1 (8):	--3-- |  38_Saracatinib_GDSC1(2) |  1241_CHIR-99021_GDSC1(4) |  2057_Remodelin_GDSC2(3) | Neuroblastoma	STAT5B (5):	--2-- |  1170_CCT-018159_GDSC1(3) |  1549_Sapitinib_GDSC2(2) | Neuroblastoma	STAT6 (3):	--2-- |  1046_Wee1 Inhibitor_GDSC1(2) |  1449_AZD1208_GDSC1(2) | Neuroblastoma	TRIM27 (3):	--2-- |  1062_Selumetinib_GDSC1(2) |  1933_P22077_GDSC2(2) | Neuroblastoma	UBR5 (13):	--4-- |  86_A-443654_GDSC1(3) |  164_JQ12_GDSC1(7) |  252_WZ3105_GDSC1(6) |  256_JW-7-24-1_GDSC1(8) | Non-Small Cell Lung Carcinoma	AKT1 (16):	--2-- |  268_Sepantronium bromide_GDSC1(12) |  1057_Dactolisib_GDSC1(13) | Non-Small Cell Lung Carcinoma	ATF1 (8):	--3-- |  170_Shikonin_GDSC1(5) |  1386_Doxorubicin_GDSC1(6) |  2057_Remodelin_GDSC2(2) | Non-Small Cell Lung Carcinoma	AURKB (5):	--3-- |  1401_AZD5438_GDSC1(3) |  1461_TANK_1366_GDSC1(2) |  1179_MK-1775_GDSC2(2) | Non-Small Cell Lung Carcinoma	BCL6 (9):	--2-- |  180_Thapsigargin_GDSC1(5) |  1379_ZL109_GDSC1(7) | Non-Small Cell Lung Carcinoma	BRD4 (13):	--3-- |  173_FH535_GDSC1(9) |  1128_FS106_GDSC1(6) |  1594_OSI-027_GDSC2(6) | Non-Small Cell Lung Carcinoma	CD276 (9):	--4-- |  279_BIX02189_GDSC1(2) |  1050_ZM447439_GDSC1(4) |  1085_Sorafenib_GDSC2(5) |  1557_LCL161_GDSC2(2) | Non-Small Cell Lung Carcinoma	CDK6 (11):	--3-- |  170_Shikonin_GDSC1(8) |  173_FH535_GDSC1(7) |  1386_Doxorubicin_GDSC1(9) | Non-Small Cell Lung Carcinoma	COP1 (19):	--4-- |  201_Epothilone B_GDSC1(11) |  252_WZ3105_GDSC1(11) |  276_CAY10603_GDSC1(13) |  1197_ZL049_GDSC1(4) | Non-Small Cell Lung Carcinoma	CYP19A1 (16):	--2-- |  262_VX-11e_GDSC1(5) |  1379_ZL109_GDSC1(14) | Non-Small Cell Lung Carcinoma	DDR2 (25):	--2-- |  170_Shikonin_GDSC1(19) |  1184_AZ20_GDSC1(18) | Non-Small Cell Lung Carcinoma	DDX4 (9):	--3-- |  170_Shikonin_GDSC1(6) |  284_JNJ38877605_GDSC1(5) |  1179_MK-1775_GDSC2(5) | Non-Small Cell Lung Carcinoma	DEK (7):	--2-- |  432_Flavopiridol_GDSC1(5) |  1911_Dactinomycin_GDSC2(5) | Non-Small Cell Lung Carcinoma	EGFR (37):	--3-- |  157_JNK-9L_GDSC1(32) |  1407_Dyrk1b_0191_GDSC1(17) |  1372_Trametinib_GDSC2(16) | Non-Small Cell Lung Carcinoma	EIF4A2 (13):	--2-- |  374_GSK1059615_GDSC1(10) |  1031_Elesclomol_GDSC1(7) | Non-Small Cell Lung Carcinoma	ETV1 (24):	--3-- |  194_Luminespib_GDSC1(17) |  1060_PD0325901_GDSC1(15) |  1401_AZD5438_GDSC1(19) | Non-Small Cell Lung Carcinoma	FGF3 (10):	--3-- |  416_CAY10566_GDSC1(2) |  1170_CCT-018159_GDSC1(6) |  1261_rTRAIL_GDSC1(5) | Non-Small Cell Lung Carcinoma	FGF4 (8):	--2-- |  190_Bleomycin_GDSC1(5) |  1911_Dactinomycin_GDSC2(5) | Non-Small Cell Lung Carcinoma	FGFR2 (33):	--3-- |  1149_TW 37_GDSC1(29) |  1409_AZD4877_GDSC1(27) |  1062_Selumetinib_GDSC2(11) | Non-Small Cell Lung Carcinoma	FGFR4 (10):	--2-- |  194_Luminespib_GDSC1(6) |  1594_OSI-027_GDSC2(5) | Non-Small Cell Lung Carcinoma	FYN (18):	--3-- |  182_Obatoclax Mesylate_GDSC1(14) |  252_WZ3105_GDSC1(11) |  1066_AZD6482_GDSC1(7) | Non-Small Cell Lung Carcinoma	GAB2 (23):	--5-- |  294_MPS-1-IN-1_GDSC1(9) |  1011_Navitoclax_GDSC1(6) |  1024_Lestaurtinib_GDSC1(10) |  1128_FS106_GDSC1(14) |  1187_CCT245232_GDSC1(15) | Non-Small Cell Lung Carcinoma	GLI1 (18):	--3-- |  310_YM201636_GDSC1(7) |  372_Pilaralisib_GDSC1(8) |  1364_BAY-HDAC11_1_GDSC1(11) | Non-Small Cell Lung Carcinoma	GREM1 (3):	--2-- |  269_NSC-207895_GDSC1(2) |  288_WHI-P97_GDSC1(2) | Non-Small Cell Lung Carcinoma	H1-4 (6):	--2-- |  262_VX-11e_GDSC1(3) |  304_SB52334_GDSC1(3) | Non-Small Cell Lung Carcinoma	IL7R (22):	--2-- |  374_GSK1059615_GDSC1(17) |  1386_Doxorubicin_GDSC1(19) | Non-Small Cell Lung Carcinoma	IRS2 (6):	--3-- |  329_QL-XI-92_GDSC1(2) |  1496_Cisplatin_GDSC1(3) |  1177_Niraparib_GDSC2(2) | Non-Small Cell Lung Carcinoma	KLF5 (4):	--2-- |  170_Shikonin_GDSC1(2) |  2057_Remodelin_GDSC2(2) | Non-Small Cell Lung Carcinoma	KRAS (31):	--5-- |  186_Bexarotene_GDSC1(7) |  1062_Selumetinib_GDSC1(11) |  1188_CCT245467_GDSC1(11) |  1458_PARP_9495_GDSC1(16) |  1060_PD0325901_GDSC2(19) | Non-Small Cell Lung Carcinoma	LGR5 (31):	--2-- |  374_GSK1059615_GDSC1(26) |  1386_Doxorubicin_GDSC1(28) | Non-Small Cell Lung Carcinoma	MCL1 (8):	--2-- |  196_Phenformin_GDSC1(4) |  1184_AZ20_GDSC1(5) | Non-Small Cell Lung Carcinoma	MECOM (35):	--4-- |  294_MPS-1-IN-1_GDSC1(12) |  1187_CCT245232_GDSC1(25) |  1401_AZD5438_GDSC1(28) |  1624_I-BET-762_GDSC2(8) | Non-Small Cell Lung Carcinoma	MET (25):	--2-- |  165_DMOG_GDSC1(21) |  371_Torin 2_GDSC1(18) | Non-Small Cell Lung Carcinoma	MGAM (64):	--4-- |  449_CD532_GDSC1(48) |  1242_(5Z)-7-Oxozeaenol_GDSC1(49) |  1059_AZD8055_GDSC2(24) |  1593_Entinostat_GDSC2(29) | Non-Small Cell Lung Carcinoma	MKI67 (26):	--2-- |  371_Torin 2_GDSC1(19) |  1386_Doxorubicin_GDSC1(23) | Non-Small Cell Lung Carcinoma	MPL (10):	--2-- |  185_Linsitinib_GDSC1(5) |  442_IMD-0354_GDSC1(7) | Non-Small Cell Lung Carcinoma	MYCL (3):	--2-- |  211_TL-2-105_GDSC1(2) |  288_WHI-P97_GDSC1(2) | Non-Small Cell Lung Carcinoma	MYCN (3):	--2-- |  186_Bexarotene_GDSC1(2) |  1367_BAY-HDAC11_4_GDSC1(2) | Non-Small Cell Lung Carcinoma	NADK (12):	--3-- |  1416_AZD8931_GDSC1(5) |  1430_IGFR_3801_GDSC1(9) |  1926_GNE-317_GDSC2(7) | Non-Small Cell Lung Carcinoma	NCSTN (14):	--3-- |  310_YM201636_GDSC1(6) |  461_NSC319726_GDSC1(10) |  1047_Nutlin-3a (-)_GDSC1(4) | Non-Small Cell Lung Carcinoma	NFE2L2 (10):	--3-- |  171_AKT inhibitor VIII_GDSC1(4) |  272_AR-42_GDSC1(6) |  1428_IAP_5620_GDSC2(2) | Non-Small Cell Lung Carcinoma	NRG1 (30):	--3-- |  196_Phenformin_GDSC1(21) |  442_IMD-0354_GDSC1(21) |  1133_Serdemetan_GDSC1(12) | Non-Small Cell Lung Carcinoma	NTRK2 (24):	--5-- |  71_Pyrimethamine_GDSC1(3) |  431_Alisertib_GDSC1(6) |  1133_Serdemetan_GDSC1(10) |  1428_IAP_5620_GDSC1(8) |  1003_Camptothecin_GDSC2(13) | Non-Small Cell Lung Carcinoma	NUP214 (32):	--3-- |  158_PF-562271_GDSC1(6) |  308_Foretinib_GDSC1(24) |  442_IMD-0354_GDSC1(26) | Non-Small Cell Lung Carcinoma	PAK5 (25):	--5-- |  29_AZ628_GDSC1(4) |  366_TWS119_GDSC1(10) |  1232_I-BET-151_GDSC1(11) |  1058_Pictilisib_GDSC2(13) |  1179_MK-1775_GDSC2(16) | Non-Small Cell Lung Carcinoma	PAX8 (9):	--4-- |  119_Lapatinib_GDSC1(2) |  294_MPS-1-IN-1_GDSC1(4) |  1022_AZD7762_GDSC1(4) |  1128_FS106_GDSC1(4) | Non-Small Cell Lung Carcinoma	PIK3CB (10):	--2-- |  268_Sepantronium bromide_GDSC1(8) |  1266_ICL1100013_GDSC1(4) | Non-Small Cell Lung Carcinoma	PIK3CD (10):	--3-- |  170_Shikonin_GDSC1(5) |  268_Sepantronium bromide_GDSC1(8) |  1359_965-D2_GDSC1(3) | Non-Small Cell Lung Carcinoma	PIK3CG (14):	--3-- |  294_MPS-1-IN-1_GDSC1(7) |  356_AT7867_GDSC1(5) |  1184_AZ20_GDSC1(10) | Non-Small Cell Lung Carcinoma	RAC1 (10):	--2-- |  262_VX-11e_GDSC1(4) |  1379_ZL109_GDSC1(8) | Non-Small Cell Lung Carcinoma	RHEB (17):	--2-- |  371_Torin 2_GDSC1(11) |  1057_Dactolisib_GDSC1(14) | Non-Small Cell Lung Carcinoma	RNASEH2A (4):	--2-- |  1362_BAY ACCi_GDSC1(1) |  1786_AZD4547_GDSC2(3) | Non-Small Cell Lung Carcinoma	RPS6KA4 (6):	--2-- |  356_AT7867_GDSC1(3) |  1803_Acetalax_GDSC2(3) | Non-Small Cell Lung Carcinoma	RPTOR (45):	--3-- |  159_HG6-64-1_GDSC1(22) |  272_AR-42_GDSC1(34) |  1184_AZ20_GDSC1(37) | Non-Small Cell Lung Carcinoma	RRAGC (8):	--3-- |  310_YM201636_GDSC1(4) |  374_GSK1059615_GDSC1(5) |  1428_IAP_5620_GDSC1(4) | Non-Small Cell Lung Carcinoma	RUNX1T1 (25):	--3-- |  294_MPS-1-IN-1_GDSC1(10) |  1242_(5Z)-7-Oxozeaenol_GDSC1(16) |  1386_Doxorubicin_GDSC1(22) | Non-Small Cell Lung Carcinoma	SET (6):	--2-- |  171_AKT inhibitor VIII_GDSC1(4) |  1062_Selumetinib_GDSC1(3) | Non-Small Cell Lung Carcinoma	SETD1A (18):	--4-- |  185_Linsitinib_GDSC1(8) |  476_SB505124_GDSC1(7) |  1091_BMS-536924_GDSC1(9) |  1997_WEHI-539_GDSC2(4) | Non-Small Cell Lung Carcinoma	SHOC2 (13):	--3-- |  257_NPK76-II-72-1_GDSC1(7) |  1091_BMS-536924_GDSC1(8) |  1170_CCT-018159_GDSC1(7) | Non-Small Cell Lung Carcinoma	SMYD3 (36):	--3-- |  133_Doxorubicin_GDSC1(29) |  1022_AZD7762_GDSC1(22) |  1594_OSI-027_GDSC2(12) | Non-Small Cell Lung Carcinoma	STK19 (8):	--3-- |  196_Phenformin_GDSC1(4) |  1129_PF-4708671_GDSC1(2) |  1549_Sapitinib_GDSC2(4) | Non-Small Cell Lung Carcinoma	TYK2 (13):	--3-- |  185_Linsitinib_GDSC1(6) |  294_MPS-1-IN-1_GDSC1(9) |  1184_AZ20_GDSC1(9) | Non-Small Cell Lung Carcinoma	UBR5 (46):	--4-- |  173_FH535_GDSC1(32) |  207_AS601245_GDSC1(20) |  252_WZ3105_GDSC1(31) |  1022_AZD7762_GDSC1(29) | Non-Small Cell Lung Carcinoma	VAV2 (33):	--3-- |  1060_PD0325901_GDSC1(23) |  1022_AZD7762_GDSC2(23) |  1593_Entinostat_GDSC2(17) | Non-Small Cell Lung Carcinoma	WWTR1 (15):	--2-- |  294_MPS-1-IN-1_GDSC1(8) |  1379_ZL109_GDSC1(13) | Oral Cavity Carcinoma	ADHFE1 (6):	--2-- |  272_AR-42_GDSC1(4) |  1135_AZD4547_GDSC1(3) | Oral Cavity Carcinoma	AFF4 (6):	--2-- |  301_PHA-793887_GDSC1(4) |  1593_Entinostat_GDSC2(4) | Oral Cavity Carcinoma	BCR (12):	--2-- |  177_GSK650394_GDSC1(9) |  1498_Selumetinib_GDSC1(5) | Oral Cavity Carcinoma	BRAF (10):	--3-- |  151_QS11_GDSC1(5) |  1367_BAY-HDAC11_4_GDSC1(4) |  1085_Sorafenib_GDSC2(8) | Oral Cavity Carcinoma	BRD4 (8):	--3-- |  180_Thapsigargin_GDSC1(5) |  1135_AZD4547_GDSC1(3) |  1799_Ibrutinib_GDSC2(5) | Oral Cavity Carcinoma	CCND2 (4):	--2-- |  449_CD532_GDSC1(2) |  1021_Axitinib_GDSC1(2) | Oral Cavity Carcinoma	CSF3R (4):	--2-- |  1614_WZ4003_GDSC2(2) |  1629_ML323_GDSC2(2) | Oral Cavity Carcinoma	DOT1L (7):	--2-- |  178_BAY-61-3606_GDSC1(5) |  291_KIN001-266_GDSC1(4) | Oral Cavity Carcinoma	ERBB4 (7):	--2-- |  1197_ZL049_GDSC1(5) |  1446_PI3Ka_4409_GDSC1(4) | Oral Cavity Carcinoma	EZH1 (5):	--2-- |  449_CD532_GDSC1(3) |  1021_Axitinib_GDSC1(2) | Oral Cavity Carcinoma	FLT3 (4):	--2-- |  190_Bleomycin_GDSC1(1) |  1578_Leflunomide_GDSC2(3) | Oral Cavity Carcinoma	FLT4 (8):	--3-- |  371_Torin 2_GDSC1(5) |  1434_JAK3_7406_GDSC1(5) |  1593_Entinostat_GDSC2(4) | Oral Cavity Carcinoma	GAB2 (4):	--2-- |  1593_Entinostat_GDSC2(3) |  1918_AZD8186_GDSC2(3) | Oral Cavity Carcinoma	GNA12 (4):	--2-- |  576_RU-SKI 43_GDSC1(3) |  1084_Rapamycin_GDSC2(2) | Oral Cavity Carcinoma	GNAQ (6):	--2-- |  301_PHA-793887_GDSC1(4) |  1236_UNC0638_GDSC1(4) | Oral Cavity Carcinoma	GNAS (4):	--2-- |  300_CX-5461_GDSC1(3) |  1069_EHT-1864_GDSC2(2) | Oral Cavity Carcinoma	HGF (5):	--2-- |  1009_Tretinoin_GDSC1(4) |  1026_Tanespimycin_GDSC1(3) | Oral Cavity Carcinoma	HIF1A (3):	--2-- |  410_MetAP2 Inhibitor, A832234_GDSC1(2) |  1360_993-D2_GDSC1(2) | Oral Cavity Carcinoma	IL7R (3):	--2-- |  372_Pilaralisib_GDSC1(2) |  1853_OF-1_GDSC2(2) | Oral Cavity Carcinoma	INSR (8):	--3-- |  179_5-Fluorouracil_GDSC1(5) |  300_CX-5461_GDSC1(4) |  1593_Entinostat_GDSC2(4) | Oral Cavity Carcinoma	JAK2 (3):	--2-- |  371_Torin 2_GDSC1(1) |  1069_EHT-1864_GDSC2(2) | Oral Cavity Carcinoma	JAK3 (7):	--2-- |  1593_Entinostat_GDSC2(4) |  1853_OF-1_GDSC2(3) | Oral Cavity Carcinoma	KDM5A (8):	--2-- |  1429_IAP_7638_GDSC1(5) |  1553_Uprosertib_GDSC2(4) | Oral Cavity Carcinoma	KSR2 (11):	--2-- |  303_PIK-93_GDSC1(6) |  1197_ZL049_GDSC1(6) | Oral Cavity Carcinoma	MAP2K2 (3):	--2-- |  1008_Methotrexate_GDSC1(2) |  1188_CCT245467_GDSC1(2) | Oral Cavity Carcinoma	MECOM (7):	--2-- |  178_BAY-61-3606_GDSC1(5) |  1853_OF-1_GDSC2(3) | Oral Cavity Carcinoma	MGAM (13):	--3-- |  203_BMS-345541_GDSC1(7) |  1164_XMD8-92_GDSC1(4) |  1593_Entinostat_GDSC2(5) | Oral Cavity Carcinoma	MLLT10 (5):	--2-- |  293_Amuvatinib_GDSC1(2) |  1009_Tretinoin_GDSC1(3) | Oral Cavity Carcinoma	MLLT3 (6):	--2-- |  272_AR-42_GDSC1(4) |  1135_AZD4547_GDSC1(3) | Oral Cavity Carcinoma	MYBL1 (9):	--2-- |  252_WZ3105_GDSC1(6) |  1046_Wee1 Inhibitor_GDSC1(5) | Oral Cavity Carcinoma	NADK (3):	--2-- |  173_FH535_GDSC1(1) |  477_A-83-01_GDSC1(2) | Oral Cavity Carcinoma	NCOA3 (7):	--2-- |  1032_Afatinib_GDSC2(3) |  2109_AZ6102_GDSC2(4) | Oral Cavity Carcinoma	NRG1 (4):	--2-- |  228_AKT inhibitor VIII_GDSC1(3) |  576_RU-SKI 43_GDSC1(3) | Oral Cavity Carcinoma	NTRK2 (6):	--2-- |  291_KIN001-266_GDSC1(4) |  1421_FGFR_0939_GDSC1(3) | Oral Cavity Carcinoma	NUP214 (4):	--2-- |  1236_UNC0638_GDSC1(3) |  1428_IAP_5620_GDSC2(2) | Oral Cavity Carcinoma	PDCD1LG2 (4):	--2-- |  449_CD532_GDSC1(2) |  1021_Axitinib_GDSC1(2) | Oral Cavity Carcinoma	PDGFRA (3):	--2-- |  356_AT7867_GDSC1(2) |  1918_AZD8186_GDSC2(2) | Oral Cavity Carcinoma	PIK3CD (4):	--2-- |  576_RU-SKI 43_GDSC1(3) |  1131_PRIMA-1MET_GDSC2(3) | Oral Cavity Carcinoma	PLCG1 (5):	--2-- |  1021_Axitinib_GDSC2(3) |  1038_NU7441_GDSC2(3) | Oral Cavity Carcinoma	PLCG2 (10):	--2-- |  382_Apitolisib_GDSC1(5) |  1496_Cisplatin_GDSC1(7) | Oral Cavity Carcinoma	PTPN11 (3):	--2-- |  282_Pelitinib_GDSC1(1) |  1188_CCT245467_GDSC1(2) | Oral Cavity Carcinoma	RAC1 (5):	--2-- |  249_Cabozantinib_GDSC1(2) |  1490_SN-38_GDSC1(3) | Oral Cavity Carcinoma	RHEB (3):	--2-- |  1421_FGFR_0939_GDSC1(2) |  1614_WZ4003_GDSC2(2) | Oral Cavity Carcinoma	RICTOR (7):	--2-- |  1009_Tretinoin_GDSC1(4) |  1853_OF-1_GDSC2(3) | Oral Cavity Carcinoma	RPTOR (10):	--2-- |  151_QS11_GDSC1(5) |  203_BMS-345541_GDSC1(7) | Oral Cavity Carcinoma	TYK2 (3):	--2-- |  1194_SB505124_GDSC1(2) |  1432_AZD1480_GDSC1(2) | Oral Cavity Carcinoma	UBR5 (10):	--2-- |  152_CP466722_GDSC1(8) |  303_PIK-93_GDSC1(7) | Oral Cavity Carcinoma	USP8 (7):	--2-- |  153_Midostaurin_GDSC1(5) |  1908_Ulixertinib_GDSC2(4) | Oral Cavity Carcinoma	VEGFA (4):	--2-- |  260_NG-25_GDSC1(2) |  344_THZ-2-49_GDSC1(3) | Oral Cavity Carcinoma	WWTR1 (8):	--3-- |  282_Pelitinib_GDSC1(5) |  1188_CCT245467_GDSC1(3) |  1498_Selumetinib_GDSC1(3) | Oral Cavity Carcinoma	XBP1 (3):	--2-- |  223_ZSTK474_GDSC1(1) |  1021_Axitinib_GDSC1(2) | Osteosarcoma	DDX4 (4):	--2-- |  179_5-Fluorouracil_GDSC1(3) |  1526_Refametinib_GDSC1(3) | Osteosarcoma	EGFR (5):	--2-- |  1051_Alisertib_GDSC2(4) |  1057_Dactolisib_GDSC2(4) | Osteosarcoma	ERBB3 (4):	--2-- |  223_ZSTK474_GDSC1(1) |  2170_AT13148_GDSC2(3) | Osteosarcoma	ETV1 (5):	--2-- |  219_AT-7519_GDSC1(4) |  1057_Dactolisib_GDSC2(4) | Osteosarcoma	LYN (4):	--2-- |  1526_Refametinib_GDSC1(3) |  1786_AZD4547_GDSC2(3) | Osteosarcoma	MECOM (5):	--2-- |  219_AT-7519_GDSC1(4) |  1057_Dactolisib_GDSC2(4) | Osteosarcoma	MSI2 (5):	--2-- |  135_Gemcitabine_GDSC1(4) |  178_BAY-61-3606_GDSC1(4) | Osteosarcoma	NTRK2 (4):	--2-- |  133_Doxorubicin_GDSC1(1) |  1009_Tretinoin_GDSC1(3) | Osteosarcoma	PPM1D (6):	--2-- |  219_AT-7519_GDSC1(4) |  1593_Entinostat_GDSC2(4) | Osteosarcoma	RPTOR (5):	--2-- |  219_AT-7519_GDSC1(4) |  1057_Dactolisib_GDSC2(4) | Osteosarcoma	SOS1 (5):	--2-- |  208_Ispinesib Mesylate_GDSC1(4) |  1057_Dactolisib_GDSC2(4) | Osteosarcoma	UBR5 (6):	--2-- |  256_JW-7-24-1_GDSC1(5) |  1079_Dasatinib_GDSC2(5) | Osteosarcoma	XPO1 (4):	--2-- |  293_Amuvatinib_GDSC1(3) |  1939_UMI-77_GDSC2(3) | Other Sarcomas	AFF4 (5):	--2-- |  155_Ponatinib_GDSC1(4) |  435_C-75_GDSC1(3) | Other Sarcomas	CCNB3 (4):	--2-- |  428_Pemetrexed_GDSC1(3) |  2109_AZ6102_GDSC2(3) | Other Sarcomas	FLT4 (7):	--2-- |  199_Pazopanib_GDSC1(4) |  1363_BAY AKT1_GDSC1(4) | Other Sarcomas	SGK1 (4):	--2-- |  306_Fedratinib_GDSC1(3) |  310_YM201636_GDSC1(3) | Other Solid Cancers	ABL1 (5):	--2-- |  86_A-443654_GDSC1(1) |  1463_AZD1332_GDSC2(4) | Other Solid Cancers	ADHFE1 (6):	--2-- |  375_Voxtalisib_GDSC1(3) |  439_LCL161_GDSC1(4) | Other Solid Cancers	AKT2 (3):	--2-- |  221_TAK-715_GDSC1(2) |  326_GSK690693_GDSC1(2) | Other Solid Cancers	AKT3 (7):	--2-- |  199_Pazopanib_GDSC1(4) |  1008_Methotrexate_GDSC1(4) | Other Solid Cancers	ERBB3 (4):	--2-- |  1021_Axitinib_GDSC1(2) |  1016_Temsirolimus_GDSC2(3) | Other Solid Cancers	ETV1 (6):	--3-- |  576_RU-SKI 43_GDSC1(2) |  1013_Nilotinib_GDSC2(3) |  1928_I-BRD9_GDSC2(2) | Other Solid Cancers	FGFR1 (5):	--2-- |  1089_Oxaliplatin_GDSC2(3) |  1933_P22077_GDSC2(3) | Other Solid Cancers	FYN (6):	--3-- |  3_Rapamycin_GDSC1(3) |  157_JNK-9L_GDSC1(3) |  1924_Ipatasertib_GDSC2(4) | Other Solid Cancers	HMGA2 (8):	--3-- |  89_Parthenolide_GDSC1(3) |  310_YM201636_GDSC1(5) |  1933_P22077_GDSC2(4) | Other Solid Cancers	IGF1R (8):	--3-- |  204_Tipifarnib_GDSC1(3) |  1012_Vorinostat_GDSC1(5) |  1511_Epirubicin_GDSC2(5) | Other Solid Cancers	KDM5A (15):	--3-- |  199_Pazopanib_GDSC1(6) |  372_Pilaralisib_GDSC1(12) |  1933_P22077_GDSC2(5) | Other Solid Cancers	KRAS (4):	--2-- |  175_PAC-1_GDSC1(2) |  474_ARRY-520_GDSC1(2) | Other Solid Cancers	MAP3K13 (7):	--3-- |  89_Parthenolide_GDSC1(3) |  285_SU11274_GDSC1(4) |  1008_Methotrexate_GDSC1(4) | Other Solid Cancers	MAP4K4 (8):	--3-- |  262_VX-11e_GDSC1(4) |  330_XMD13-2_GDSC1(4) |  2148_POMHEX_GDSC2(3) | Other Solid Cancers	MDM2 (6):	--2-- |  1445_AZD8835_GDSC1(4) |  1924_Ipatasertib_GDSC2(4) | Other Solid Cancers	MLLT3 (6):	--3-- |  54_CGP-082996_GDSC1(2) |  1804_Acetalax_GDSC2(3) |  1928_I-BRD9_GDSC2(2) | Other Solid Cancers	MST1R (3):	--2-- |  326_GSK690693_GDSC1(2) |  1084_Rapamycin_GDSC2(2) | Other Solid Cancers	NCOA3 (6):	--2-- |  175_PAC-1_GDSC1(3) |  474_ARRY-520_GDSC1(4) | Other Solid Cancers	PAK1 (4):	--3-- |  1004_Vinblastine_GDSC1(1) |  1012_Vorinostat_GDSC1(1) |  1511_Epirubicin_GDSC2(2) | Other Solid Cancers	PLCG2 (11):	--4-- |  245_UNC0638_GDSC1(3) |  1059_AZD8055_GDSC1(6) |  1186_FS112_GDSC1(5) |  1922_Cediranib_GDSC2(4) | Other Solid Cancers	PRKACA (9):	--4-- |  151_QS11_GDSC1(5) |  1494_SN-38_GDSC2(3) |  1529_Pevonedistat_GDSC2(5) |  1924_Ipatasertib_GDSC2(5) | Other Solid Cancers	RAC1 (3):	--2-- |  86_A-443654_GDSC1(1) |  376_Brivanib, BMS-540215_GDSC1(2) | Other Solid Cancers	RPTOR (15):	--2-- |  299_OSI-027_GDSC1(9) |  1031_Elesclomol_GDSC1(8) | Other Solid Cancers	SF3B1 (6):	--2-- |  329_QL-XI-92_GDSC1(3) |  563_Kobe2602_GDSC1(3) | Other Solid Cancers	STAT6 (5):	--3-- |  261_TL-1-85_GDSC1(3) |  474_ARRY-520_GDSC1(3) |  1069_EHT-1864_GDSC2(3) | Other Solid Cancers	VAV1 (7):	--3-- |  366_TWS119_GDSC1(3) |  1128_FS106_GDSC1(3) |  1180_Dinaciclib_GDSC2(3) | Other Solid Cancers	VEGFA (6):	--3-- |  1004_Vinblastine_GDSC1(4) |  1732_TAF1_5496_GDSC2(3) |  1928_I-BRD9_GDSC2(2) | Other Solid Cancers	XPO1 (5):	--3-- |  89_Parthenolide_GDSC1(3) |  1630_Entospletinib_GDSC2(2) |  2173_PFI-1_GDSC2(2) | Other Solid Cancers	YAP1 (3):	--2-- |  221_TAK-715_GDSC1(2) |  1428_IAP_5620_GDSC1(2) | Ovarian Carcinoma	ABL1 (9):	--3-- |  1149_TW 37_GDSC2(4) |  1916_AZD5363_GDSC2(5) |  1999_N25720-51-A1_GDSC2(3) | Ovarian Carcinoma	AGO1 (8):	--3-- |  326_GSK690693_GDSC1(4) |  1010_Gefitinib_GDSC1(3) |  1849_Sabutoclax_GDSC2(5) | Ovarian Carcinoma	ARHGEF28 (14):	--4-- |  222_BX-912_GDSC1(6) |  261_TL-1-85_GDSC1(5) |  381_AST-1306_GDSC1(11) |  1368_BAY-MPS1_GDSC1(8) | Ovarian Carcinoma	ARID3B (6):	--3-- |  171_AKT inhibitor VIII_GDSC1(2) |  1494_SN-38_GDSC1(3) |  1168_Erlotinib_GDSC2(3) | Ovarian Carcinoma	BCL2 (3):	--2-- |  1036_PLX-4720_GDSC2(2) |  1997_WEHI-539_GDSC2(2) | Ovarian Carcinoma	BCL6 (3):	--2-- |  1261_rTRAIL_GDSC1(2) |  1425_BPTES_GDSC1(2) | Ovarian Carcinoma	BRAF (15):	--3-- |  179_5-Fluorouracil_GDSC1(10) |  1053_MK-2206_GDSC2(7) |  1062_Selumetinib_GDSC2(7) | Ovarian Carcinoma	BRD4 (6):	--2-- |  356_AT7867_GDSC1(4) |  1047_Nutlin-3a (-)_GDSC1(3) | Ovarian Carcinoma	BTK (14):	--3-- |  156_AZD6482_GDSC1(6) |  1066_AZD6482_GDSC1(7) |  1091_BMS-536924_GDSC2(10) | Ovarian Carcinoma	CARD11 (12):	--3-- |  1070_CRT0105950_GDSC1(6) |  1444_AZD8186_GDSC1(6) |  1073_5-Fluorouracil_GDSC2(4) | Ovarian Carcinoma	CCNB3 (8):	--2-- |  272_AR-42_GDSC1(4) |  1441_AZD2014_GDSC1(6) | Ovarian Carcinoma	CCND2 (4):	--3-- |  223_ZSTK474_GDSC1(1) |  273_CUDC-101_GDSC1(2) |  1425_BPTES_GDSC1(2) | Ovarian Carcinoma	CCNE1 (10):	--4-- |  135_Gemcitabine_GDSC1(4) |  151_QS11_GDSC1(4) |  1058_Pictilisib_GDSC2(5) |  1190_Gemcitabine_GDSC2(6) | Ovarian Carcinoma	CD276 (4):	--2-- |  1799_Ibrutinib_GDSC2(2) |  1999_N25720-51-A1_GDSC2(2) | Ovarian Carcinoma	CDK6 (5):	--2-- |  283_Omipalisib_GDSC1(3) |  1434_JAK3_7406_GDSC1(3) | Ovarian Carcinoma	COP1 (7):	--2-- |  1377_Afatinib_GDSC1(4) |  1073_5-Fluorouracil_GDSC2(3) | Ovarian Carcinoma	CTLA4 (3):	--2-- |  436_CAP-232, TT-232, TLN-232_GDSC1(2) |  1164_XMD8-92_GDSC1(2) | Ovarian Carcinoma	CYSLTR2 (3):	--2-- |  230_GSK429286A_GDSC1(2) |  1203_QL-XII-61_GDSC1(2) | Ovarian Carcinoma	DCUN1D1 (6):	--2-- |  269_NSC-207895_GDSC1(3) |  1924_Ipatasertib_GDSC2(3) | Ovarian Carcinoma	E2F3 (5):	--2-- |  1195_FY026_GDSC1(2) |  1940_WIKI4_GDSC2(3) | Ovarian Carcinoma	EGFL7 (6):	--2-- |  1168_Erlotinib_GDSC2(3) |  1820_123829_GDSC2(3) | Ovarian Carcinoma	EGFR (11):	--2-- |  223_ZSTK474_GDSC1(7) |  1183_CRT0160829_GDSC1(6) | Ovarian Carcinoma	EIF4A2 (8):	--2-- |  442_IMD-0354_GDSC1(6) |  1441_AZD2014_GDSC1(6) | Ovarian Carcinoma	EPOR (6):	--2-- |  1066_AZD6482_GDSC1(4) |  1434_JAK3_7406_GDSC1(4) | Ovarian Carcinoma	ERBB2 (8):	--3-- |  299_OSI-027_GDSC1(4) |  1464_TTK_3146_GDSC1(5) |  1930_Telomerase Inhibitor IX_GDSC2(5) | Ovarian Carcinoma	ERBB4 (9):	--2-- |  261_TL-1-85_GDSC1(6) |  1032_Afatinib_GDSC1(5) | Ovarian Carcinoma	ESR1 (6):	--2-- |  310_YM201636_GDSC1(3) |  1441_AZD2014_GDSC1(4) | Ovarian Carcinoma	EWSR1 (8):	--2-- |  273_CUDC-101_GDSC1(5) |  1066_AZD6482_GDSC1(5) | Ovarian Carcinoma	FGFR1 (11):	--3-- |  223_ZSTK474_GDSC1(6) |  1135_AZD4547_GDSC1(5) |  1912_Afuresertib_GDSC2(7) | Ovarian Carcinoma	FGFR2 (11):	--3-- |  273_CUDC-101_GDSC1(7) |  428_Pemetrexed_GDSC1(6) |  1939_UMI-77_GDSC2(5) | Ovarian Carcinoma	FGFR3 (7):	--4-- |  182_Obatoclax Mesylate_GDSC1(2) |  272_AR-42_GDSC1(3) |  1036_PLX-4720_GDSC2(2) |  1916_AZD5363_GDSC2(4) | Ovarian Carcinoma	FGFR4 (13):	--3-- |  260_NG-25_GDSC1(7) |  381_AST-1306_GDSC1(10) |  1011_Navitoclax_GDSC1(6) | Ovarian Carcinoma	FLI1 (11):	--3-- |  272_AR-42_GDSC1(7) |  1490_SN-38_GDSC1(4) |  1014_Refametinib_GDSC2(4) | Ovarian Carcinoma	GNA12 (5):	--2-- |  309_Y-39983_GDSC1(3) |  436_CAP-232, TT-232, TLN-232_GDSC1(2) | Ovarian Carcinoma	GNAS (16):	--3-- |  295_NVP-BHG712_GDSC1(6) |  1378_Bleomycin (50 uM)_GDSC1(10) |  1091_BMS-536924_GDSC2(10) | Ovarian Carcinoma	GSK3B (7):	--3-- |  223_ZSTK474_GDSC1(4) |  1135_AZD4547_GDSC1(4) |  1062_Selumetinib_GDSC2(4) | Ovarian Carcinoma	GTF2I (11):	--3-- |  342_Tenovin-6_GDSC1(6) |  1062_Selumetinib_GDSC2(6) |  1912_Afuresertib_GDSC2(7) | Ovarian Carcinoma	HDAC7 (8):	--2-- |  265_Tubastatin A_GDSC1(3) |  1070_CRT0105950_GDSC1(6) | Ovarian Carcinoma	HIF1A (5):	--2-- |  1021_Axitinib_GDSC1(2) |  1185_KU-60019_GDSC1(3) | Ovarian Carcinoma	IRS1 (8):	--4-- |  326_GSK690693_GDSC1(4) |  1135_AZD4547_GDSC1(4) |  1249_BMS-345541_GDSC2(2) |  1847_BEN_GDSC2(3) | Ovarian Carcinoma	JAK2 (14):	--3-- |  178_BAY-61-3606_GDSC1(6) |  1370_BAY-MPS-combo 2 (paclitaxel 1 uM)_GDSC1(8) |  1498_Selumetinib_GDSC1(8) | Ovarian Carcinoma	KDR (11):	--2-- |  356_AT7867_GDSC1(5) |  1444_AZD8186_GDSC1(7) | Ovarian Carcinoma	KIT (10):	--3-- |  261_TL-1-85_GDSC1(4) |  1032_Afatinib_GDSC1(5) |  1192_GSK269962A_GDSC1(6) | Ovarian Carcinoma	LCK (4):	--2-- |  288_WHI-P97_GDSC1(2) |  1021_Axitinib_GDSC1(2) | Ovarian Carcinoma	LGR5 (10):	--3-- |  235_QL-XII-47_GDSC1(5) |  1377_Afatinib_GDSC1(5) |  1803_Acetalax_GDSC2(4) | Ovarian Carcinoma	LTK (8):	--3-- |  134_Etoposide_GDSC1(2) |  287_KIN001-244_GDSC1(5) |  1529_Pevonedistat_GDSC1(4) | Ovarian Carcinoma	LYN (7):	--2-- |  279_BIX02189_GDSC1(2) |  1377_Afatinib_GDSC1(5) | Ovarian Carcinoma	MAP2K2 (7):	--2-- |  1114_Cetuximab_GDSC1(3) |  1188_CCT245467_GDSC1(5) | Ovarian Carcinoma	MAP3K13 (11):	--3-- |  229_Enzastaurin_GDSC1(4) |  1032_Afatinib_GDSC1(5) |  1494_SN-38_GDSC2(7) | Ovarian Carcinoma	MAP4K4 (13):	--3-- |  223_ZSTK474_GDSC1(8) |  1008_Methotrexate_GDSC1(4) |  1377_Afatinib_GDSC1(6) | Ovarian Carcinoma	MAPK1 (6):	--3-- |  222_BX-912_GDSC1(3) |  326_GSK690693_GDSC1(3) |  1924_Ipatasertib_GDSC2(3) | Ovarian Carcinoma	MDM2 (3):	--2-- |  1010_Gefitinib_GDSC1(2) |  1461_TANK_1366_GDSC1(2) | Ovarian Carcinoma	MDM4 (8):	--2-- |  1549_Sapitinib_GDSC2(4) |  1849_Sabutoclax_GDSC2(5) | Ovarian Carcinoma	MEF2B (3):	--2-- |  1261_rTRAIL_GDSC1(2) |  1005_Cisplatin_GDSC2(2) | Ovarian Carcinoma	MET (8):	--2-- |  1008_Methotrexate_GDSC1(3) |  1422_FGFR_3831_GDSC1(6) | Ovarian Carcinoma	MGAM (26):	--4-- |  260_NG-25_GDSC1(12) |  1015_CI-1040_GDSC1(11) |  1413_EphB4_9721_GDSC1(14) |  1617_AZD5582_GDSC2(12) | Ovarian Carcinoma	MLLT3 (4):	--2-- |  1016_Temsirolimus_GDSC2(3) |  1799_Ibrutinib_GDSC2(2) | Ovarian Carcinoma	MSI1 (6):	--2-- |  1195_FY026_GDSC1(4) |  1382_AZD3514_GDSC1(3) | Ovarian Carcinoma	MST1R (5):	--2-- |  1434_JAK3_7406_GDSC1(3) |  1038_NU7441_GDSC2(3) | Ovarian Carcinoma	NCSTN (8):	--3-- |  151_QS11_GDSC1(3) |  252_WZ3105_GDSC1(3) |  1066_AZD6482_GDSC1(6) | Ovarian Carcinoma	NFE2L2 (6):	--2-- |  317_WYE-125132_GDSC1(4) |  1031_Elesclomol_GDSC1(4) | Ovarian Carcinoma	NR4A3 (5):	--2-- |  223_ZSTK474_GDSC1(2) |  363_PF-00299804_GDSC1(3) | Ovarian Carcinoma	NT5C2 (9):	--2-- |  331_QL-X-138_GDSC1(3) |  1031_Elesclomol_GDSC1(7) | Ovarian Carcinoma	NTRK3 (13):	--2-- |  223_ZSTK474_GDSC1(7) |  1393_Gemcitabine_GDSC1(8) | Ovarian Carcinoma	NUP214 (12):	--3-- |  179_5-Fluorouracil_GDSC1(8) |  208_Ispinesib Mesylate_GDSC1(7) |  1053_MK-2206_GDSC2(6) | Ovarian Carcinoma	NUP98 (17):	--4-- |  177_GSK650394_GDSC1(6) |  310_YM201636_GDSC1(5) |  1219_PFI-1_GDSC1(10) |  1026_Tanespimycin_GDSC2(12) | Ovarian Carcinoma	PAK5 (5):	--2-- |  1057_Dactolisib_GDSC1(3) |  1933_P22077_GDSC2(2) | Ovarian Carcinoma	PAX8 (5):	--2-- |  1021_Axitinib_GDSC1(2) |  1463_AZD1332_GDSC2(4) | Ovarian Carcinoma	PDCD1LG2 (5):	--3-- |  249_Cabozantinib_GDSC1(2) |  1010_Gefitinib_GDSC1(2) |  1434_JAK3_7406_GDSC1(3) | Ovarian Carcinoma	PDGFRA (9):	--2-- |  1070_CRT0105950_GDSC1(5) |  1444_AZD8186_GDSC1(6) | Ovarian Carcinoma	PDGFRB (8):	--3-- |  151_QS11_GDSC1(3) |  1008_Methotrexate_GDSC1(3) |  1131_PRIMA-1MET_GDSC2(5) | Ovarian Carcinoma	PLCG1 (6):	--2-- |  155_Ponatinib_GDSC1(3) |  1050_ZM447439_GDSC2(4) | Ovarian Carcinoma	PPARG (7):	--3-- |  223_ZSTK474_GDSC1(4) |  272_AR-42_GDSC1(4) |  1188_CCT245467_GDSC1(4) | Ovarian Carcinoma	PRKACA (9):	--2-- |  252_WZ3105_GDSC1(4) |  1031_Elesclomol_GDSC1(7) | Ovarian Carcinoma	REL (3):	--2-- |  265_Tubastatin A_GDSC1(2) |  1736_Selumetinib_GDSC2(2) | Ovarian Carcinoma	RHEB (5):	--2-- |  1021_Axitinib_GDSC1(2) |  1940_WIKI4_GDSC2(3) | Ovarian Carcinoma	RHOA (3):	--2-- |  265_Tubastatin A_GDSC1(2) |  1010_Gefitinib_GDSC1(2) | Ovarian Carcinoma	RICTOR (15):	--3-- |  1019_Bosutinib_GDSC1(8) |  1022_AZD7762_GDSC2(11) |  1131_PRIMA-1MET_GDSC2(7) | Ovarian Carcinoma	RNASEH2A (3):	--2-- |  1249_BMS-345541_GDSC2(2) |  1560_Alpelisib_GDSC2(2) | Ovarian Carcinoma	ROS1 (15):	--3-- |  326_GSK690693_GDSC1(5) |  415_CPI-613_GDSC1(5) |  1460_PARP_9482_GDSC1(9) | Ovarian Carcinoma	RRAS (3):	--2-- |  436_CAP-232, TT-232, TLN-232_GDSC1(2) |  1421_FGFR_0939_GDSC1(2) | Ovarian Carcinoma	SET (5):	--3-- |  171_AKT inhibitor VIII_GDSC1(2) |  262_VX-11e_GDSC1(3) |  1021_Axitinib_GDSC1(2) | Ovarian Carcinoma	SETD1A (8):	--3-- |  186_Bexarotene_GDSC1(2) |  1007_Docetaxel_GDSC2(5) |  1549_Sapitinib_GDSC2(4) | Ovarian Carcinoma	SF3B1 (10):	--2-- |  1037_BX795_GDSC1(6) |  1066_AZD6482_GDSC1(7) | Ovarian Carcinoma	SGK1 (6):	--3-- |  326_GSK690693_GDSC1(3) |  1010_Gefitinib_GDSC1(2) |  1849_Sabutoclax_GDSC2(4) | Ovarian Carcinoma	SRC (11):	--2-- |  223_ZSTK474_GDSC1(7) |  1460_PARP_9482_GDSC1(5) | Ovarian Carcinoma	TCL1A (3):	--2-- |  1008_Methotrexate_GDSC1(2) |  1047_Nutlin-3a (-)_GDSC2(2) | Ovarian Carcinoma	TFE3 (6):	--2-- |  292_Masitinib_GDSC1(4) |  1919_Osimertinib_GDSC2(2) | Ovarian Carcinoma	TYK2 (10):	--2-- |  275_I-BET-762_GDSC1(6) |  1019_Bosutinib_GDSC1(6) | Ovarian Carcinoma	UBR5 (13):	--3-- |  299_OSI-027_GDSC1(8) |  310_YM201636_GDSC1(4) |  1409_AZD4877_GDSC1(10) | Ovarian Carcinoma	WWP1 (7):	--3-- |  222_BX-912_GDSC1(4) |  304_SB52334_GDSC1(3) |  1421_FGFR_0939_GDSC1(2) | Ovarian Carcinoma	XPO1 (6):	--2-- |  1032_Afatinib_GDSC1(4) |  1434_JAK3_7406_GDSC1(4) | Ovarian Carcinoma	YES1 (7):	--2-- |  1549_Sapitinib_GDSC2(4) |  1849_Sabutoclax_GDSC2(5) | Pancreatic Carcinoma	ABL2 (4):	--2-- |  225_Genentech Cpd 10_GDSC1(3) |  1712_Eg5_9814_GDSC2(3) | Pancreatic Carcinoma	AKT1 (5):	--3-- |  356_AT7867_GDSC1(2) |  1011_Navitoclax_GDSC1(2) |  1136_Capivasertib_GDSC1(3) | Pancreatic Carcinoma	BRAF (3):	--2-- |  265_Tubastatin A_GDSC1(2) |  1192_GSK269962A_GDSC1(2) | Pancreatic Carcinoma	CARD11 (5):	--2-- |  172_Embelin_GDSC1(2) |  1926_GNE-317_GDSC2(3) | Pancreatic Carcinoma	COP1 (5):	--3-- |  449_CD532_GDSC1(2) |  1026_Tanespimycin_GDSC1(2) |  1434_JAK3_7406_GDSC1(3) | Pancreatic Carcinoma	DNMT1 (7):	--2-- |  306_Fedratinib_GDSC1(5) |  1058_Pictilisib_GDSC2(3) | Pancreatic Carcinoma	ERBB2 (4):	--2-- |  1072_Avagacestat_GDSC1(2) |  1149_TW 37_GDSC1(2) | Pancreatic Carcinoma	ERBB3 (6):	--2-- |  170_Shikonin_GDSC1(4) |  1496_Cisplatin_GDSC1(4) | Pancreatic Carcinoma	ERBB4 (8):	--3-- |  317_WYE-125132_GDSC1(3) |  1378_Bleomycin (50 uM)_GDSC1(4) |  1463_AZD1332_GDSC1(5) | Pancreatic Carcinoma	ETV1 (7):	--2-- |  1004_Vinblastine_GDSC1(4) |  2171_BMS-754807_GDSC2(5) | Pancreatic Carcinoma	FLT3 (6):	--2-- |  1192_GSK269962A_GDSC1(2) |  1011_Navitoclax_GDSC2(4) | Pancreatic Carcinoma	GATA2 (4):	--2-- |  275_I-BET-762_GDSC1(3) |  439_LCL161_GDSC1(3) | Pancreatic Carcinoma	GLI1 (4):	--2-- |  175_PAC-1_GDSC1(3) |  1188_CCT245467_GDSC1(3) | Pancreatic Carcinoma	GNA12 (4):	--2-- |  1197_ZL049_GDSC1(2) |  1401_AZD5438_GDSC2(3) | Pancreatic Carcinoma	GNAS (6):	--2-- |  175_PAC-1_GDSC1(4) |  225_Genentech Cpd 10_GDSC1(5) | Pancreatic Carcinoma	HDAC7 (5):	--2-- |  133_Doxorubicin_GDSC1(3) |  1932_NVP-ADW742_GDSC2(2) | Pancreatic Carcinoma	HIF1A (5):	--2-- |  194_Luminespib_GDSC1(3) |  1128_FS106_GDSC1(3) | Pancreatic Carcinoma	HMGA2 (4):	--2-- |  133_Doxorubicin_GDSC1(2) |  1932_NVP-ADW742_GDSC2(2) | Pancreatic Carcinoma	IGF1R (6):	--3-- |  363_PF-00299804_GDSC1(2) |  1091_BMS-536924_GDSC1(4) |  1022_AZD7762_GDSC2(2) | Pancreatic Carcinoma	INSR (4):	--2-- |  175_PAC-1_GDSC1(3) |  1070_CRT0105950_GDSC1(3) | Pancreatic Carcinoma	KSR2 (8):	--3-- |  284_JNJ38877605_GDSC1(3) |  1070_CRT0105950_GDSC1(4) |  1085_Sorafenib_GDSC2(4) | Pancreatic Carcinoma	LTK (5):	--2-- |  1011_Navitoclax_GDSC1(2) |  1259_Talazoparib_GDSC2(3) | Pancreatic Carcinoma	MAP4K4 (6):	--2-- |  228_AKT inhibitor VIII_GDSC1(4) |  1136_Capivasertib_GDSC1(3) | Pancreatic Carcinoma	MDM4 (6):	--2-- |  170_Shikonin_GDSC1(4) |  416_CAY10566_GDSC1(2) | Pancreatic Carcinoma	MECOM (8):	--2-- |  222_BX-912_GDSC1(5) |  1003_Camptothecin_GDSC2(5) | Pancreatic Carcinoma	NCSTN (4):	--2-- |  330_XMD13-2_GDSC1(2) |  1070_CRT0105950_GDSC1(3) | Pancreatic Carcinoma	NSD2 (3):	--2-- |  292_Masitinib_GDSC1(2) |  1188_CCT245467_GDSC1(2) | Pancreatic Carcinoma	PIK3CA (3):	--2-- |  284_JNJ38877605_GDSC1(2) |  1050_ZM447439_GDSC2(2) | Pancreatic Carcinoma	PRKACA (5):	--3-- |  184_BMS-754807_GDSC1(2) |  374_GSK1059615_GDSC1(3) |  1046_Wee1 Inhibitor_GDSC1(2) | Pancreatic Carcinoma	RAC1 (4):	--2-- |  1007_Docetaxel_GDSC2(3) |  1085_Sorafenib_GDSC2(3) | Pancreatic Carcinoma	RICTOR (4):	--2-- |  133_Doxorubicin_GDSC1(2) |  1932_NVP-ADW742_GDSC2(2) | Pancreatic Carcinoma	SGK1 (4):	--2-- |  175_PAC-1_GDSC1(3) |  225_Genentech Cpd 10_GDSC1(3) | Pancreatic Carcinoma	SMO (7):	--2-- |  262_VX-11e_GDSC1(4) |  306_Fedratinib_GDSC1(5) | Pancreatic Carcinoma	SQSTM1 (5):	--2-- |  194_Luminespib_GDSC1(3) |  1407_Dyrk1b_0191_GDSC1(2) | Pancreatic Carcinoma	UBR5 (12):	--3-- |  175_PAC-1_GDSC1(5) |  407_kb NB 142-70_GDSC1(7) |  1058_Pictilisib_GDSC2(6) | Pancreatic Carcinoma	VAV2 (11):	--3-- |  449_CD532_GDSC1(6) |  1526_Refametinib_GDSC1(4) |  1190_Gemcitabine_GDSC2(7) | Plasma Cell Myeloma	ABL2 (5):	--2-- |  279_BIX02189_GDSC1(3) |  1778_GSK2110183B_GDSC2(4) | Plasma Cell Myeloma	AFF4 (4):	--2-- |  1020_Lenalidomide_GDSC1(3) |  1054_Palbociclib_GDSC1(3) | Plasma Cell Myeloma	AGO1 (3):	--2-- |  224_AS605240_GDSC1(1) |  1422_FGFR_3831_GDSC1(2) | Plasma Cell Myeloma	ATXN7 (3):	--2-- |  224_AS605240_GDSC1(1) |  1422_FGFR_3831_GDSC1(2) | Plasma Cell Myeloma	BRAF (6):	--2-- |  71_Pyrimethamine_GDSC1(3) |  2173_PFI-1_GDSC2(4) | Plasma Cell Myeloma	BRD3 (4):	--2-- |  1047_Nutlin-3a (-)_GDSC1(3) |  1060_PD0325901_GDSC2(3) | Plasma Cell Myeloma	CCNB3 (3):	--2-- |  416_CAY10566_GDSC1(2) |  1630_Entospletinib_GDSC2(2) | Plasma Cell Myeloma	CCND1 (5):	--2-- |  269_NSC-207895_GDSC1(4) |  1021_Axitinib_GDSC2(4) | Plasma Cell Myeloma	DDR2 (5):	--2-- |  1259_Talazoparib_GDSC2(3) |  2046_MK-8776_GDSC2(4) | Plasma Cell Myeloma	EGFL7 (4):	--2-- |  1089_Oxaliplatin_GDSC2(3) |  1558_Lapatinib_GDSC2(3) | Plasma Cell Myeloma	ERBB2 (3):	--2-- |  1630_Entospletinib_GDSC2(2) |  1833_741909_GDSC2(2) | Plasma Cell Myeloma	FLT4 (4):	--2-- |  262_VX-11e_GDSC1(2) |  1129_PF-4708671_GDSC1(2) | Plasma Cell Myeloma	FURIN (4):	--2-- |  416_CAY10566_GDSC1(2) |  1047_Nutlin-3a (-)_GDSC2(3) | Plasma Cell Myeloma	FUS (3):	--2-- |  224_AS605240_GDSC1(1) |  1422_FGFR_3831_GDSC1(2) | Plasma Cell Myeloma	GNAS (6):	--2-- |  175_PAC-1_GDSC1(3) |  1026_Tanespimycin_GDSC1(4) | Plasma Cell Myeloma	KRAS (5):	--2-- |  1218_JQ1_GDSC1(4) |  1526_Refametinib_GDSC1(4) | Plasma Cell Myeloma	LRP6 (5):	--2-- |  285_SU11274_GDSC1(3) |  1054_Palbociclib_GDSC1(3) | Plasma Cell Myeloma	MDM4 (4):	--2-- |  439_LCL161_GDSC1(3) |  1617_AZD5582_GDSC2(2) | Plasma Cell Myeloma	MPL (3):	--2-- |  224_AS605240_GDSC1(1) |  1422_FGFR_3831_GDSC1(2) | Plasma Cell Myeloma	NSD2 (4):	--2-- |  1047_Nutlin-3a (-)_GDSC1(3) |  1855_KRAS (G12C) Inhibitor-12_GDSC2(3) | Plasma Cell Myeloma	NTRK2 (5):	--2-- |  1133_Serdemetan_GDSC2(4) |  1598_LGK974_GDSC2(3) | Plasma Cell Myeloma	NUF2 (4):	--2-- |  1019_Bosutinib_GDSC1(3) |  1020_Lenalidomide_GDSC1(3) | Plasma Cell Myeloma	NUP98 (8):	--2-- |  1736_Selumetinib_GDSC2(4) |  1916_AZD5363_GDSC2(6) | Plasma Cell Myeloma	PIK3CA (6):	--2-- |  1054_Palbociclib_GDSC1(3) |  1052_RO-3306_GDSC2(4) | Plasma Cell Myeloma	PLCG2 (9):	--2-- |  309_Y-39983_GDSC1(6) |  1016_Temsirolimus_GDSC2(7) | Plasma Cell Myeloma	ROS1 (7):	--2-- |  1426_AZD7969_GDSC1(4) |  1806_Oxaliplatin_GDSC2(5) | Plasma Cell Myeloma	RPS6KA4 (3):	--2-- |  1049_PD173074_GDSC1(2) |  1630_Entospletinib_GDSC2(2) | Plasma Cell Myeloma	RPTOR (9):	--2-- |  428_Pemetrexed_GDSC1(6) |  1806_Oxaliplatin_GDSC2(6) | Plasma Cell Myeloma	SGK1 (6):	--2-- |  1047_Nutlin-3a (-)_GDSC1(3) |  1133_Serdemetan_GDSC2(5) | Plasma Cell Myeloma	SHOC2 (4):	--2-- |  1069_EHT-1864_GDSC2(3) |  1089_Oxaliplatin_GDSC2(3) | Plasma Cell Myeloma	SOS1 (5):	--2-- |  1066_AZD6482_GDSC1(3) |  1598_LGK974_GDSC2(3) | Plasma Cell Myeloma	SQSTM1 (4):	--2-- |  293_Amuvatinib_GDSC1(1) |  1463_AZD1332_GDSC1(3) | Plasma Cell Myeloma	STAT3 (4):	--2-- |  1089_Oxaliplatin_GDSC2(3) |  1629_ML323_GDSC2(3) | Plasma Cell Myeloma	STAT5B (4):	--2-- |  1629_ML323_GDSC2(3) |  1826_50869_GDSC2(3) | Plasma Cell Myeloma	VAV1 (5):	--2-- |  1463_AZD1332_GDSC1(3) |  1718_JAK1_8709_GDSC2(3) | Plasma Cell Myeloma	XPO1 (6):	--2-- |  1713_ERK_2440_GDSC2(5) |  2111_VE821_GDSC2(3) | Small Cell Lung Carcinoma	ABL2 (10):	--3-- |  211_TL-2-105_GDSC1(4) |  1012_Vorinostat_GDSC1(7) |  1149_TW 37_GDSC1(7) | Small Cell Lung Carcinoma	AGO1 (8):	--3-- |  223_ZSTK474_GDSC1(2) |  1386_Doxorubicin_GDSC1(3) |  1012_Vorinostat_GDSC2(5) | Small Cell Lung Carcinoma	AKT1 (9):	--2-- |  245_UNC0638_GDSC1(6) |  1069_EHT-1864_GDSC2(4) | Small Cell Lung Carcinoma	ARAF (4):	--2-- |  89_Parthenolide_GDSC1(2) |  284_JNJ38877605_GDSC1(2) | Small Cell Lung Carcinoma	AXL (17):	--4-- |  152_CP466722_GDSC1(6) |  317_WYE-125132_GDSC1(11) |  439_LCL161_GDSC1(7) |  1843_LMP744_GDSC2(6) | Small Cell Lung Carcinoma	CCND2 (8):	--3-- |  258_STF-62247_GDSC1(2) |  261_TL-1-85_GDSC1(3) |  1918_AZD8186_GDSC2(3) | Small Cell Lung Carcinoma	CD79B (3):	--2-- |  151_QS11_GDSC1(2) |  175_PAC-1_GDSC1(2) | Small Cell Lung Carcinoma	DNMT1 (20):	--2-- |  274_Belinostat_GDSC1(14) |  1997_WEHI-539_GDSC2(12) | Small Cell Lung Carcinoma	FLT4 (13):	--2-- |  1441_AZD2014_GDSC1(5) |  1012_Vorinostat_GDSC2(10) | Small Cell Lung Carcinoma	GNA12 (9):	--2-- |  224_AS605240_GDSC1(5) |  1910_ABT737_GDSC2(4) | Small Cell Lung Carcinoma	HIF1A (9):	--2-- |  268_Sepantronium bromide_GDSC1(7) |  1133_Serdemetan_GDSC1(3) | Small Cell Lung Carcinoma	HMGA2 (4):	--2-- |  175_PAC-1_GDSC1(2) |  230_GSK429286A_GDSC1(2) | Small Cell Lung Carcinoma	IDH2 (5):	--2-- |  1066_AZD6482_GDSC1(3) |  1170_CCT-018159_GDSC1(3) | Small Cell Lung Carcinoma	JAK2 (17):	--3-- |  224_AS605240_GDSC1(8) |  1026_Tanespimycin_GDSC2(11) |  1038_NU7441_GDSC2(6) | Small Cell Lung Carcinoma	LMO2 (7):	--3-- |  328_SNX-2112_GDSC1(3) |  1071_CRT0105446_GDSC1(2) |  1089_Oxaliplatin_GDSC2(4) | Small Cell Lung Carcinoma	MYCN (3):	--2-- |  1017_Olaparib_GDSC2(2) |  1133_Serdemetan_GDSC2(2) | Small Cell Lung Carcinoma	NRAS (5):	--2-- |  279_BIX02189_GDSC1(2) |  1012_Vorinostat_GDSC2(3) | Small Cell Lung Carcinoma	PGR (10):	--4-- |  229_Enzastaurin_GDSC1(5) |  1050_ZM447439_GDSC1(5) |  1368_BAY-MPS1_GDSC1(5) |  1416_AZD8931_GDSC1(5) | Small Cell Lung Carcinoma	RAB35 (4):	--2-- |  230_GSK429286A_GDSC1(2) |  1581_Bromosporine_GDSC2(2) | Small Cell Lung Carcinoma	RAC1 (6):	--2-- |  157_JNK-9L_GDSC1(4) |  1427_AZD5582_GDSC1(2) | Small Cell Lung Carcinoma	RRAS2 (4):	--2-- |  245_UNC0638_GDSC1(2) |  1175_Rucaparib_GDSC1(2) | Small Cell Lung Carcinoma	SHOC2 (6):	--2-- |  252_WZ3105_GDSC1(4) |  461_NSC319726_GDSC1(3) | Small Cell Lung Carcinoma	TLX3 (4):	--2-- |  245_UNC0638_GDSC1(2) |  1069_EHT-1864_GDSC2(2) | Small Cell Lung Carcinoma	VEGFA (10):	--2-- |  245_UNC0638_GDSC1(6) |  1446_PI3Ka_4409_GDSC1(6) | Small Cell Lung Carcinoma	WWTR1 (11):	--3-- |  223_ZSTK474_GDSC1(6) |  252_WZ3105_GDSC1(8) |  1054_Palbociclib_GDSC1(3) | Squamous Cell Lung Carcinoma	ABL1 (3):	--2-- |  1010_Gefitinib_GDSC1(2) |  1080_Paclitaxel_GDSC2(2) | Squamous Cell Lung Carcinoma	AKT3 (3):	--2-- |  1434_JAK3_7406_GDSC1(2) |  1458_PARP_9495_GDSC1(2) | Squamous Cell Lung Carcinoma	AXL (5):	--2-- |  1001_AICA Ribonucleotide_GDSC1(4) |  1908_Ulixertinib_GDSC2(4) | Squamous Cell Lung Carcinoma	BCL9 (3):	--2-- |  1010_Gefitinib_GDSC1(2) |  1458_PARP_9495_GDSC1(2) | Squamous Cell Lung Carcinoma	BRD4 (3):	--2-- |  1060_PD0325901_GDSC1(1) |  1052_RO-3306_GDSC2(2) | Squamous Cell Lung Carcinoma	CD79B (5):	--2-- |  282_Pelitinib_GDSC1(1) |  1419_FEN1_3940_GDSC1(4) | Squamous Cell Lung Carcinoma	COP1 (5):	--2-- |  1192_GSK269962A_GDSC1(4) |  1419_FEN1_3940_GDSC1(4) | Squamous Cell Lung Carcinoma	DNMT1 (5):	--2-- |  1014_Refametinib_GDSC1(4) |  1186_FS112_GDSC1(1) | Squamous Cell Lung Carcinoma	EGFR (7):	--3-- |  362_CI-1033_GDSC1(4) |  1248_Daporinad_GDSC1(2) |  1459_PARP_0108_GDSC1(3) | Squamous Cell Lung Carcinoma	EZH1 (3):	--2-- |  1010_Gefitinib_GDSC1(2) |  1458_PARP_9495_GDSC1(2) | Squamous Cell Lung Carcinoma	FGFR1 (5):	--2-- |  1133_Serdemetan_GDSC1(3) |  2044_Pyridostatin_GDSC2(4) | Squamous Cell Lung Carcinoma	FLT1 (5):	--2-- |  1558_Lapatinib_GDSC2(3) |  1924_Ipatasertib_GDSC2(3) | Squamous Cell Lung Carcinoma	INSR (6):	--2-- |  1186_FS112_GDSC1(2) |  1908_Ulixertinib_GDSC2(5) | Squamous Cell Lung Carcinoma	JAK2 (6):	--2-- |  1617_AZD5582_GDSC2(5) |  1827_Dihydrorotenone_GDSC2(4) | Squamous Cell Lung Carcinoma	KDR (6):	--3-- |  382_Apitolisib_GDSC1(2) |  449_CD532_GDSC1(2) |  474_ARRY-520_GDSC1(2) | Squamous Cell Lung Carcinoma	KSR2 (9):	--2-- |  1259_Talazoparib_GDSC1(6) |  1427_AZD5582_GDSC1(6) | Squamous Cell Lung Carcinoma	MECOM (5):	--2-- |  179_5-Fluorouracil_GDSC1(3) |  1827_Dihydrorotenone_GDSC2(4) | Squamous Cell Lung Carcinoma	MEF2B (3):	--2-- |  1458_PARP_9495_GDSC1(2) |  1080_Paclitaxel_GDSC2(2) | Squamous Cell Lung Carcinoma	MLLT3 (4):	--2-- |  1359_965-D2_GDSC1(3) |  1739_JAK_8517_GDSC2(3) | Squamous Cell Lung Carcinoma	MYBL1 (3):	--2-- |  1010_Gefitinib_GDSC1(2) |  1185_KU-60019_GDSC1(2) | Squamous Cell Lung Carcinoma	NTRK2 (5):	--2-- |  264_ACY-1215_GDSC1(4) |  446_MIM1_GDSC1(4) | Squamous Cell Lung Carcinoma	PAK1 (5):	--2-- |  282_Pelitinib_GDSC1(1) |  1419_FEN1_3940_GDSC1(4) | Squamous Cell Lung Carcinoma	PIK3CG (3):	--2-- |  1803_Acetalax_GDSC2(2) |  1919_Osimertinib_GDSC2(2) | Squamous Cell Lung Carcinoma	RAB35 (3):	--2-- |  1371_PLX-4720_GDSC1(2) |  1080_Paclitaxel_GDSC2(2) | Squamous Cell Lung Carcinoma	RET (5):	--2-- |  372_Pilaralisib_GDSC1(3) |  1037_BX795_GDSC1(4) | Squamous Cell Lung Carcinoma	RHOA (3):	--2-- |  1803_Acetalax_GDSC2(2) |  1919_Osimertinib_GDSC2(2) | Squamous Cell Lung Carcinoma	RPTOR (5):	--2-- |  1559_Luminespib_GDSC2(2) |  1932_NVP-ADW742_GDSC2(4) | Squamous Cell Lung Carcinoma	USP8 (3):	--2-- |  1010_Gefitinib_GDSC1(2) |  1080_Paclitaxel_GDSC2(2) | Squamous Cell Lung Carcinoma	XPO1 (3):	--2-- |  1371_PLX-4720_GDSC1(2) |  1403_AZD6094_GDSC1(2) | T-Lymphoblastic Leukemia	ARID3B (5):	--2-- |  62_BMS-536924_GDSC1(4) |  111_Salubrinal_GDSC1(4) | T-Lymphoblastic Leukemia	AURKB (4):	--2-- |  1392_Bleomycin (10 uM)_GDSC1(3) |  1853_OF-1_GDSC2(3) | T-Lymphoblastic Leukemia	AXL (4):	--2-- |  376_Brivanib, BMS-540215_GDSC1(3) |  1939_UMI-77_GDSC2(1) | T-Lymphoblastic Leukemia	BCL9 (4):	--2-- |  376_Brivanib, BMS-540215_GDSC1(3) |  1183_CRT0160829_GDSC1(1) | T-Lymphoblastic Leukemia	CALR (4):	--2-- |  206_Ruxolitinib_GDSC1(2) |  1392_Bleomycin (10 uM)_GDSC1(3) | T-Lymphoblastic Leukemia	EIF4A2 (4):	--2-- |  1014_Refametinib_GDSC1(3) |  1062_Selumetinib_GDSC1(3) | T-Lymphoblastic Leukemia	ERBB3 (6):	--3-- |  55_A-770041_GDSC1(4) |  2010_HKMTI-1-005_GDSC2(3) |  2046_MK-8776_GDSC2(3) | T-Lymphoblastic Leukemia	ERBB4 (6):	--3-- |  62_BMS-536924_GDSC1(4) |  1392_Bleomycin (10 uM)_GDSC1(4) |  2046_MK-8776_GDSC2(3) | T-Lymphoblastic Leukemia	ETV1 (5):	--2-- |  1066_AZD6482_GDSC1(3) |  1835_Elephantin_GDSC2(2) | T-Lymphoblastic Leukemia	EZH1 (6):	--2-- |  63_BMS-509744_GDSC1(4) |  1732_TAF1_5496_GDSC2(4) | T-Lymphoblastic Leukemia	FGF3 (3):	--2-- |  211_TL-2-105_GDSC1(1) |  574_Wnt-C59_GDSC1(2) | T-Lymphoblastic Leukemia	FGFR4 (6):	--2-- |  1827_Dihydrorotenone_GDSC2(4) |  2046_MK-8776_GDSC2(3) | T-Lymphoblastic Leukemia	FYN (3):	--3-- |  1006_Cytarabine_GDSC1(1) |  1426_AZD7969_GDSC1(1) |  1490_SN-38_GDSC1(1) | T-Lymphoblastic Leukemia	GNA13 (3):	--2-- |  206_Ruxolitinib_GDSC1(2) |  1007_Docetaxel_GDSC2(1) | T-Lymphoblastic Leukemia	GNAQ (4):	--2-- |  1014_Refametinib_GDSC2(2) |  1931_MIRA-1_GDSC2(3) | T-Lymphoblastic Leukemia	GNB1 (4):	--2-- |  1392_Bleomycin (10 uM)_GDSC1(3) |  1853_OF-1_GDSC2(3) | T-Lymphoblastic Leukemia	HGF (3):	--2-- |  427_Ara-G_GDSC1(1) |  1026_Tanespimycin_GDSC1(2) | T-Lymphoblastic Leukemia	HIF1A (4):	--2-- |  206_Ruxolitinib_GDSC1(2) |  1392_Bleomycin (10 uM)_GDSC1(3) | T-Lymphoblastic Leukemia	HMGA2 (4):	--2-- |  376_Brivanib, BMS-540215_GDSC1(3) |  1183_CRT0160829_GDSC1(1) | T-Lymphoblastic Leukemia	IRS2 (3):	--2-- |  362_CI-1033_GDSC1(1) |  1023_GW441756_GDSC1(2) | T-Lymphoblastic Leukemia	JAK2 (7):	--3-- |  1053_MK-2206_GDSC1(3) |  1840_630600_GDSC2(2) |  2173_PFI-1_GDSC2(4) | T-Lymphoblastic Leukemia	KDR (4):	--2-- |  1079_Dasatinib_GDSC2(3) |  2037_GSK343_GDSC2(3) | T-Lymphoblastic Leukemia	KLF5 (3):	--2-- |  206_Ruxolitinib_GDSC1(2) |  1007_Docetaxel_GDSC2(1) | T-Lymphoblastic Leukemia	LRP6 (5):	--2-- |  55_A-770041_GDSC1(4) |  262_VX-11e_GDSC1(3) | T-Lymphoblastic Leukemia	MAP2K1 (4):	--2-- |  1259_Talazoparib_GDSC1(1) |  1079_Dasatinib_GDSC2(3) | T-Lymphoblastic Leukemia	MAP2K2 (3):	--3-- |  1001_AICA Ribonucleotide_GDSC1(1) |  1007_Docetaxel_GDSC2(1) |  1021_Axitinib_GDSC2(1) | T-Lymphoblastic Leukemia	MLLT10 (7):	--2-- |  55_A-770041_GDSC1(5) |  1392_Bleomycin (10 uM)_GDSC1(4) | T-Lymphoblastic Leukemia	MLLT3 (4):	--2-- |  206_Ruxolitinib_GDSC1(2) |  1392_Bleomycin (10 uM)_GDSC1(3) | T-Lymphoblastic Leukemia	MSI2 (4):	--2-- |  262_VX-11e_GDSC1(3) |  1392_Bleomycin (10 uM)_GDSC1(3) | T-Lymphoblastic Leukemia	MYC (5):	--2-- |  55_A-770041_GDSC1(4) |  1079_Dasatinib_GDSC2(4) | T-Lymphoblastic Leukemia	NRAS (6):	--2-- |  1015_CI-1040_GDSC1(4) |  2010_HKMTI-1-005_GDSC2(3) | T-Lymphoblastic Leukemia	PAX8 (5):	--2-- |  1732_TAF1_5496_GDSC2(4) |  2046_MK-8776_GDSC2(2) | T-Lymphoblastic Leukemia	PDGFRA (3):	--2-- |  1495_Olaparib_GDSC1(2) |  1739_JAK_8517_GDSC2(1) | T-Lymphoblastic Leukemia	PDGFRB (3):	--2-- |  362_CI-1033_GDSC1(1) |  1023_GW441756_GDSC1(2) | T-Lymphoblastic Leukemia	PIK3CD (6):	--3-- |  62_BMS-536924_GDSC1(4) |  1392_Bleomycin (10 uM)_GDSC1(4) |  2046_MK-8776_GDSC2(3) | T-Lymphoblastic Leukemia	PIK3CG (3):	--2-- |  1362_BAY ACCi_GDSC1(2) |  1495_Olaparib_GDSC1(2) | T-Lymphoblastic Leukemia	PLCG1 (3):	--2-- |  206_Ruxolitinib_GDSC1(2) |  1007_Docetaxel_GDSC2(1) | T-Lymphoblastic Leukemia	RET (3):	--2-- |  206_Ruxolitinib_GDSC1(2) |  1007_Docetaxel_GDSC2(1) | T-Lymphoblastic Leukemia	RPS6KA4 (6):	--2-- |  376_Brivanib, BMS-540215_GDSC1(4) |  1778_GSK2110183B_GDSC2(5) | T-Lymphoblastic Leukemia	RUNX1T1 (5):	--3-- |  1070_CRT0105950_GDSC1(2) |  1052_RO-3306_GDSC2(2) |  2159_UNC0379_GDSC2(2) | T-Lymphoblastic Leukemia	SCG5 (3):	--2-- |  206_Ruxolitinib_GDSC1(2) |  1007_Docetaxel_GDSC2(1) | T-Lymphoblastic Leukemia	SF3B1 (4):	--2-- |  1392_Bleomycin (10 uM)_GDSC1(3) |  1853_OF-1_GDSC2(3) | T-Lymphoblastic Leukemia	SGK1 (3):	--2-- |  206_Ruxolitinib_GDSC1(2) |  1362_BAY ACCi_GDSC1(2) | T-Lymphoblastic Leukemia	SMYD3 (3):	--2-- |  1495_Olaparib_GDSC1(2) |  1739_JAK_8517_GDSC2(1) | T-Lymphoblastic Leukemia	STAT5B (6):	--2-- |  55_A-770041_GDSC1(4) |  1392_Bleomycin (10 uM)_GDSC1(4) | T-Lymphoblastic Leukemia	TLX3 (3):	--2-- |  206_Ruxolitinib_GDSC1(2) |  1007_Docetaxel_GDSC2(1) | T-Lymphoblastic Leukemia	YAP1 (4):	--2-- |  1014_Refametinib_GDSC1(3) |  1062_Selumetinib_GDSC1(3) | Thyroid Gland Carcinoma	ALK (6):	--2-- |  152_CP466722_GDSC1(5) |  1005_Cisplatin_GDSC1(5) | Thyroid Gland Carcinoma	CCNE1 (4):	--2-- |  226_GSK1070916_GDSC1(3) |  1427_AZD5582_GDSC1(3) | Thyroid Gland Carcinoma	CSF3R (6):	--2-- |  226_GSK1070916_GDSC1(3) |  356_AT7867_GDSC1(5) | Thyroid Gland Carcinoma	ERBB4 (7):	--2-- |  1170_CCT-018159_GDSC1(5) |  1183_CRT0160829_GDSC1(5) | Thyroid Gland Carcinoma	GTF2I (3):	--2-- |  185_Linsitinib_GDSC1(2) |  1190_Gemcitabine_GDSC2(1) | Thyroid Gland Carcinoma	JAK3 (5):	--2-- |  152_CP466722_GDSC1(4) |  203_BMS-345541_GDSC1(3) | Thyroid Gland Carcinoma	MKI67 (5):	--2-- |  156_AZD6482_GDSC1(3) |  203_BMS-345541_GDSC1(3) | Thyroid Gland Carcinoma	MTOR (5):	--2-- |  225_Genentech Cpd 10_GDSC1(4) |  1005_Cisplatin_GDSC1(4) | Thyroid Gland Carcinoma	NRAS (3):	--2-- |  185_Linsitinib_GDSC1(2) |  1190_Gemcitabine_GDSC2(1) | Thyroid Gland Carcinoma	PDGFRB (4):	--2-- |  1185_KU-60019_GDSC1(3) |  1617_AZD5582_GDSC2(3) | Thyroid Gland Carcinoma	PIK3CD (3):	--2-- |  376_Brivanib, BMS-540215_GDSC1(2) |  1414_Fulvestrant_GDSC1(2) | Thyroid Gland Carcinoma	PLCG1 (4):	--2-- |  226_GSK1070916_GDSC1(3) |  1561_Taselisib_GDSC2(3) | Thyroid Gland Carcinoma	RUNX1T1 (5):	--2-- |  152_CP466722_GDSC1(4) |  303_PIK-93_GDSC1(4) | Thyroid Gland Carcinoma	UBR5 (5):	--2-- |  295_NVP-BHG712_GDSC1(3) |  306_Fedratinib_GDSC1(4) | 